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ABSTRACT 
Brominated flame retardants (BFRs) are synthetic compounds which are added to consumer and 
industrial products to inhibit the propagation of fire.  Several of the most predominantly used 
BFRs have been banned or phased out of use due to their toxicity, persistence in the 
environment, and potential to bioaccumulate.  Novel brominated flame retardants (NBFRs) are 
replacement compounds of legacy BFRs and are generally designed to be less bioaccumulative 
and persistent in the environment.  The NBFRs, bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate 
(TBPH), 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB), and 1,2,5,6-tetrabromocyclooctane 
(TBCO) are components of several flame retardants mixtures including Firemaster® 550 and 
Saytex® BC-48 and are (potential) major replacements of legacy BFRs. These compounds have 
been detected in the outdoor and indoor environments, in tissues of wildlife, and serum/tissues of 
humans, though little information exists regarding potential toxicities and concentrations of these 
compounds in the indoor environment. Therefore, the aim of this research was to characterize 
toxicities of these compounds and investigate important parameters of exposure in early 
childhood environments (ECEs).  Preliminary characterization of toxicities of TBPH, TBB, and 
TBCO focused on potential endocrine disrupting effects as these compounds were structurally 
similar to known endocrine disrupting compounds (EDCs).  The screening level investigations of 
toxicity employed cellular assay systems to determine binding activities with hormone receptors 
and modulation of production of sex steroid hormones. Results obtained with these in vitro 
assays demonstrated potentials of NBFRs to modulate endocrine function through interactions 
with estrogen and androgen receptors and via alterations to the synthesis of 17-β-estradiol and 
testosterone.  Therefore, further characterization of endocrine disrupting effects of these NBFRs 
was warranted.  Short-term fish fecundity assays coupled to investigations of molecular 
mechanisms of effect along the hypothalamus-pituitary-gonadal-liver (HPGL) axis confirmed 
that TBPH, TBB, and TBCO affected normal endocrine functions.  Exposure to a mixture of 
TBPH:TBB or TBCO reduced fecundity of Japanese medaka (Oryzias latipes) and caused 
alterations in transcript abundances of genes across the HPGL-axis.  Though no distinct 
mechanisms of effects were determined, a pattern of down-regulation of genes across all tissues 
of the HPGL-axis was observed following exposure to the mixture of TBPH:TBB, while 
exposure to TBCO alone elicited organ-specific and dose-dependent alterations of expression of 
genes involved in steroidogenesis, metabolism of cholesterol, and estrogen signaling.  
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Concentrations of TBPH and TBB in dust from ECEs collected during summer and winter were 
determined to elucidate important factors of exposure of children.  Novel hydroxylated isomers 
of TBPH and TBB were detected and characterized in dust from ECEs for the first time.  
Concentrations of TBPH, TBB, OH-TBPHs, and OH-TBBs in dust from ECEs from Saskatoon, 
SK, Canada were among the greatest reported globally though no seasonal differences in 
concentrations of compounds in dust were observed. Greater concentrations of these NBFRs 
were detected in microenvironments with greater numbers of children’s toys which indicated that 
concentrations in dust might be related to increases in density of these consumer products. To 
further characterize exposure of children to NBFRs, bioaccessibilities of TBPH, TBB, OH-
TBPHs, and OH-TBBs in dust from ECEs were assessed in an in vitro incubation assay system.  
TBPH and OH-TBPHs were minimally bioaccessible where TBB and OH-TBBs were 
moderately-highly bioaccessible, which indicated that TBPH and OH-TBPHs would not likely 
be readily bioavailable from dust in in vivo systems.  The data generated in this thesis is 
important to inform accurate assessments of risk of these novel brominated flame retardants. 
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PREFACE 
Chapter 1 is a general introduction and literature review regarding the topics of flame retardants, 
novel brominated flame retardants, their toxicities and prevalence in the indoor and outdoor 
environments, and relevant characteristics of exposure. Chapter 1 also includes the overall goals 
and objectives of the project and each study in particular, and includes null hypotheses.   
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1.1 Flame retardants 
Uncontrolled fires are major sources of damage to property and loss of life.  In 2007 in the 
United States alone, uncontrolled fires resulted in $14 billion in damages and over 3,000 deaths1.  
Many of these fires were likely due to the use of greatly flammable materials, which included 
synthetic polymers and electronics that were incorporated into consumer and industrial products.  
In efforts to limit uncontrolled fires and their subsequent damage, industries within several 
countries, which included Canada and the U.S., developed strict standards of fire retardancy that 
required the addition of flame retardant chemicals to consumer and industrial materials.  In 1975, 
the California State government proposed Technical Bulletin 117 (TB 117), which required 
upholstered furniture and children's products to withstand a small open flame for 12 seconds, a 
feat that was generally achieved through the addition of flame retardant compounds.  Due to the 
scale of the Californian economy, several manufacturers have applied the standards of TB 117 to 
all products destined for North American markets.  There were several classes of flame 
retardants which included a variety of inorganic compounds, most notably metal oxides and 
aluminum trihydrate, that accounted for 50% of the global annual production of FRs, 
phosphorous and nitrogen flame retardants which together accounted for 25%, and halogenated 
flame retardants which accounted for 25%2. Of the halogenated flame retardants, brominated 
flame retardants (BFRs) had the greatest magnitude of total production volume and were most 
frequently added to consumer and industrial materials3.   
Halogenated flame retardants inhibit the propagation of fire via the halogen atom's 
interaction with free radicals. These free radicals are formed during the combustion process and 
act as oxidizing agents.  Halogens are effective at trapping free radicals, thereby reducing the 
capability of the fire to propagate.  All four halogens can effectively interact with free radicals, 
but bromine's properties which include a greater trapping efficiency than chlorine and fluorine 
and a greater decomposing temperature than iodine, are the best suited to the requirements of 
flame retardants.  Brominated flame retardants can be divided into three categories: additive, 
reactive, and polymeric, designations which depend on their mode of incorporation into the 
polymer1.   Additive BFRs are mixed with the components of a polymer and tend to leach over 
time whereas reactive and polymeric BFRs are chemically bonded or incorporated directly into 
the backbone of molecules and are more resistant to release2.  Due to their tendency of leaching 
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into the environment and potential effects on health of humans and ecosystems, additive BFRs 
are the focus of this program of study. 
1.2 Brominated flame retardants 
Brominated flame retardants are added to numerous products that range from home electronics, 
furniture, polyurethane foam, and children’s toys to industrial cables, plastics, and textiles4.   
There are over 75 brominated compounds that are listed as flame retardants, which include the 
current major use BFRs tetrabromobisphenol-A (TBBPA), hexabromocyclodecane (HBCD), and  
deca-polybrominated diphenyl ethers (DecaBDEs) (Figure 1.1)4.  From 1992 to 2000 total annual 
global production of BFRs increased by 207% (Table 1.1).  In the same period, production of 
TBBPA increased from 33% of total BFRs to 68% of total annual production, which makes this 
compound the greatest volume produced globally.  Based on total production of BFRs in 2001 
and market estimates of HBCD production in 2000, HBCD comprised roughly 5.4% of annual 
total BFR production and is the second greatest volume BFR used in Europe5. 
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Figure 1.1. Chemical structures of the major BFRs, TBBPA, HBCD, and Deca-BDE. 
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Table 1.1.  Estimated global production volumes of total BFRs, TBBPA, ƩHBCDs, and 
ƩPBDE congeners for years 1992, 2000, and 2001. 
Compound Volume (tonnes/yr) Year Reference 
ΣBFRs 150 000 1992 4 
 >310 000 2000 2 
TBBPA 50 000 1992 2, 4 
 210 000 2000  
ΣHBCD 16 700 2001 6 
ΣPBDEs 16 700 2001 7 
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Several high production volume BFRs including HBCD, and the Penta-, Octa-, and  
Deca- formulations of polybrominated diphenyl ethers (PBDEs) are ubiquitous in the 
environment and accumulate in wildlife and humans8.  PBDEs and HBCD have been detected 
air, sediment, soil, and sewage sludge in Asia7, 9, North America10-14, and Europe8, 15-19 and in 
fish15, fish eating birds19, 20, marine mammals19-21, and adipose tissues, serum, and mother’s milk 
of humans4, 22-25.  Among the major-use BFRs, PBDEs and HBCD were of particular interest 
because of their larger volumes of production, ubiquity in the environment, and toxic potencies.  
Potential and known effects of PBDEs which include, endocrine and thyroid modulation, 
abnormal development, and neurotoxicity25, have led to global actions imposed on PBDE 
mixtures. Polybrominated diphenyl ethers were the most widely produced and distributed BFRs 
until 2004 when manufacturing of two of three technical mixtures was discontinued in the U.S.; 
in 2009, these mixtures were subsequently added to the list of Persistent Organic Pollutants 
(POPs) under the international Stockholm Convention1.  PentaBDE and OctaBDE technical 
mixtures were phased out of production and importation to North America and Europe.  The 
remaining technical mixture, DecaBDE,  has been banned in electrical equipment in the EU and 
was phased out of production and importation to the U.S. by 201326.  HBCD was also considered 
bioaccumulative, persistent, and was shown to cause harmful reproductive and developmental 
effects, as such, the EU's REACH program mandated the phase-out of HBCD from Europe by 
201526.  Though many countries, which included Canada and the U.S., have phased out the use 
of several formulations of PBDEs, global demand for BFRs has continued to rise, with a 5% 
annual increase in production in 20059.  Consequently, the production and consumption of 
replacement brominated flame retardants might increase drastically. 
1.3 Novel brominated flame retardants 
Withdrawal of PBDEs from North American markets led to increased production of non-PBDE 
BFRs which include novel brominated flame retardants (NBFRs)27.  Recent investigations show 
that many replacement NBFRs have similar potential for long-range atmospheric transport 
(LRAT)27, environmental persistence, and bioaccumulation28, however, environmental fates of 
these replacement compounds remain unclear.  Many NBFRs are derivatives of existing BFR 
chemical structures. Some NBFRs are designed to have greater molecular weights, molecular 
sizes, and log Kows (Figure 1.2), which has implications for their bioavailabilities and presence in 
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aquatic systems.  These large NBFRs have theoretical log Kows of 8-12 which, due to bulkiness 
and extreme hydrophobicity, might limit the molecules’ bioavailability and bioaccumulation, but 
increase their persistence in the environment.  In spite of these physical-chemical characteristics, 
several NBFRs have been discovered in biotic and abiotic samples1, though few toxicological 
data and environmental measurements yet exist.  More information is required to understand the 
toxicological profiles, transportation mechanisms, and fate of these NBFRs.  To date, the most 
intensively studied emerging NBFRs are: 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB or 
TBB), bis(2-ethylhexyl)-3,4,5,6-tetrabromophthalate (BEH-TEBP or TBPH),  1,2-bis-(2,4,6-
tribromophenoxy)ethane (BTBPE), decabromodiphenyl ethane (DBDPE), and the 
tetrabromobisphenol A derivatives:TBBPA-2,3-dibromopropyl ether (TBBPA-DBPE), TBBPA-
dihydroxyethyl ether (TBBPA-DHEE), and TBBPA-bis (allyl ether)  (TBBPA-DAE) (Figure 
1.2). 
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Figure 1.2. Chemical structures of major replacement NBFRs, BTBPE, DBDPE, TBBPA-
DBPE, TBBPA-DHEE, and TBBPA-DAE. 
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1.4 Selection of novel brominated flame retardants 
Criteria for the selection of NBFRs to include in the current program of study were as follows: 
The compound should have, (a) moderate to high production volumes. The production volumes 
are defined by use of EU definitions of high production volume (HPV), chemicals produced 
above 1000 tonnes/yr; (b) indications of potential persistence, bioaccumulation, or toxicities 
from studies of analogous compounds or via modeling software (i.e. PBT profiler, EpiWeb 4.1).  
Concurrently the NBFRs must have few toxicological data which represents a relevant gap in 
knowledge; and (c) the compounds should be detected in abiotic/biotic environmental samples.  
Three NBFRs adequately fit these simple criteria: TBPH, TBB, and tetrabromocyclooctane 
(TBCO) (Figure 1.3).  
TBB and TBPH are additive flame retardants and are components of the technical 
mixtures Firemaster® 550 (35% TBB, 15% TBPH), Firemaster® BZ-54 (70% TBB, 30% TBPH), 
and DP-45 (TBPH only), marketed by the Chemtura Corporation29, 30.  TBCO is an additive 
flame retardant and is a component of Saytex® BC-48, marketed by the Albermarle 
Corporation31.  Firemaster® 550 is used as a replacement for PentaBDE mixtures in polyurethane 
foams, PVC, and neoprene and TBPH has been used as a plasticizer and listed as a high 
production volume chemical by the U.S. EPA30.  From 1990 to 2006, TBPH had a U.S. 
production volume of 450 – 4,500 metric tons/yr31 but there is little data on the production 
volumes of TBB.  TBCO is mainly employed as an additive flame retardant in textiles, paints, 
and plastics32, and there is currently no information regarding production volumes.  TBCO is on 
the Canadian Environmental Protection Act’s non-domestic substances list with as much as 10 
tons/yr currently imported into Canada and is a potential replacement compound for HBCD32, 33.      
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Figure 1.3. Chemical structures of selected NBFRs, TBB, TBPH, and TBCO included in 
subsequent studies. 
 
 
 
 
 
 
 
 
12 
 
1.4.1 Detection of novel brominated flame retardants in the environment 
Certain NBFRs, which include TBPH, TBB and TBCO, have similar potentials for 
bioaccumulation, persistence, and long-range atmospheric transport as PBDEs and HBCD30, 34, 35.  
For example TBPH and TBB have both been detected in several environmental matrices, which 
include dust, air, and biota and have been listed as NBFRs relevant for further investigation and 
monitoring in the Norwegian environment36.  From 2008 to 2010, as part of the Integrated 
Atmospheric Deposition Network (IADN), TBPH and TBB were detected in the particle-phase 
at six locations near the North American Great Lakes, and in urban areas from Chicago and 
Cleveland30.  The study showed that concentrations of both TBPH and TBB in the atmosphere 
increased rapidly during the two year sampling period, which indicated that use and/or 
accumulation of these NBFRs was increasing.  As of 2011, the two compounds have also been 
detected in samples from the Global Atmospheric Sampling (GAPS) Network37, in house dust in 
the U.S.38, and indoor dust in New Zealand39. TBPH and TBB have been detected in 
polyurethane foam in retail baby products in the U.S. as the second most abundant BFRs40, and 
were detected in couch foam at 4.2% by weight of flame retardant41. Both compounds were 
detected in sewage sludge from wastewater treatment plants in San Francisco, California31, and 
TBPH alone was detected in environmental samples from the high arctic34. TBB and TBPH have 
been discovered in biota, which included blubber from humpback dolphins (mean: <0.04 ng/g, 
lw; 0.51 ± 1.3 ng/g, lw)  and finless porpoises (mean: 5.6 ± 17 ng/g, lw; 342 ± 883 ng/g, lw) from 
Hong-Kong, South China42, in filter feeding bivalves (2220 ng/g, lw; 1370 ng/g, lw) , and 
grazing gastropods (1740 ng/g, lw; 380 ng/g, lw) collected downstream from a textile 
manufacturing outfall26. TBPH has also been detected in 89% of sampled livers from ring-billed 
gull collected from an industrialized section of the St. Lawrence River downstream from 
Montreal, Canada35.  The ring-billed gull samples from the St. Lawrence site boast both the 
greatest detection frequency of TBPH and the greatest concentration in any avian species (17.6 
ng/g, ww).  TBCO was detected in herring gull eggs in the North American Great Lakes, though 
it could not be quantified27. TBCO was classified as a potential aquatic hazard and a very 
persistent and bioaccumulative substance. As such, it was surprising that few data had been 
collected regarding its occurrence in environmental and biotic matrices.  Though data which 
exhibited the deposition and concentrations of TBPH, TBB, and TBCO in biotic and abiotic 
environments have been collected, there have been few investigations of their potential toxicities. 
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1.4.2 Toxicities of TBPH, TBB and TBCO 
There are limited data regarding sub-lethal toxicities of TBPH, TBB, and TBCO.  TBPH and 
TBB are brominated analogues of bis(2-ethylhexyl)-phthalate (DEHP) and 2-ethylhexyl 
benzoate (EHB) respectively.  DEHP, is a known toxicant and endocrine disrupting compound 
(EDC) and is a controlled substance in Canada.  Both TBPH and TBB have been observed to 
undergo sequential debromination in photodegradation experiments43.  Total debromination of 
TBPH which leads to the formation of DEHP is possible, and requires further investigation due 
to DEHP’s noted biological effects.  DEHP and its active metabolites have several sub-lethal 
toxicological effects which include, endocrine disruption44, reproductive dysfunction45, 46,  
activation of the aryl hydrocarbon receptor44, 47,  and peroxisome proliferation48.  The potential 
endocrine disruption and ability to affect functions of biological pathways of reproduction of 
DEHP has been tested in several fish species.  A Zebrafish (Danio rerio) in vitro hepatocyte 
assay system has been used to measure reproductive dysfunction caused by DEHP.  Researchers 
measured modulation of transcript abundances of the estrogen receptor (ER) and production of 
vitellogenin (VTG).  DEHP exposures resulted in significant increases of VTG in male/female 
hepatocytes, though no definitive pattern was observed regarding modulation of ER48. DEHP 
also affected reproduction of fishes by altering sexual behaviours, egg production, circulating 
hormone concentrations, and VTG synthesis, a marker of exposure to estrogen-like compounds.  
In a recent experiment, exposure of Chinese rare minnow (Gobiocypris rarus) to DEHP, resulted 
in greater circulating concentrations of testosterone (T) and 17-β-estradiol (E2) with increased 
abundances of transcripts of Cyp17 and Cyp19a in female fish and male gonads49. Transcription 
of VTG was also increased in liver of both male and female fish.  Exposures of Japanese medaka 
(Oryzias latipes) to DEHP caused decreases in gonadal-somatic indices, decreases in 
concentrations of VTG in blood, and a reduction in the percentage of females with mature 
oocytes in ovaries50.  The anti-estrogenic potential of DEHP might arise from competition with 
endogenous compounds for interaction with the ER, while the perturbation of oocyte growth and 
maturation signals have been proposed as mechanism of a decreased ratio of mature oocytes in 
female ovaries51.   DEHP is a non-brominated structural analog to TBPH and the NBFR might 
elicit similar toxic effects, as such, it is surprising there are limited data regarding potential 
toxicities of TBPH. 
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While few investigations of toxic effects of TBPH and TBB exist, those studies which 
have tested sub-lethal endpoints generally exposed test system to the technical mixtures, 
Firemaster® 550 and Firemaster® BZ-54.  Though TBPH and TBB are principle components of 
these technical mixture, due to the proprietary nature of these formulations, there is little 
information regarding total components of the mixture. Recent studies have identified at least 
four components of Firemaster® 550: triphenyl phosphate (TPP), mixtures of isopropylated 
triphenylphosphate isomers (ITPs), TBPH, and TBB38, 40.  These previously unidentified flame 
retardants, TPP and mixtures of ITPs, have associated toxicological properties. Thus exposure to 
technical mixtures represent the mixed toxicities of all components.  These mixed effects might 
be additive, synergistic, or antagonistic, and cannot represent single component toxicities. Indeed 
due to differences in the physical-chemical properties of these four components, the compounds 
would likely enact differing toxicities, differ in partitioning, and differ in their bioavailabilities 
and bioaccumulative properties.  Though exposures to technical mixtures are useful, they are 
limited in that they cannot identify mechanisms of toxic effect due to potential interactions of the 
components and alterations to toxicities.  Therefore, interpretation and use of toxicological data 
produced from exposure to technical mixtures requires caution. 
Recent studies of the toxic effects of TBPH and TBB have demonstrated potential 
endocrine disrupting properties of these compounds.  Rats exposed to environmentally relevant 
concentrations of the Firemaster® 550 mixture (1000 μg/day) have shown a 65% increase in 
concentrations of serum thyroxin, advanced female pubertal onset, and weight gain52.  This study 
was one of the first to observe endocrine disrupting effects in terrestrial mammals following 
exposure to Firemaster® 550 at concentrations less than the no-observed-adverse-effect-level 
(NOAEL) previously reported by the manufacturer.   Due to the toxicities of DEHP, researchers 
isolated TBPH for further toxicological investigations.  A yeast in vitro assay system was used to 
determine potential agonism or antagonism of TBPH to the estrogen and androgen receptors 
(ER/AR)53.  The yeast assay demonstrated no agonistic or antagonistic effects to either receptor 
at all concentrations of TBPH.  Because the yeast assay is a receptor mediated system, these 
results have implications regarding the mode of endocrine disruption of TBPH.  The major 
metabolite of TBPH, mono-(2-ethylhexyl) tetrabromophthalate (TBMEHP) was also tested in in 
vivo systems for potential toxicities54.  Pregnant rats were exposed to TBMEHP for two days 
which resulted in hepatotoxicity and maternal hypothyroidism with decreased triiodothyronine 
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(T3) serum concentrations.  Similar to DEHP, the bioactivation and subsequent metabolites of 
TBPH might have greater toxicological implications than the parent compound.  A single 
investigation which exposed fish to TBPH was conducted; fathead minnow (Pimephales 
promelas) were exposed to the Firemaster® 550 and Firemaster® BZ-54 at 1 mg fish/day29.  DNA 
damage, specifically DNA strand breaks, were detected in liver cells during exposure to both 
Firemaster® formulations, while the effect was lost during subsequent depuration.  Both technical 
mixtures adversely affected DNA integrity in fish, though any of the noted components of the 
mixtures might have caused the observed effects.  These investigations represent the breadth of 
information regarding toxic effects of TBPH and TBB and have successfully demonstrated 
potential toxicities of these compounds as well as a current gap in toxicological knowledge.  
Based on EU criteria TBCO is a potential aquatic hazardous substance and is characterized as a 
potentially persistent and bioaccumulative compound55.  Though TBCO is a potential aquatic 
hazard, there exists no sub-lethal data regarding the toxicological profile or potency of this 
compound.  
1.5 Novel brominated flame retardants in the indoor environment   
TBPH, TBB, and TBCO are found in consumer products which include paint, insulation, textiles, 
polyurethane foams, and adhesives3, 30, 31 and have been detected in several environmental 
matrices30, 36, 37. Though these NBFRs have been detected in the outdoor environment, BFRs are 
distinguished from other POPs, such as PCBs, as exposures are principally from indoor sources.  
BFRs likely migrate from consumer products and partition to dust and air via several processes 
which include, chemical (volatilization – adsorption) and mechanical (abrasion or direct contact). 
The processes by which these compounds migrate to dust have implications for distribution 
within the indoor environment, seasonal changes in concentrations, and bioavailability. Though 
we are aware of these emission processes, little is known about indoor partitioning, distribution, 
and exposures to NBFRs and few studies have investigated the presence and concentrations of 
TBPH, TBB, and TBCO in house dust38, 39, 56. Concentrations of these NBFRs in dust are 
important to exposure characterization and subsequent assessments of risk as dust is considered a 
relevant vector of exposure; pharmacokinetic models have suggested up to 82% of total BFR 
exposure in children might be of dust origin57.  Due to recent global restrictions on legacy BFRs, 
production of these NBFRs is expected to increase, thus investigations are required to report 
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concentrations of these compounds in indoor dust and monitor potential changes.  As of 2011, 
there are few data regarding concentrations of TBPH, TBB, or TBCO in house or office dust, 
and to our knowledge, there exists no data regarding concentrations in dust at Canadian sites 
(Table 1.2).  Additionally, little data exists regarding concentrations of these NBFRs in dust from 
early childhood environments (ECEs), such as childcare centers or schools.  Those data that do 
exist for homes or offices show that TBPH and TBB are detected at concentrations roughly one 
order of magnitude lower than PBDEs38. This data paired with time course monitoring 
experiments indicate these compounds might not have yet reached peak production volumes.  
Indeed, a recent investigation of house dust documented an approximate 2-fold increase in 
concentrations of TBPH and TBB from 2006 to 2011 (Table 1.2)56.  Dust is an important vector 
of exposure for BFRs, thus, investigations into current concentrations and documentation of 
potential shifts with increases in production of NBFRs are required.   
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Table 1.2. Median concentrations of TBPH, TBB, and TBCO reported in indoor dust (ng/g, 
dust) 
Country Location TBPH TBB TBCO Reference 
U.S. Homes 142 133 - 38 
U.S. Homes 140 48 <2 56 
U.S. Homes 260 100 <d.l 56 
UK School 96 25 - 58 
Belgium Homes 13 1 - 58 
Belgium Offices 64 7 - 58 
New Zealand Homes 12 2 - 39 
Pakistan Homes 3.5 0.03 - 59 
‘<d.l’ – below limit of detection 
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1.5.1 Dust as an important vector of exposure to brominated flame retardants 
Initial investigations into sources and human exposure pathways of BFRs used studies of 
organochlorines as reference models.  Humans are exposed to dioxins primarily through outdoor 
and dietary sources60. BFRs challenge this paradigm as the primary route of exposure is likely 
from dietary and indoor sources such as, electronics, furniture and other consumer products. 
Indications of this paradigm shift arose from the discrepancies discovered between food intake of 
PBDEs and concentrations found in serum57, 61.  Scientists noted that food could not account for 
total body burdens of PBDEs, and concluded there were likely other sources of exposure. For 
example, concentrations of PBDEs in food and differences in consumption rates could not 
explain differences in serum concentrations of PBDEs between North Americans and 
Europeans62.  Concentrations of PBDEs in dust and serum were compared in California and 
Massachusetts63. Median concentrations of PBDEs in Californian house dust were 4 to 10 times 
greater than previously reported in the U.S., and serum concentrations of Californian residents 
were nearly 2-fold greater than residents of Massachusetts. These elevated concentrations of 
PBDEs in dust from California were likely due to TB 117. 
Despite growing evidence of indoor dust as a relevant vector of exposure of BFRs, 
attempts to correlate concentrations between dust and serum have been hindered.  Error in 
attaining correlative significance was likely due to the inherent variability and challenges of dust 
collection and variability in type and quantity of FRs added to consumer products.  For example, 
many preliminary investigations sampled dust by collection of vacuum bags from participants62.  
This method was cost-effective, simple, and enhanced participation from the public as it did not 
require researchers to enter the home.  However, samples collected from vacuum bags did not 
accurately reflect exposure scenarios, because dust from numerous microenvironments was 
integrated into a single sample60.  This integration might have reduced the accuracy of exposure 
assessments if there were varying durations spent in each room or if concentrations of BFRs 
differed between rooms.  Such issues in dust sampling techniques introduced measurement error 
that might have obscured potential relationships between concentrations of BFRs in dust and 
serum.  Though many challenges were encountered in sample collection, several studies have 
observed significant correlations between concentrations of BFRs in dust and serum.  For 
example, Swedish researchers have reported significant differences in serum concentrations of 
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PBDEs in the population, though they were not able to link the differences to occupational or 
dietary factors.  In an investigation of different households and dust, researchers reported a 
positive linear relationship between concentrations of ΣPBDEs in dust and plasma64.  However, 
the relationship was significantly dependent on one observation.  In a Belgian study of adults 
with duplicate diets, concentrations of HBCD in dust, but not diet, were significantly, positively 
correlated with those in serum65.  A Danish study of 51 pregnant women from Copenhagen 
determined concentrations of PBDEs in maternal and umbilical cord plasma and house dust.  
Positive correlations were found for ΣPBDEs in maternal and umbilical cord plasma and house 
dust66.  One of the only associations with PBDE body burdens and dust in North America was 
conducted in the Greater Boston Area of Massachusetts67.  Breast milk from 46 first time 
mothers and a subset of house dust was collected and analyzed for PBDEs.  The researchers 
found a significant positive association between concentrations of PBDEs, excluding BDE 209, 
between the two sample groups.  Another European study of Danish participants observed a 
significant positive correlation between concentrations of BDE-47 in dust and placental tissue, 
though the correlation did not exist for any other congener68.   
Significant positive correlations between concentrations of BFRs in dust and serum 
support dust as an important vector of exposure.  As of yet, there are no standard methods for 
dust collection, which might affect future investigations of concentrations in house dust and 
assessments of risk60. Given the benefits and disadvantages of each sampling method, and 
uncertainty regarding their relevance, there is yet insufficient information to develop a standard 
method of sample collection.  Additionally, in any assessment of exposure, the predicted 
ingestion rates of dust are generally conservative (protective). The daily intake for dust is 
estimated at 60-100 mg/day for small children (1-4 yr) and 50 mg/day for adults69.  The 
estimated dust ingestion rate used in most risk assessments of dust is based on a small number of 
primary studies designed to derive estimates of soil ingestion.  These intake estimates generally 
do not account for different densities and organic content of the matrix or differences in time 
spent indoors or outdoors.  These latter parameters are important for Canadian populations as in 
winter months, time spent indoors can increase to > 90%61.   These predicted ingestion rates 
might skew exposure estimates for at-risk populations which include children. 
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1.5.2 Exposure of children to brominated flame retardants 
Young children are a susceptible population and are at greater risk of exposure to BFRs than 
adults. There has recently been greater attention regarding BFRs in dust at ECEs (childcare 
centers and schools)70.  It has been noted by several researchers that children generally have 
greater body burdens of BFRs than adults71-73.  For example, measurements of PBDE congeners 
in serum from 2-5 yr children in California discovered concentrations that were 2 to 10 times 
greater than in most adults in the U.S.74.  Increased body burdens in children might be partially 
explained by increased exposures to dust. Young children exhibit greater exploratory behaviours 
which include hand-to-mouth actions and other activities that place them in direct contact with 
contaminated surfaces. Young children generally have greater associations with floors/surfaces, 
and have poor hygienic practices.  Children also have smaller body masses relative to adults, 
breathe more air, and eat more food per unit of body mass75.  In addition, small children are 
susceptible to the adverse effects of BFRs because they are still developing and have not matured 
immunologically and physiologically.    
In North America, young children spend a great amount of time in ECEs.  Many young 
children spend as much as ten hours per day, five days per week in child care and preschool 
centers.  In California alone there are over 49 000 licensed childcare facilities with 80% listed as 
family run centers located in homes75.  By kindergarten over 50% of all children attend some 
licensed childcare facility.  Recent studies indicate that childcare facilities might be sources of 
contaminants that are hazardous to children's health75, 76.  Greater exposure of children to BFRs 
in care facilities might be due to the relatively greater amounts of children's products and toys 
within.  A research group from North Carolina recently detected great concentrations of BFRs in 
78% of all children's products tested40 with detection frequencies of TBPH and TBB at roughly 
17%.  TBPH and TBB are replacement compounds for Penta-BDE mixtures, and as such, are 
added to polyurethane foam products.  Due to the clumsy nature of children, many products 
including furniture and toys contain polyurethane foam.  It has also been discovered that in 
California some baby products are considered juvenile furniture, and as such, must comply with 
the stringent fire-safety standards of TB 11740.  The amount of time spent in childcare facilities 
coupled with increased densities of children's products that generally contain great quantities of 
BFRs likely result in increased exposures to children, and might explain heightened 
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concentrations of BFRs in children's serum.  Children represent a relevant demographic for 
characterization of exposure to BFRs.  But due to ethical and practical purposes there are limited 
studies that have attempted to correlate dust and serum concentrations of these compounds in 
children.  Some researchers have used organisms that mimic environmental exposures and 
behaviour patterns of children.  In California, serum congener profiles of PBDEs in house cats 
correlated significantly with congener profiles in house dust, but did not correlate with dietary 
congener patterns, which indicates a non-dietary source of PBDE exposure77.  Though the study 
did not mention differential metabolism of PBDEs between organisms or differences in time 
spent indoors/outdoors, it represented new research that attempted to address relevant gaps in 
current knowledge of BFR exposures.   
1.6 Conclusions 
Due to recent global regulations which have banned all congener formulations of PBDEs, and 
increased scrutiny of HPV compounds such as HBCD, there have been increases in production 
of several NBFRs.  The increased production of these compounds was accompanied by increases 
in frequencies of detection, and concentrations detected in biotic and abiotic environmental 
samples.  In silico modeling predicted similar physical-chemical characteristics of many NBFRs 
and legacy BFRs which would have implications for a NBFR’s persistence, bioaccumulation, 
and toxicological profiles.  The NBFRs, TBPH, TBB, and TBCO were selected as candidate 
compounds for this program of study due to their high production volumes, presence in 
environmental samples, and potential toxicities.  These compounds were of concern to regulatory 
entities which include Environment and Climate Change Canada, the U.S. EPA, and the 
Norwegian Pollution Control Authority and were targets in several active monitoring programs 
which include the IADN and GAPS.  There existed few toxicological data regarding these 
compounds, yet initial screening data generated from in silico and in vitro experiments indicated 
these NBFRs were potential EDCs.  Further explorations into mechanisms of toxic effects, 
whole-organism effects, and concentrations in the indoor environment are required to generate 
data to more accurately characterize toxicological profiles and potential exposures to TBPH, 
TBB, and TBCO.   
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1.7 Objectives   
The overall objective of this research program was to produce data which described the potential 
toxicities and exposures of TBPH, TBB, and TBCO to humans in the indoor environment. Two 
distinct but connected phases of research were used to characterize the hazards and risks to 
human health associated with these NBFRs.  The first phase of this research program focused on 
the characterization of toxicity of TBPH, TBB, and TBCO.  Specific goals of this phase were 
reviewed in objectives 1 and 2 (chapters 2,3,4). The second phase of this research program 
focused on the characterization of exposure to these NBFRs from the indoor environment. 
Specific goals of this phase were reviewed in objectives 3 and 4 (chapters 5 and 6). Though these 
two phases of research were distinct, together they constituted a comprehensive program of 
research which described the toxicities and exposures of these NBFRs. 
Objective 1. Generate screening level data regarding endocrine disruption and TCDD-like 
effects for TBPH, TBB, and TBCO by use of in vitro bioassays (Chapter 2). 
Little was known about the potential endocrine modulating and TCDD-like effects of TBPH, 
TBB, or TBCO. DEHP, the non-brominated analogue of TBPH is a controlled substance with 
endocrine disrupting effects which can lead to changes in fertility and fecundity and has been 
shown to interact with- and activate the AhR44, 47.   Experiments of in vitro metabolism have also 
shown that TBPH is metabolized to mono(2-ethylhexyl) tetrabromophthalate (TBMEHP)78, a 
brominated analogue of MEHP which itself was shown to affect concentrations of steroid 
hormones including estradiol and testosterone in rat ovarian follicles79, 80.  Due to similarities of 
these NBFRs with known EDCs, screening level experiments to characterize potential endocrine 
modulating effects were necessary. Therefore, the specific objectives and associated null 
hypotheses were: 
1) To determine receptor mediated endocrine disrupting effects of TBPH, TBB, and TBCO by 
use of the yeast estrogen screen (YES) and yeast androgen screen (YAS) assay systems and 
non-receptor mediated steroidogenic effects via the mammalian H295R cell model.   
H01: There are no statistically significant differences in activity of β-galactosidase in the 
YES or YAS assay between control cells and cells exposed to TBPH, TBB, or TBCO 
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H02: There are no statistically significant differences in activity of β-galactosidase in the 
YES or YAS assay between control cells activated by E2 or DHT respectively, and 
activated cells co-exposed to TBPH, TBB or TBCO. 
H03: There are no statistically significant differences in concentrations of T in H295R 
conditioned media between control cells and cells exposed to TBPH, TBB, or TBCO. 
H04: There are no statistically significant differences in concentrations of E2 in H295R 
conditioned media between control cells and cells exposed to TBPH, TBB, or TBCO. 
   2) To determine aryl hydrocarbon receptor (AhR) binding activities of TBPH, TBB, and TBCO 
by use of the H4IIE rat hepatoma cell reporter assay. 
H01: There are no statistically significant differences in AhR activity in the H4IIE assay 
between control cells and cells exposed to TBPH, TBB, or TBCO 
Objective 2. Identify potential endocrine disrupting effects of a mixture of TBPH and TBB 
or TBCO via fecundity of Japanese medaka (Oryzias latipes) and investigate potential 
mechanisms of action via expression of genes across the HPGL-axis (Chapters 3,4).   
TBPH, TBB and TBCO elicited endocrine disrupting effects in in vitro assessment of ER and 
AR activity, and via modulation of concentrations of hormones (Chapter 2).  Positive results 
from these screening level assessments necessitated further characterization of the endocrine 
disrupting effects of these compounds. Small fish models were appropriate test organisms to 
further test EDC like effects due to the significant conservation of the HPGL axis across 
vertebrates, which allowed for extrapolation of results from fish tests to predict mechanisms of 
action in other vertebrates (mammals).  Therefore these studies determined the potential 
modulation of fish fecundity and reproductive success in Japanese medaka (Oryzias latipes) 
following exposures to a mixture of TBPH and TBB or TBCO. It further investigated potential 
mechanisms of action via expression of genes along the HPGL-axis. Therefore, the specific 
objectives and associated null hypotheses were: 
1) To determine if exposure to the mixture of TBPH and TBB or TBCO alters fecundity of 
Japanese medaka (Oryzias latipes).  
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H01: There is no statistically significant difference in daily egg production between fish 
exposed to the mixture of TBPH and TBB and freshwater/solvent control fish. 
H02: There is no statistically significant difference in daily egg production between fish 
exposed to TBCO and freshwater/solvent control fish. 
H03: There is no statistically significant difference in transcript abundance of the 36 genes 
along the HPGL axis between fish exposed to the mixture of TBPH and TBB and 
freshwater/solvent control fish. 
H04: There is no statistically significant difference in transcript abundance of the 36 genes 
along the HPGL axis between fish exposed to TBCO and freshwater/solvent control fish. 
Objective 3. Detect, identify and quantify TBPH and the hydroxylated contaminants, OH-
TBPH1 and OH-TBPH2 in, analytical standards, the technical mixtures Firemaster® 550 
and BZ-54, and environmental samples (Chapter 5). 
In an effort to quantify TBPH in dust from ECEs, a new analytical method which used ultra-high 
resolution LC/MS was developed.  Due to the high resolution of the instrument, peaks which 
represented two novel compounds were observed in chromatograms from analytical standards of 
TBPH. Further examination of the technical mixtures, Firemaster® 550 and BZ-54, confirmed 
the presence of these unknown peaks.  Therefore, this study determined their chemical formula 
and structures and attempted to detect and quantify these compounds in samples of indoor dust.  
The specific objectives and associated null hypotheses were: 
1) To determine the precise chemical formulae of the two compounds and discover the 
molecular structures via fragmentation (MS2) analysis and confirm via H1 NMR. 
H01: There is no difference between predicted chemical formulae and actual chemical 
formulae derived from molecular structures of these two OH-compounds and TBPH. 
2) To determine the presence and concentrations of these compounds in environmental samples 
H01: There are no statistical differences between concentrations of the novel compounds in 
dust and procedural or laboratory blanks. 
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3) To determine differences in relative contributions of TBPH and the two novel compounds in 
technical formulations and in environmental samples. 
H01: There are no statistical differences between relative contributions of TBPH and the 
two novel compounds in technical formulations and environmental samples. 
Objective 4. Quantify TBPH, OH-TBPH1, OH-TBPH2, TBB and ƩOH-TBBs in samples of 
dust from ECEs to determine seasonal differences in concentrations and microenvironment 
specific influences. Further characterize exposure to children by determining 
bioaccessibilities of these compounds (Chapter 6). 
TBPH and TBB are endocrine disrupting compounds (Chapters 2,3) which have been detected in 
environmental samples, though few studies have attempted to quantify these compounds in dust 
from ECEs.  Further, ingestion of dust is an important exposure pathway of BFRs, particularly 
for children, though there have been few studies regarding bioaccessibilities of these compounds. 
To more accurately evaluate exposure of children to NBFRs via ingestion of dust, the oral 
bioaccessibility of NBFRs associated with dust were investigated.  Studies have shown that 
concentrations of legacy BFRs in indoor dust can differ between summer and winter and 
between microenvironments with varying amounts and types of consumer products. Therefore, 
this study attempted to determine concentrations of these compounds in ECEs and characterize 
seasonal differences or microenvironment specific influences on concentrations.  It further 
characterized the bioaccessibilities of these compounds in the dust matrix.  The specific 
objectives and associated null hypotheses were: 
1) To determine concentrations of TBPH, OH-TBPH1, OH-TBPH2, TBB and ƩOH-TBBs in 
samples of dust from ECEs in summer and winter seasons. 
H01: There are no statistical differences between concentrations of TBPH, OH-TBPH1, 
OH-TBPH2, TBB or ƩOH-TBBs in dust from ECEs in summer and winter. 
2) To determine differences in concentrations of TBPH, OH-TBPH1, OH-TBPH2, TBB or 
ƩOH-TBBs in three microenvironments in ECEs. 
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H01: There are no statistical differences between concentrations of TBPH, OH-TBPH1, 
OH-TBPH2, TBB or ƩOH-TBBs in high traffic/high toy and low traffic/low toy 
microenvironments.  
H02: There are no statistical differences between concentrations of TBPH, OH-TBPH1, 
OH-TBPH2, TBB or ƩOH-TBBs in high traffic/high toy and high traffic/low toy 
microenvironments.  
H03: There are no statistical differences between concentrations of TBPH, OH-TBPH1, 
OH-TBPH2, TBB or ƩOH-TBBs in low traffic/low toy and high traffic/low toy 
microenvironments.  
3) To determine differences in bioaccessibilities of TBPH and OH-TBPHs via the Tenax 
enhanced colon-extended, physiologically based extraction method (CE-PBET). 
H01: There is no statistical difference between bioaccessibilities of TBPH and OH-TBPHs 
in the CE-PBET model system.  
4) To determine differences in bioaccessibilities of TBB and OH-TBBs via the Tenax enhanced 
colon-extended, physiologically based extraction method (CE-PBET). 
H01: There is no statistical difference between bioaccessibilities of TBB and OH-TBBs in 
the CE-PBET model system.  
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PREFACE 
Little was known about the potential endocrine disrupting- and TCDD-like effects of TBPH, 
TBB, and TBCO. For example, DEHP, the non-brominated analogue of TBPH is a known 
endocrine disrupting compound and has been shown to interact with the AhR, though no studies 
have investigated these effects for TBPH.  The aim of Chapter 2 was to utilize in vitro screening 
level assessment tools, similar to procedures used by the U.S. EPA Endocrine Disruptor 
Screening Program (EDSP), to determine if these NBFRs elicited endocrine disrupting, or 
TCDD-like effects. Initial screening level assessments allowed for rapid determinations of 
potential endocrine disrupting effects and were necessary to ensure the appropriate use of further 
in vivo experimentation.  This chapter was included in the first phase of this research program, 
the characterization of potential toxicities of TBPH, TBB, and TBCO. 
 The content of Chapter 2 was reprinted (adapted) from Toxicology Letters, 
(10.1016/j.toxlet.2013.09.009) D.M.V. Saunders, E.B. Higley, M. Hecker, R. Mankidy, J.P. 
Giesy, “In vitro endocrine disruption and TCDD-like effects of three novel brominated flame 
retardants: TBPH, TBB, & TBCO” 223, 252-259. Copyright 2013, with permission from 
Elsevier. 
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2.1 Abstract 
The novel brominated flame retardants (NBFRs), 2-ethylhexyl-2,3,4,5-tetrabromobenzoate 
(TBB), Bis(2-ethylhexyl)-2,3,4,5-tetrabromophtalate (TBPH), and 1,2,5,6-
tetrabromocyclooctane (TBCO) are components of flame retardant mixtures including 
Firemaster® 550 and Saytex® BC-48. Despite the detection of these NBFRs in environmental and 
biotic matrices, studies regarding their toxicological effects are poorly represented in the 
literature. The present study examined endocrine disruption by these three NBFRs using the 
yeast YES/YAS reporter assay and the mammalian H295R steroidogenesis assay. Activation of 
the aryl hydrocarbon receptor (AhR) was also assessed using the H4IIE reporter assay. The 
NBFRs produced no TCDD-like effects in the H4IIE assay or agonistic effects in the YES/YAS 
assays. TBB produced a maximal antiestrogenic effect of 62% at 0.5 mg/L in the YES assay 
while TBPH and TBCO produced maximal antiandrogenic effects of 74% and 59% at 300 mg/L 
and 1500 mg/L, respectively, in the YAS assay. Significant effects were also observed in the 
H295R assay. At 0.05, 15, and 15 mg/L TBB, TBPH, and TBCO exposures, respectively 
resulted in a 2.8-fold, 5.4-fold, and 3.3-fold increase in concentrations of E2. This is one of the 
first studies to demonstrate the in vitro endocrine disrupting potentials of TBB, TBPH, and 
TBCO.  
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2.2 Introduction 
Brominated flame retardants (BFRs) are added to materials such as electronics, textiles, 
polyurethane foams, and plastics to increase their fire resistance. There are at least 175 
brominated compounds that are listed as flame retardants2 including hexabromocyclododecane 
(HBCD) and tetrabromobisphenol A (TBBPA) which had the largest worldwide production 
volumes at 22,000 tons/yr in 200327 and 170,000 tons/yr in 2004, respectively. Polybrominated 
diphenyl ethers (PBDEs) were once the most widely used BFRs, but several of the technical 
mixtures were phased-out of use in Europe, followed by several U.S. states. In an agreement 
between the U.S. EPA and chemical manufacturers, the PentaBDE and OctaBDE technical 
mixtures were voluntarily phased out of production. The two PBDE formulations were 
eventually added to the list of Persistent Organic Pollutants (POPs) under the international 
Stockholm Convention30 while the remaining technical mixture of PBDE, DecaBDE, will be 
phased out of production and importation to the U.S. by 2013.  
Withdrawal of PBDEs from North American markets has led to increased production of 
non-PBDE BFRs including novel BFRs (NBFRs)27. Though some of these replacement NBFRs 
have potential for long-range atmospheric transport, environmental persistence, and 
bioaccumulation, their environmental concentrations and toxicological effects are poorly 
represented in the literature31. Examples of NBFRs are 2-ethylhexyl tetrabromobenzoate (TBB), 
bis-(2-ethylhexyl) tetrabromophthalate (TBPH), and 1,2,5,6-tetrabromocyclooctane (TBCO). 
TBB and TBPH are components of the technical mixtures, Firemaster® 550 (35% TBB, 15% 
TBPH), Firemaster® BZ-54 (70% TBB, 30% TBPH), and DP-45 (TBPH only) marketed by 
Chemtura Corporation29, 30 and TBCO is a component of Saytex® BC-48 marketed by 
Albermarle Corporation31. Firemaster® 550, which is a technical mixture of TBPH and TBB, was 
used as a replacement for PentaBDE mixtures in polyurethane foams, and both compounds have 
been listed as high production volume chemicals by the U.S. EPA30. From 1990 to 2006, TBPH 
had a U.S production volume of 450–4,500 metric tons/yr31, but there is little data on production 
volumes of TBB or TBCO.  
Certain NBFRs including TBB, TBPH, and TBCO have similar potentials for 
bioaccumulation, persistence, and long-range atmospheric transport as PBDEs and HBCDs30, 34, 
35. For example, TBB and TBPH have both been detected in several environmental matrices 
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including dust, air, and biota and have been listed as NBFRs requiring further investigation and 
monitoring in the Norwegian environment36. From 2008 to 2010, as part of the Integrated 
Atmospheric Deposition Network, TBB and TBPH had been detected in the particle-phase at six 
locations near the North American Great Lakes, and in urban areas from Chicago and 
Cleveland30. The study showed that atmospheric concentrations of both TBB and TBPH 
increased rapidly during the two-year sampling period possibly indicating that the use and/or 
accumulation of these NBFRs was increasing. The two compounds have also been detected in 
samples from the Global Atmospheric Sampling (GAPS) Network37, in house dust in the U.S.38, 
and indoor dust in New Zealand39. TBPH and TBB have been detected in polyurethane foam in 
retail baby products in the United States as the second most abundant BFRs40, and were detected 
in couch foam at 4.2% by weight of total flame retardants41. Both compounds were detected in 
sewage sludge from wastewater treatment plants in San Francisco, California31, and TBPH alone 
was detected in environmental samples from the high arctic9. TBB and TBPH have been detected 
in biota, including blubber from hump-back dolphins (mean: <0.04 ng/g, lw; 0.51 ± 1.3 ng/g, lw) 
and finless porpoises (mean: 5.6 ± 17 ng/g, lw; 342 ± 883 ng/g, lw) from Hong-Kong, South 
China (Lam et al., 2009), in filter feeding bivalves (2220 ng/g, lw; 1370 ng/g, lw), and grazing 
gastropods (1740 ng/g, lw; 380 ng/g, lw) collected downstream from a textile manufacturing 
outfall26. TBPH has also recently been detected in 89% of sampled ring-billed gull livers 
collected from an industrialized section of the St. Lawrence River downstream from Montreal, 
Canada35. The ring-billed gull livers from the St. Lawrence site exhibit the greatest frequency of 
detection of TBPH and the greatest concentrations in any bird (17.6 ng g−1ww). TBCO has been 
detected but was not quantifiable in herring gull eggs in the North American Great Lakes27, but 
overall few data have been collected regarding the occurrence of TBCO in environmental and 
biotic matrices.  
Based on screening-level assessments using EU criteria, TBCO is a potential aquatic 
hazardous substance and is characterized as a potentially persistent and bioaccumulative 
compound55. TBCO is also included on the Canadian non-domestic Substances List with as 
much as 10 tons/yr being imported into Canada27. Though TBCO is a potential aquatic hazard, 
few data on mode of action or toxic potency are available. There are limited data regarding sub-
lethal toxicological studies for either TBPH or TBB; Fathead Minnow exposed to the technical 
mixtures, Firemaster® 550 and Firemaster® BZ-54 (1 mg fish/d), exhibited acute genotoxicity 
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with DNA damage observed in liver cells29. In a recent investigation, rats exposed to Firemaster® 
550 (1000 ug/day) exhibited a 65% increase in total concentrations of thyroxine in serum and a 
significantly advanced pubertal onset52. TBPH and TBB which are derived from bis(2-
ethylhexyl)-phthalate (DEHP) and 2-ethylhexyl benzoate (EHB),respectively have been 
observed to undergo sequential debromination in photodegradation experiments43. Total 
debromination of TBPH leading to the formation of di-(2-ethylhexyl) phthalate (DEHP) is 
possible, and requires further investigation due to DEHP’s possible biological effects.  
The purpose of this investigation was to generate toxicological data for TBB, TBPH, and 
TBCO by use of in vitro bioassays. The in vitro bioassay endpoints were based on the toxicities 
of structural analogs of the compounds (Figure 2.1). Recent in vitro metabolism experiments 
have shown that TBPH is metabolized to mono(2-ethylhexyl) tetrabromophthalate (TBMEHP)78, 
a brominated analog of MEHP which itself has been shown to affect concentrations of steroid 
hormones including estradiol and testosterone in rat ovarian follicles79, 80.  
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Figure 2.1. Chemical structures of 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB), bis(2-
ethylhexyl)-3,4,5,6-tetrabromo-phthalate (TBPH), and 1,2,5,6-tetrabromocyclooctane (TBCO). 
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In this study, the capabilities of three NBFRs to disrupt normal endocrine functions were 
investigated. Potential as receptor agonists or antagonists were measured by use of the yeast 
estrogen screen (YES) and yeast androgen screen (YAS) reporter assays while non-receptor 
mediated steroidogenic effects were investigated by use of the mammalian cell model, the 
H295R steroidogenesis assay. Following reports of aryl hydrocarbon receptor (AhR) activity by 
DEHP44, 47, the three NBFRs were tested for AhR binding activities by use of the H4IIE rat 
hepatoma cell reporter assay. To our knowledge this report presents the first data regarding these 
potential sub-lethal effects of TBB and TBCO. 
2.3 Materials and methods 
2.3.1 Chemicals 
2-Ethylhexyl tetrabromobenzoate (TBB) was obtained from Wellington Laboratories (Ontario, 
Canada), bis-(2-ethylhexyl) tetrabromophthalate (TBPH) was obtained from Waterstone 
Technology (Indiana, U.S.), and 1,2,5,6-tetrabromocyclooctane (TBCO) was obtained from 
Specs (Delft, Netherlands). All single compounds were reported to be >95% pure by the 
manufacturer. All solvents, DMSO, EtOH, ethylacetate, and hexane, were of analytical grade and 
obtained from Sigma–Aldrich (Ontario, Canada). 
2.3.2 Cell viability 
Cytotoxic effects of the three NBFRs to the H4IIE and H295R cells were evaluated by use of the 
WST-1 assay (Roche Applied Science, Indiana, U.S.). Cells were propagated as mentioned 
below. Cytotoxicities were determined after 48 hr incubation with individual NBFRs. WST-1 
reagent was used to determine metabolically active cells at the end of the incubation period 
according to the manufacturer’s recommendations.  
In the YES/YAS assays, cytotoxic effects were measured by use of optical density (690 
nm)81. After 48 hr incubation, each well was assayed for turbidity and compared to solvent 
control values. Cellular cytotoxicity was defined as ≥30% reduction in cell density from solvent 
controls. 
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2.3.3 H4IIE-luc transactivation reporter gene assay 
The H4IIE-luc cellular assay is derived from rat hepatoma cells which have been stably 
transfected with a luciferase gene under control of a dioxin-responsive element82-84. H4IIE-luc 
cells were propagated as previously described85. Cells were incubated for 24 hr prior to dosing. 
Test and control wells were dosed with 1% per well volume of the individual NBFRs prepared in 
DMSO. Luciferase activity was measured by use of the SteadylitePlus Kit (Perkin Elmer, MA, 
U.S.). The following concentrations of the test compounds were used: (TBB) 5 × 10−5, 5 × 10−4, 
5 × 10−3, 5 × 10−2 mg/L, (TBPH) 0.75, 1.5, 3, 15, 30, 150 mg/L, and (TBCO) 0.3, 1.5, 3, 15, 30 
mg/L. A TCDD standard curve was included in each plate to control for inter-plate variability. 
2.3.4 YES/YAS assays 
Estrogenic and androgenic activities of the three NBFRs: TBB, TBPH, and TBCO were 
measured via production of β-galactosidase and the subsequent metabolism of chlorophenol red- 
β-D-galactopyranoside (CPRG). All media and procedures used for the YES/YAS assays were 
prepared according to the original protocol81. 17 β-estradiol (E2) and dihydrotestosterone (DHT) 
standards were included with each plate to control for inter-plate variability. Activity was 
measured at 570 nm and 690 nm by use of Eq. (1). The corrected value represents the test 
response corrected for potential toxicity to cells.  
Corrected value = A570 nm – A690 nm………………………………………………………(2.1) 
Anti-estrogenic (YES) and anti-androgenic (YAS) activities of the three NBFRs were measured 
by reduction in activity of  β-galactosidase in yeast cells in the presence of 8.17 × 10−4mg/L E2 
(YES), and 1.45 × 10−3 mg/L DHT (YAS). 4-Hydroxytamoxifen (3.88 × 10−9 mg/L), and 
hydroxyflutamide (2.92 × 10−8 mg/L) were used as E2 and DHT antagonist controls for the YES 
and YAS assays, respectively. Concentrations of the three NBFRs which elicited the greatest 
inhibition (YES: 5 × 10−01, 0.03, 30 mg/L; YAS: 5 × 10−01, 1000, 300 mg/L; TBB, TBPH and 
TBCO, respectively) were used to test for recovery of activation signals of the cellular assay 
systems. This control was employed to test for inhibitory effects due to non-receptor mediated 
mechanisms. To elicit an inhibitory response, each NBFR was combined with a specific receptor 
agonist, E2 or DHT, then incubated with an additional volume of agonist at three different 
concentrations. Recoveries of activation signals were tested by use of three concentrations of E2: 
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2.72 × 10−4, 8.17 × 10−4, and 2.72 × 10−3 mg/L (YES) and three concentrations of DHT: 2.90 × 
10−4, 1.45 × 10−3, and 2.90 × 10−3 mg/L (YAS) (Figures C2.S1., C2.S2). All procedures for the 
anti-estrogenic and anti-androgenic assays were the same as those for the YES/YAS agonist 
assays described above.  
2.3.5 H295R cell culture and exposure 
The H295R human adrenocarcinoma cell line was cultured according to the standardized H295R 
assay protocol approved by the OECD86. H295R cells were dosed with the following 
concentrations of the test compounds: (TBB) ranging from 5x10-5 to 5x10-2 mg/L, (TBPH) 
ranging from 1.5 to 30 mg/L, and (TBCO) ranging from 0.3 to 15 mg/L.  Forskolin (4.11 mg/L), 
a strong inducer of both E2 and T production, and prochloraz (1.13 mg/L), a strong inhibitor of 
both E2 and T production, were used as controls in the H295R steroidogenesis assay.  The final 
concentration of the solvent carriers did not exceed 0.1%.  Conditioned media was collected 
following 48 hr of exposure and assayed for [E2] and [T] by use of ELISA. 
2.3.6 17β-Estradiol and testosterone extraction and quantification by use of EIA 
Extraction of E2 and T from media was performed according to established protocol87.  
Concentrations of E2 and T were determined by competitive EIA according to the 
manufacturer’s recommended method (Caymen Chemical Company, MI, U.S.).   
2.3.7 Statistics 
Statistical analysis for all cellular assays was completed by use of IBM SPSS Statistics software 
(V.20).  Data was initially tested for normality by use of the Shapiro-Wilk’s test and 
homogeneity of variance by use of Levene’s test (p>0.05).  If assumptions of normality and 
homogeneity of variance were met a one-way ANOVA was used to evaluate differences between 
sample treatment and solvent controls.  Differences were considered significant at a p-value < 
0.05.  In those cases where the basic assumptions for parametric statistics were not met, 
distribution-free tests such as Kruskal-Wallace followed by Mann-Whitney U tests were 
employed. All data is reported as mean ± SE. 
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2.4 Results 
2.4.1 TCDD-like potencies of compounds 
The three NBFRs, TBB, TBPH, and TBCO caused no TCDD-like activities in the H4IIE-luc 
bioassay.  A TCDD standard curve [2.25x10-7 mg/L to 4.83x10-5 mg/L] was used to calculate 
TCDD equivalents.  The three NBFRs had no cytotoxic effects at the tested concentrations.   
2.4.2 Receptor-mediated androgenic and estrogenic activities of compounds 
The three NBFRs, TBB, TBPH, and TBCO caused no estrogen-like or androgen-like activities in 
the YES/YAS bioassays.   A six point E2 standard curve [2.72x10-6 mg/L to 2.72x10-3 mg/L] 
(YES), and a seven point DHT standard curve [2.90x10-6 mg/L to 8.71x10-3 mg/L] (YAS) were 
used to calculate E2 and androgen equivalents.  The three NBFRs had no cytotoxic effects at the 
tested concentrations. 
2.4.3 Androgen receptor mediated antiandrogenic activities of NBFRs 
The three NBFRs, TBB, TBPH, and TBCO were screened for antiandrogenic activities by use of 
the YAS assay.  The signal from cells activated by a 1.45x10-3 mg/L DHT control was set at 
100%.  Cells co-treated with androgen antagonist control hydroxyflutamide [2.92x10-8 mg/L] 
exhibited a 52% reduction in β-galactosidase signal.  The following concentrations of the test 
compounds were used in the YAS assay: (TBB) 5x10-10 , 5x10-8 , 5x10-6 , 5x10-4 , 5x10-3 , 5x10-2, 
5x10-01 mg/L, (TBPH) 3x10-2, 0.3, 3, 15, 30, 150, 300, 1500 mg/L, and (TBCO) 3x10-3,  3x10-2, 
0.3, 3, 15, 150, 300 mg/L.  Each NBFR tested resulted in statistically significant inhibition of 
receptor mediated β-galactosidase production.  At 0.5 mg/L TBB exposures resulted in a 
maximal antiandrogenic response of 31% inhibition of β-galactosidase production compared to 
the DHT control (Figure 2.2A).  TBPH, the brominated structural analogue of the phthalate 
DEHP, demonstrated dose-dependent inhibition of β-galactosidase production.  At 1500 mg/L 
TBPH exposures resulted in a maximal antiandrogenic response of 59% compared to the DHT 
control (Figure 2.2B).  TBCO responded in a dose-dependent manner and produced the greatest 
inhibition of β-galactosidase production of all tested compounds.  At 300 mg/L TBCO exposures 
resulted in a maximal antiandrogenic response of 74% compared to the DHT control (Figure 
2.2C).    
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Figure 2.2.  The antiandrogenic activity of (A) TBB at seven exposure concentrations, (B) 
TBPH at eight exposure concentrations, and (C) TBCO at eight exposure concentrations, in 
mg/L measured by the yeast androgen screen.  Antiandrogenic activity is presented as the 
reduction in signal intensity (mean ± SE) compared to DHT activated control cells (CTRL).  
Hydroxyflutamide (HF) acted as a positive control.  Each assay contained four wells per NBFR 
exposure concentration and a total of four assays were used for analysis.  Exposure 
concentrations that resulted in effects that were significantly different than activated controls are 
indicated by asterisks (*p<0.05). 
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2.4.4 Estrogen receptor mediated antiestrogenic activities of compounds 
The three NBFRs were screened for antiestrogenic activities by use of the YES assay. The signal 
from cells activated by 8.17x10-4 mg/L E2 controls was set at 100%.  Cells co-treated with 
hydroxytamoxifen [3.88x10-9 mg/L] exhibited a 71% reduction in -galactosidase signal. The 
following concentrations of the test compounds were used in the YES assay: (TBB) 5x10-10 , 
5x10-8 , 5x10-6 , 5x10-4 , 5x10-3 , 5x10-2, 5x10-01 mg/L, (TBPH)  3x10-3, 3x10-2, 0.3, 3, 15, 30, 150 
mg/L, and (TBCO) 3x10-3, 3x10-2, 0.3, 3, 15, 30 mg/L.  Each NBFR resulted in statistically 
significant inhibition of receptor mediated -galactosidase production.   Of the three NBFRs, 
TBB resulted in the greatest reduction of -galactosidase production while responding in a dose-
dependent manner. At 0.5 mg/L TBB exposures resulted in a maximal antiestrogenic response of 
62% compared to the E2 control (Figure 2.3A).  TBPH and TBCO exposures resulted in maximal 
antiestrogenic responses of 21% and 46% at concentrations of 3 x10-2 mg/L and 30 mg/L, 
respectively compared to E2 controls (Figures 2.3B, 2.3C).  TBPH exposures resulted in a 
reverse dose response trend where the lesser exposure concentrations resulted in the greatest 
inhibition.   
2.4.5 Effects of NBFRs on testosterone synthesis 
Only two of three NBFRs, TBPH and TBCO significantly affected the production of testosterone 
in conditioned media compared to solvent controls in the H295R cellular assay.  The maximal 
exposure concentration of TBPH, 30 mg/L, resulted in a moderate1.96 fold increase in 
concentrations of T compared to controls (Figure 2.4A).   Across four exposure concentrations 
TBPH exposures produced a range of 1.17 to 1.96 indicating limited dose-responsive behaviour.  
At doses of 3 mg/L and 15 mg/L TBCO exposures resulted in slightly lesser concentrations of T 
compared to solvent controls.  At 15 mg/L TBCO, the concentration of T was 0.79 fold lesser 
compared to solvent controls (Figure 2.4B), while exposures of 0.3 and 1.5 mg/L produced no 
significant differences from solvent controls.   
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Figure 2.3. The antiestrogenic activity of (A) TBB at seven exposure concentrations, (B) TBPH 
at seven exposure concentrations, and (C) TBCO at six exposure concentrations in mg/L 
measured by the yeast estrogen screen.  Antiestrogenic activity is presented as the reduction in 
signal intensity (mean ± SE) compared to E2 activated control cells (CTRL).  4-
Hydroxytamoxifen (HT) acted as a positive control.  Each assay contained four wells per NBFR 
exposure concentration and a total of four assays were used for analysis.  Exposure 
concentrations that resulted in effects that were significantly different than activated controls are 
indicated by asterisks (*p<0.05).   
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Figure 2.4. The effects of (A) TBPH and (B) TBCO exposures on relative testosterone hormone 
concentrations measured in the H295R cell assay.  Four concentrations (mg/L) of TBPH and 
TBCO were tested and data are given as relative fold change in hormone production (mean ± SE) 
compared to solvent controls (DMSO).  Each assay contained four wells per NBFR exposure 
concentration and a total of four assays were used for analysis. Exposure concentrations that 
resulted in effects that were significantly different than solvent controls are indicated by asterisks 
(*p<0.05).   
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2.4.6 Effects of NBFRs on E2 synthesis 
At all exposure doses, the three NBFRs elicited significant increases in concentrations of E2 in 
conditioned media compared to solvent controls.  TBB exposed cells responded at a maximum of 
2.82 fold change compared to solvent controls (Figure 2.5A). TBPH exposure resulted in the 
greatest increase of concentrations of E2 eliciting a maximal response of 5.29 fold change 
compared to solvent controls (Figure 2.5B). At 15 mg/L, TBCO elicited a maximal response of 
3.29 fold change compared to solvent controls (Figure 2.5C).    
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Figure 2.5. The effects of (A) TBB, (B) TBPH, and (C) TBCO exposures on relative 17-β-
estradiol hormone concentrations measured in the H295R cell assay.  Four concentrations (mg/L) 
of each NBFR were tested and data are given as relative fold change in hormone production 
(mean ± SE) compared to solvent controls (DMSO).  Each assay contained four wells per NBFR 
exposure concentration and a total of four assays were used for analysis. Exposure 
concentrations that resulted in effects that were significantly different than solvent controls are 
indicated by asterisks (*p<0.05).   
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2.5 Discussion 
The three NBFRs TBB, TBPH, and TBCO are components of several flame retardant technical 
mixtures and have been discovered in numerous environmental and biotic samples. TBPH is a 
brominated analogue of the phthalate plasticizer DEHP, which has several associated toxicities 
including endocrine disruption, AhR agonism, and developmental and reproductive toxicities88, 
89.  There are yet few published reports of toxicities of TBB and TBCO.  Our investigation 
elucidated the potential biological effects with respect to the endocrine disrupting and TCDD-
like properties of the three NBFRs.   
 Dosing concentrations of the three NBFRs were based on pilot data regarding 
cytotoxicity and solubility in media, which was previously generated by the authors.  In this 
study, antagonism was defined as a dose dependent inhibitory effect that was comparable in 
magnitude to the inhibitory controls, hydroxyflutamide or 4-hydroxytamoxifen.  Compounds that 
did not meet these criteria but demonstrated significant inhibitory effects were deemed potential 
weak antagonists.  Controls for recovery of activation signals with exposures to TBB, TBPH, 
and TBCO showed recoveries of activation responses with the addition of three concentrations of 
DHT: 2.90x10-4, 1.45x10-3, and 2.90x10-3 mg/L (YAS) and E2: 2.72x10-4, 8.17x10-4, and 
2.72x10-3 mg/L (YES) (Figures C2.S1, C2.S2).   
2.5.1 TCDD-like effects 
The three NBFRs TBB, TBPH, and TBCO did not result in any TCDD-like effects at tested 
concentrations.  DEHP has previously elicited weak agonistic AhR activity44, 47.  Discrepancies 
between the TCDD-like activities of TBPH and its structural analogue DEHP are likely due to 
the bromine atoms at the 2, 3, 4, 5 positions.  The bromine atoms increase steric hindrance and 
change the physical-chemical characteristics of the compound resulting in differential interaction 
with the AhR. To our knowledge this is the first investigation of the TCDD-like effects of TBB, 
TBPH, or TBCO. 
2.5.2 (Anti) androgenic effects 
DEHP is a known endocrine disruptor with several toxic effects that can act via antiandrogenic 
mechanisms89. It has been previously detailed that the antiandrogenic toxicity of DEHP is 
moderated through its mono ester metabolite MEHP80. Several studies have shown that MEHP 
45 
 
exerts little affinity for the androgen receptor and does not produce androgen receptor mediated 
effects90. MEHP likely exerts its antiandrogenic effects by blocking activities of enzymes of the 
steroidogenic pathway and through the inhibition of cholesterol transportation90. Unlike its mono 
ester metabolite, in vitro androgenic screening of DEHP has demonstrated that the un-
metabolized phthalate might bind to the androgen and estrogen receptors90, 91. TBPH 
demonstrated no agonistic effects in the YAS assay (data not shown), but produced significant 
antiandrogenic effects. Contrary to previous studies53 TBPH produced antagonistic effects 
greater than hydroxyflutamide, and responded in a dose dependant trend (Figure 2.2B). 
Differences from previous in vitro investigations can be attributed to differences in exposure 
doses in the yeast system. Previous investigations which have used mammalian cellular assays 
have demonstrated the inability of DEHP to bind with the androgen receptor, though this might 
be due to rapid biotransformation of DEHP to its metabolite MEHP. Yeast cells might have 
different mechanisms and/or rates of metabolism of DEHP than mammalian cells, which might 
help to explain the observed antagonistic effects of DEHPs brominated analog, TBPH.  
The results presented here represent some of the first data regarding potential androgenic 
effects of TBB and TBCO. The weak antagonistic response of TBB might be due to limitations 
in dosing concentrations which were restricted by the concentrations of the stock solutions and 
cytotoxicity. TBCO can be characterized as an androgen receptor antagonist; the compound 
responded in a dose-dependent manner and had a significantly greater antagonistic response than 
hydroxyflutamide at 2.92 x 10−8 mg/L (Figure 2.2C). Further exposure and investigations of 
mechanisms are required to confirm the potential antiandrogenic effects of TBCO. 
2.5.3 (Anti) estrogenic effects 
By use of the aforementioned characteristics of an antagonist, the three NBFRs can be classified 
as weak estrogen antagonists. The antagonistic effects of the three compounds indicated weak 
antagonism, while only TBB and TBPH responded in dose-dependent trends (Figures 2.3A–C). 
Contrary to previous in vitro investigations in which no antagonistic effects were observed53, 
TBPH exposures resulted in weak antagonistic effects. The discrepancies between these data and 
previous investigations might be due to differences in exposure concentrations. The rationale of 
the reverse TBPH dose-response is unknown, though initial cytotoxicity experiments showed no 
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significant increase in cellular cytotoxicity at greater concentrations. The weak antagonistic 
effects of TBPH indicate that it differs from DEHP in its interaction with the estrogen receptor. 
The results of this investigation are the first to indicate the potential for antagonism of 
TBB and TBCO with the ER. Further in vitro investigations and in vivo assays are required to 
elucidate any mechanisms of toxicity and gauge potential organismal effects. 
2.5.4 Effects on testosterone production in the H295R steroidogenesis assay 
TBB did not demonstrate statistically significant changes in concentrations of T (data not shown) 
at any of the tested concentrations. TBPH is a structural analog to the plasticizer DEHP which is 
ubiquitously found in the environment and causes several toxic effects including male 
reproductive abnormalities in animal models89. It is hypothesized that several of the toxic effects 
of DEHP are mediated through interactions and disruption of endocrine homeostasis89, 90. The 
results of TBPH exposures, though significantly different than controls, represent a weak 
increase in concentrations of T (Figure 2.4A). These results are contrary to existing data for 
DEHP44, 90, 92 and might be attributed to the bromine atoms attached to the phthalate moiety, 
differences in exposure concentrations, or differences in the cellular physiology of the assay 
system. For example the observed reductions in concentrations of testosterone in DEHP exposed 
cells are partially moderated through the activation of the PPARα (peroxisome proliferator 
activated receptor) nuclear receptors. Activation of PPARα via exposure to DEHP has been 
linked to decreases in concentrations of T.  Experimentation with PPARα null mice has resulted 
in lesser reductions of concentrations of testosterone than in their wild-type counterparts93, 94. 
Though PPARα affects the concentration of T in vivo and in vitro, PPARs in general have 
differential tissue and species specific expression patterns95. For example, DEHP has 
demonstrated limited effects on the liver in humans, due to the limited expression, and/or 
truncated or mutant variations of PPARα95, 96. These differences between in vitro 
experimentation and cellular physiologies might account for differences in results.  
Exposure of H295R cells to TBCO resulted in a statistically significant decrease in 
concentrations of T at the two greatest concentrations (Figure 2.4B). Similar to the TBPH 
exposures, TBCO elicited a weak response in the H295R system. This is the first data regarding 
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the potential androgen disrupting effects of TBCO. From this preliminary data, further 
investigations into TBCO’s endocrine disrupting potentials are warranted. 
2.5.5 Effects on estrogen production in the H295R steroidogenesis assay 
The three NBFRs significantly increased synthesis of E2 in the H295R system. TBPH exposures 
resulted in the greatest increase of concentrations of E2 (Figure 2.5B), though of the three 
compounds only TBCO responded in a dose-dependent fashion (Figure 2.5C). These results for 
TBPH exposures are in accordance with previous in vitro exposures of DEHP which 
demonstrated the compounds potential endocrine disrupting effects44, 97.  
A greater understanding of the effects/mechanisms of the three NBFRs can be achieved 
in the comparison of the two specific assay systems, the YES and H295R. The YES system 
represent a receptor mediated endpoint that is relegated to those elements that have been 
transfected into the cells, specifically the human estrogen receptor (hER)81, while the H295R 
cellular system inherently expresses the complete biosynthetic pathway of E2. The data from the 
YES assay shows that the NBFRs do not interact with the estrogen receptor in an agonistic 
fashion; a hypothesis for TBPH that is supported by investigations into toxicities of DEHP90. 
While data from the H295R assays suggest that the three compounds target the biosynthetic 
pathway of E2. Indeed MEHP, the metabolite of DEHP is known to affect aromatase, a major 
enzyme in E2 synthesis97. Due to the analogous structures of TBPH and DEHP, many of the 
limited toxicological investigations currently focus on potential androgenic disruption. To our 
knowledge the results from the YES and H295R assays represent some of the first data regarding 
potential estrogen specific mechanisms of endocrine disruption of TBB, TBPH, and TBCO in an 
in vitro system. 
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3 CHAPTER 3: A MIXTURE OF THE NOVEL BROMINATED 
FLAME RETARDANTS TBPH AND TBB AFFECTS FECUNDITY AND 
TRANSCRIPT PROFILES OF THE HPGL-AXIS IN JAPANESE MEDAKA 
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PREFACE 
Chapter 2 demonstrated that TBPH and TBB did not activate the AhR, but each compound 
elicited effects in the EDC screening assays.  TBB produced antiestrogenic effects in the YES 
assay while TBPH produced antiandrogenic effects in the YAS assay system. TBPH and TBB 
also altered concentrations of the steroid hormone E2 in the H295R assay.  Following positive 
responses of TBPH, TBB in the in vitro screening level assessment, the goal of Chapter 3 was to 
characterize whole-organism endocrine-related adverse effects and mechanisms of action.  In-
depth characterization of adverse effects and mechanisms of action was critical to increase 
knowledge regarding profiles of toxicity of these compounds to inform accurate assessments of 
risk.  This chapter was included in the first phase of this research program, the characterization 
of potential toxicities of TBPH, TBB, and TBCO. 
 The content of Chapter 3 was reprinted (adapted) from Aquatic Toxicology, 
(10.1016/j.aquatox.2014.10.019) D.M.V. Saunders, M. Podaima, G. Codling, J.P. Giesy, Steve 
Wiseman “A mixture of the novel brominated flame retardants TBPH and TBB affects fecundity 
and transcript profiles of the HPGL-axis in Japanese medaka” 158, 14-21. Copyright 2015, with 
permission from Elsevier. 
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3.1 Abstract 
The novel brominated flame retardants (NBFRs), bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate 
(TBPH) and 2-ethylhexyl-2,3,4,5 tetrabromobenzoate (TBB) are components of the flame 
retardant mixture Firemaster® 550 and both TBPH and TBB have recently been listed as high 
production volume chemicals by the U.S. EPA. These NBFRs have been detected in several 
environmental matrices but very little is known about their toxic effects or potencies. Results of 
in vitro assays demonstrated potentials of these NBFRs to modulate endocrine function through 
interactions with estrogen (ER) and androgen receptors (AR) and via alterations to synthesis of 
17-β-estradiol (E2) and testosterone T, but in vivo effects of these chemicals on organisms are 
not known. Therefore a 21-day short term fish fecundity assay with Japanese medaka (Oryzias 
latipes) was conducted to investigate if these NBFRs affect endocrine function in vivo. Medaka 
were fed a diet containing either 1422 TBPH:1474 TBB or 138:144 µg/g food, wet weight 
(w/w). Cumulative production of eggs was used as a measure of fecundity and abundances of 
transcripts of 34 genes along the HPGL-axis were quantified to determine mechanisms of 
observed effects. Cumulative fecundity was impaired by 32% in medaka exposed to the greatest 
dose of the mixture of TBPH/TBB. A pattern of global down-regulation of gene transcription at 
all levels of the HPGL axis was observed, but effects were sex-specific. In female medaka the 
abundance of transcripts of ERβ was lesser in livers, while abundances of transcripts of VTG II 
and CHG H were greater. In male medaka, abundances of transcripts of ERα, ERβ, and ARα 
were lesser in gonads and abundances of transcripts of ERβ and ARα were lesser in brain. 
Abundances of transcripts of genes encoding proteins for synthesis of cholesterol (HMGR), 
transport of cholesterol (HDLR), and sex hormone steroidogenesis (CYP 17 and 3β-HSD) were 
significantly lesser in male medaka, which might have implications for concentrations of sex 
hormones. The results of this study demonstrate that exposure to components of the flame 
retardant mixture Firemaster® 550 has the potential to impair the reproductive axis of fishes.  
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3.2 Introduction 
Brominated flame retardants (BFRs) are synthetic compounds that are added to consumer and 
industrial products to inhibit propagation of fire. Polybrominated diphenyl ethers (PBDEs), 
which have three technical mixtures (PentaBDE, OctaBDE, and DecaBDE) have historically 
been the most widely used BFRs worldwide, but due to their ubiquity in the environment and 
potential toxic effects, PBDEs have been increasingly scrutinized and two of three technical 
mixtures (PentaBDE and OctaBDE)  have  been  phased-out of production from North American 
and global markets. Though PBDEs have been phased out of global use, legislation in North 
America and other countries requires that consumer and industrial products adhere to specific 
standards of fire retardation. Additionally, demand for BFRs has continued to grow with a 5% 
increase in production in 2005 alone9. Consequently there has been an increase in production of 
novel brominated flame retardants (NBFRs). Many NBFRs are replacement compounds for 
PBDE formulations though in several instances their PBT (persistence, bioaccumulation, 
toxicity) profiles are similar to the legacy BFRs they have replaced27, 31. 
The two NBFRs bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (TBPH or BEHTBP) and 
2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB or EHTBB) are components of several mixtures 
of additive flame retardants including, Firemaster® 550 (35% TBB, 15% TBPH), Firemaster® 
BZ-54 (70% TBB, 30% TBPH), and DP-45 (TBPH only)29, 30. Firemaster® 550 is a replacement 
for PentaBDE technical mixtures used in polyurethane foams, PVC, and neoprene. Both TBPH 
and TBB have been listed as high production volume chemicals by the U.S. EPA30, and due to 
the phase-out of legacy BFRs, production of these two compounds is hypothesized to be 
increasing. In partial confirmation of this hypothesis, these compounds have been detected in a 
variety of abiotic and biotic matrices. TBPH and TBB have been detected in air by the Global 
Atmospheric Sampling Network37, in air collected in the great lakes area of North America by 
the Integrated Atmospheric Deposition Network30 and in dust in North America38 and New 
Zealand39. TBPH and TBB have also been detected in blubber from humpback dolphins and 
finless porpoises in South China42, and Ring-Billed Gulls in the St. Lawrence River downstream 
of Montréal, Canada35. 
TBPH and TBB have been detected in several environmental matrices but due to their 
novelty there is little information regarding toxic effects or potencies. TBPH and TBB are 
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brominated analogues of di(2-ethylhexyl)-phthalate (DEHP), a controlled substance in Canada 
and the EU, and 2-ethylhexyl benzoate (EHB), respectively, and due to similarities in structure, 
might have comparable toxicities. DEHP and its active metabolites are known to exert adverse 
effects which include hepatic carcinogenicity98, endocrine disruption44, and impairment of 
reproduction45, 46. For example, exposure of the Chinese rare minnow (Gobiocypris rarus) to 
DEHP resulted in greater concentrations of testosterone (T) and 17-β-estradiol (E2) in blood 
plasma and greater abundances of transcripts of vitellogenin (VTG) in livers of male and female 
minnow49. In another study Japanese medaka (Oryzias latipes) exposed to DEHP had lesser 
concentrations of VTG in blood plasma and the percentage of female medaka with mature 
oocytes in their ovaries was lesser50. Due to the endocrine disrupting effects of DEHP and its 
metabolites, there is concern that organisms exposed to TBPH and TBB might experience similar 
impacts. 
Few studies have investigated endocrine disrupting effects of TBPH and TBB. By use of 
the yeast estrogen/androgen screening assays (YES/YAS) it was demonstrated that TBPH and 
TBB at 1500 mg/L and 0.5 mg/L, respectively, interact antagonistically with the human 
estrogen/androgen receptors (hERα/hARα)99. In the same study, concentrations of E2 increased 
2.8- fold and 5.4-fold in H295R cells exposed to 15 mg/L of TBPH and 0.05 mg/L of TBB, 
respectively. Greater synthesis of T and E2, possibly because of greater expression of enzymes 
of steroidogenesis such as Cyp19A, was also detected in porcine primary testicular cells exposed 
to 0.15 mg/mL of TBPH100. It is of particular interest that effects elicited in these in vitro studies 
were similar to effects of DEHP on Chinese rare minnow49. There are yet few assessments of 
potential endocrine disrupting effects in vivo. In one study Wistar rats exposed to the technical 
mixture Firemaster® 550 (1000 µg/day) exhibited greater concentrations of thyroxine in serum 
and a significantly advanced pubertal onset52.  
Additional studies are required to verify and augment the understanding of potential 
endocrine disrupting effects of TBPH and TBB in vivo. Therefore, the purpose of this study was 
to investigate the endocrine disrupting potentials of TBPH and TBB by use of the OECD, 21-day 
short-term fecundity assay101 with Japanese medaka (O. latipes). Male and female medaka were 
exposed to a mixture of these chemicals via their diet and cumulative fecundity, which is an 
integrated and holistic measure of endocrine disruption and can represent population-level 
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biological effects, was assessed. In addition, abundances of transcripts of 34 genes along the 
hypothalamic–pituitary–gonadal–liver (HPGL) axis were quantified by use of a PCR array102-104. 
3.3 Materials and methods 
3.3.1 Chemicals and reagents 
Bis(2-ethylhexyl)tetrabromophthalate (TBPH), bis(2-ethylhexyl-d17)-tetrabromo[
13C6]phthalate 
(`TBPH), 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB), and 2-ethylhexyl-d17-
tetrabromo[13C6]benzoate (`TBB) were obtained from Wellington Laboratories (Ontario, 
Canada).  All solvents including acetone, toluene, hexane, and dichloromethane (DCM) were of 
analytical grade and obtained from Fisher Scientific (Ontario, Canada).   
3.3.2 Animal care 
Embryos of medaka were obtained from the aquatic culture unit at the U.S. Environmental 
Protection Agency Mid-Continent Ecology Division (Minnesota, U.S.).  Medaka were 
maintained in 30 L tanks under static-renewal conditions (27°C, 16:8 light/dark) and fed to 
satiation with flaked food and artemia 4-times daily.  Culturing of medaka and exposures were 
performed in accordance with protocols approved by the University of Saskatchewan Committee 
on Animal Care and Supply and Animal Research Ethics Board (# 200090108). 
3.3.3 Exposure protocol 
Food was prepared according to methods described previously105.  Briefly, commercial flaked 
food (Nutrafin Basix Staple Food)  was ground with a mortar and pestle and spiked with a 150 
mL solution of 1.4x10-2 M:1.8x10-2 M or 1.4x10-3 M:1.8x10-3 M, TBPH:TBB to attain 1500:1500 
μg TBPH:TBB /g food or 150:150 µg TBPH:TBB/g food. 
Flasks containing spiked food were shaken for 30 min to ensure thorough mixing of food 
and chemicals and subsequently air dried in a dark fume hood for 7 hr.  An identical protocol 
was used to prepare food spiked with acetone for use as a control diet.  Concentrations of TBPH 
and TBB were selected from a previous study where exposure to these chemicals via their diet 
caused DNA damage in fathead minnows (Pimephales promelas)29.     
Exposure protocols were adapted from the Fish Short Term Reproductive Assay, OECD 
test 229101.  Japanese medaka (14-wk-old) which ranged in mass from 0.3 to 0.6 g were 
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randomly assigned to 10 L tanks to which dechlorinated, City of Saskatoon municipal water was 
supplied under flow-through conditions.  Eight females and eight males were placed into each 
tank and acclimated at 25±2 °C with a 16:8 light/dark cycle and fed to satiation with flaked food 
for 7-d prior to initiation of experiments.  There were no mortalities during the acclimation 
period, after which, medaka were exposed to either dose (greater/lesser) of the mixture of 
TBPH/TBB or the vehicle control (acetone prepared food) for 21-d.  Each treatment was 
replicated in quadruplicate. Medaka were fed approximately 6% of body mass per day, and to 
ensure all food was consumed it was provided in two feeding events (morning and afternoon).  
At each 24 hr interval, eggs from female medaka in each tank were collected and enumerated, 
and the total number of eggs collected in each tank normalized to number of females per tank.  A 
single mortality was observed in the solvent control treatment during the exposure period.  At the 
end of the 21-d experiment medaka were euthanized by cervical dislocation and total mass of 
each individual was recorded.  Masses of livers and gonads were recorded to determine hepatic 
somatic index (HSI) and gonadal somatic index (GSI).  Livers, brains (including pituitary), and 
gonads from each medaka were immediately frozen in liquid nitrogen and stored at -80 °C for 
quantification of abundances of transcripts by real-time PCR (qPCR). 
3.3.4 Chemical analysis 
Three replicates of each food type were homogenized with clean sodium sulphate and a mortar 
and pestle. Stainless steel extraction cells (33 mL) were packed with an in-cell absorbent 
(activated alumina) to remove lipids (20:1, absorbent:lipid ratio) and 0.5 g of food106, spiked 
with an internal standard - `TBB and extracted by use of a pressurized liquid extraction (ASE 
200, Dionex, California, U.S.).  Cells were extracted with a 1:1 solution of hexane and DCM at a 
temperature of 100 °C and 1500 psi for 10 min.  The resulting extract was reduced in volume to 
500 μL under a gentle stream of nitrogen and 100 ng of `TBPH was added.  Three laboratory 
blanks and matrix spikes (spiked with 1.0 x 105 ng of TBB, TBPH, and 100 ng of `TBB) were 
extracted for quality assurance purposes.   
Extracts were analyzed for TBPH and TBB by use of an Agilent (California, U.S.) 7890A 
gas chromatograph (GC) system coupled to an Agilent 5975C mass spectrometer (MS) operating 
in the electron impact ionization mode (EI).  Two (2) μL samples were injected at an injection 
port temperature of 280 °C in the splitless mode.  Chromatographic separation was achieved with 
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a 15-m x 250-μm i.d. Rtx-1614 fused silica capillary GC column, which had a 0.1-μm film 
thickness (Restek Corporation, Pennsylvania, U.S.).  The carrier gas was helium at a constant 
flow of 1.5 mL/min.  The following GC oven temperature program was used: 80 °C for 2 min, 
25 °C/min to 250 °C, 3 °C/min to 270 °C, 25 °C/min to 300 °C, and 300 °C for 6 min30.  
Selected ion monitoring of m/z 467/465 and 421/419 was used for TBPH and TBB 
quantification/confirmation, respectively.  TBPH and TBB were quantified by use of the internal 
standard method using `TBB.  Recovery of `TBB was measured as 89.1±6.3%.  TBPH and TBB 
were not detected in the laboratory blanks.  The mean and standard error of the mean for TBB 
and TBPH recovery in the matrix spikes were 91.2±7.3 and 94.3±9.5%, respectively.  
3.3.5 Gene selection and graphical model 
A total of 34 genes which represent key signaling pathways, genes in steroidogenesis, and 
biomarkers of exposure to estrogens in the HPGL axis of Japanese medaka were selected for 
study based on results of previous research 102-104, 107.  Primers not mined from previous 
experiments were designed by use of NCBI Primer-Blast software and were based on sequences 
available in the NCBI GeneBank database.  Sequences of nucleotide primers and efficiencies of 
reactions with these primers are given in the appendix (Table C3.S1).  Graphical models 
depicting abundances of transcripts of 34 genes across the HPGL axis were produced by use of 
GenMapp 2.0 (Gladstone Institutes, U.S.) and were constructed and maintained by Dr. Xiaowei 
Zhang (Nanjing University, China).  Two criteria were required for inclusion in the graphical 
model (a) statistically significant changes in abundances of transcripts and (b) ≥ 2-fold change in 
abundances of transcripts to represent physiological relevance (Figure 3.2). 
3.3.6 Quantitative real-time PCR 
Total RNA was extracted from livers, brains, and gonads by use of the RNeasy Plus Mini Kit 
(Qiagen, Ontario, Canada) according to the protocol provided by the manufacturer.  
Concentrations of RNA were determined by use of a NanoDrop ND-1000 Spectrophotometer 
(Nanodrop Technologies, Delaware, U.S.) and stored at -80°C.  First strand cDNA was 
synthesized from 1 μg RNA and was performed by use of the QuantiTect Reverse Transcription 
Kit (Qiagen) according to the protocol provided by the manufacturers.  Real-time quantitative 
PCR (qPCR) was performed in 96-well plates by use of an ABI 7300 Real-Time PCR System 
(Applied Biosystems, California City, U.S.).  A 50 µL reaction mixture of 25 μL of 2x 
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concentrated Power SYBR Green master mix (Qiagen), an optimized concentration of cDNA, 10 
pmol of gene-specific primers, and nuclease free water was prepared for each combination of 
cDNA sample and primer.  Reactions were conducted in duplicate with 20 µl reaction volumes 
per well.  The reaction mixture for PCR was denatured at 95 °C for 10 min before the first PCR 
cycle.  The thermal cycle profile consisted of denaturing at 95 °C for 10 s and extension for 1 
min at 60 °C for a total of 40 PCR cycles.  Amplification of a single product from PCR was 
confirmed by melt curve analysis and target gene transcript abundance was quantified by use of 
the 2-ΔΔCt method by normalizing to expression of the RPL-7 housekeeping gene 108, 109.   
3.3.7 Statistical analysis 
Statistical analyses were conducted by use of SPSS statistics software (V.20). Normality of each 
dataset was determined by use of the Kolmogorov-Smirnov Test and homogeneity of variance 
was determined by use of Levene’s Test.  Unless otherwise noted, data were analyzed by use of 
analysis of variance (ANOVA) or Kruskal-Wallis test, followed by Tukey’s Test or Mann-
Whitney U Test, respectively.  Differences in daily production of eggs within groups were 
determined by use of repeated-measures ANOVA.  If sphericity, an assumption of repeated 
measures ANOVA was violated a Greenhouse-Geisser correction was applied.  Further post hoc 
tests were corrected by use of a Bonferroni adjustment.  Due to the conservative nature of the 
Bonferroni adjustment, data points were pooled according to statistical difference which was 
assessed by pairwise comparison.  All post hoc comparisons were made to group 1 which 
represented initial egg deposition numbers in the experiment.  Profile analyses to test parallelism 
between control and exposed groups were completed by use of multivariate ANOVA 
(MANOVA) tests.  A probability level of p ≤ 0.05 was considered significant except in cases of 
Bonferroni adjustments.  All data are shown as mean ± standard error of mean (S.E.M.). 
3.4 Results 
3.4.1 Concentrations of chemicals in food 
Measured concentrations of TBPH and TBB in three food types did not significantly differ from 
nominal concentrations (Table 3.1). The measured concentration of TBPH was 95% and 92% of 
the desired nominal concentration in both types of spiked food, while the measured concentration 
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of TBB accounted for 98% and 96%, respectively.  Concentrations of TBPH and TBB in food 
spiked with clean acetone were below the method limits of detection. 
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Table 3.1. Concentrations of TBPH and TBB in three diets used in the 21-day fish fecundity 
assay. Concentrations of TBPH and TBB are presented as mean ± standard error (μg/g food).  
Three replicates were extracted and analyzed for each food type 
Feed TBPH TBB 
Control ND ND 
1500:1500 μg/g food 1422±156.4 1474±265.9 
150:150 μg/g food 138±22.1 144±28.8 
ND: below limit of detection 
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3.4.2 Chemical-induced effects of fecundity of medaka 
Neither the HSI nor GSI of medaka fed either concentration of the mixture of TBPH/TBB was 
significantly different from the HSI or GSI of medaka exposed to the control diet (Table C3.S2).  
The proportion of eggs that were fertilized was determined on days 7, 14, and 21.  There were no 
differences between groups of medaka exposed to the control diet and medaka exposed to either 
concentration of the mixture of TBPH/TBB.  
Exposure to the mixture of TBPH/TBB affected fecundity of Japanese medaka (Figure 
3.1).  There were no significant differences in cumulative production of eggs between medaka 
exposed to solvent controls and the lesser concentration of TBPH/TBB (150:150 μg/g food).  
However, statistically significant differences in cumulative production of eggs between medaka 
exposed to solvent controls and the greatest concentration of TBPH/TBB (1500:1500 μg/g food) 
were observed.  Numbers of eggs produced relative to solvent control were 68% and 94% by 
female medaka exposed to the greater and lesser concentrations of the mixture of TBPH/TBB, 
respectively.  Profiles of daily production of eggs were significantly different (non-parallel 
profiles) between medaka exposed to the control and the greatest concentration of the mixture of 
TBPH/TBB but not the lesser concentration of TBPH/TBB (Figure C3.S1).  Furthermore, a 
within-group repeated measures analysis indicated significant differences in daily production of 
eggs over time by medaka exposed to the greatest concentration of TBPH/TBB (Figure 
C3.S2A.), but not by medaka exposed to either the control diet or the diet containing the lesser 
concentration of TBPH/TBB.  Across 21-repeated measures, a post hoc analysis with a 
Bonferroni adjustment was prohibitively conservative, so time points were grouped according to 
general trends in inflection points and statistically significant changes in daily production of eggs 
(Figure C3.S2B.).  Days were grouped as follows: group 1 (days 1-5), group 2 (days 6-12), group 
3 (days 13-16), and group 4 (days 17-21).  Pooled group 1 was set at 100% fecundity, as this 
group represented the initial period of production of eggs during the exposure; statistically 
significant differences between initial production of eggs, group 1, and all subsequent groups (2, 
3, and 4) were observed.   
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Figure 3.1.  Cumulative production of eggs (fecundity) by medaka exposed to the high dose of 
the TBPH/TBB mixture (1422:1474 µg/ g food, w/w), the low dose of the TBPH/TBB mixture 
(138:144 µg/g food, w/w) and solvent control.  The values represent the mean cumulative 
number of eggs per female over a 21-day period.  The experiment included 4 replicate tanks, and 
each contained 8 female/male medaka.  Asterisks (*) indicate a significant difference (p < 0.05) 
when compared to the control group. 
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3.4.3 Gene expression profiles of TBPH/TBB exposures 
Abundances of transcripts of genes of the HPGL axis were quantified in male and female 
medaka exposed to the greatest concentration of TBPH/TBB because this concentration had the 
greatest effect on fecundity.  In general, abundances of transcripts of target genes were lesser in 
males and females exposed to the greatest concentration of the mixture of TBPH/TBB compared 
to controls (Table 3.2), but profiles of gene expression and magnitude of effects were different 
between sexes.  Although abundances of transcripts of several genes, such as sGnRH (-15.59-
fold) and Activin BA (-11.70-fold), were much lesser in the brains and gonads from female 
medaka, neither effect was statistically significant because of the variability in the magnitude of 
effect (Table 3.2). There were incongruities in patterns of abundances of transcripts of ER and 
AR between male and female medaka.  Abundances of transcripts of ERβ (-23.53-fold), ARα (-
11.61-fold) and annexin max2 (-29.00-fold) were much lesser in livers from female medaka 
exposed to TBPH/TBB whereas abundances of these transcripts were not altered in brains or 
gonads.  In contrast, abundances of transcripts of ERα, ERβ or ARα were not significantly 
different in livers from male medaka exposed to TBPH/TBB, whereas abundances of transcripts 
of ERα (-14.00-fold), ERβ (-9.37-fold), and ARα (-3.03-fold) were significantly lesser in gonads 
and ERβ (-3.11-fold) and ARα (-7.37-fold) were significantly lesser in brains.  Abundances of 
transcripts of eight genes - ERα, ERβ, ARα, HDLR, HMGR, CYP 17, 3β-HSD, and activin BA -  
were significantly lesser in gonads from male medaka (Table 3.2 and Figure 3.2), but these 
effects were not observed in female medaka.   
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Table 3.2. Response profiles of genes of the hypothalamic-pituitary-gonadal-liver (HPGL) axis in 
Japanese medaka exposed to the greater dose of the TBPH/TBB mixture (1422:1474 μg/g food, w/w).  
Abundances of transcripts are expressed as fold change compared to corresponding solvent controls. 
    
Tissue Gene Male Female 
    
Brain ERα -2.25 2.83 
ERβ -3.11* 1.76 
ARα -7.37* -2.08 
Neuropep Y -1.87 1.68 
cGnRH II -1.24 -2.57 
mfGnRH 1.17 1.88 
sGnRH -3.61 -15.59 
GnRH RI -1.56 -4.71 
GnRH RII -2.72 -4.34 
GnRH RIII -2.25 -1.04 
GTHa -4.59 -2.20 
LH- β -13.54 -1.11 
CYP19B -2.92 -4.45 
   
Gonad ERα -14.00*** -1.92 
ERβ -9.37*** -2.86 
ARα -3.03** 1.11 
FSHR -1.06 -5.55 
LHR -1.04 -4.63 
HDLR -5.22** -7.33 
LDLR -1.87 -1.09 
HMGR -16.38* 1.17 
StAR -1.79 -8.20 
CYP11A -1.81 -1.44 
CYP17 -15.50*** -1.30 
CYP19A -1.97 -1.67 
20β-HSD -1.11 3.53 
3β-HSD -2.85* -4.08 
Inhibin A -3.94 -1.84 
Activin BA -2.32* -11.70 
Activin BB 1.16 -2.32 
   
Liver ERα -1.92 1.07 
ERβ -1.01 -23.53* 
ARα -1.78 -11.61* 
VTG I 1.31 1.22 
VTG II 1.91 8.91* 
CHG H 1.05 6.45* 
CHG HM 1.43 2.51 
CHG L 3.61 -2.55 
CYP3A 1.54 -2.03 
Annexin max2 -1.59 -29.00** 
   
Animal replicate (n = 4-6). * p < 0.05; ** p < 0.01; *** p < 0.001 
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Figure 3.2. Graphical representation of the transcript response profile of the HPGL-axis in Japanese 
medaka exposed to the greater dose of the TBPH/TBB mixture (1422:1474 µg/ g food, w/w).  Gene 
expression data are represented as striped colour sets with notches denoting sex of medaka. Eight colours 
were used to represent different fold-change thresholds.  Criteria not met denotes a lack of statistical 
difference (p < 0.05) or lack of physiological relevance (< ±2-fold change).  E2, 17β-estradiol; T, 
testosterone; KT, 11-ketotestosterone; FSH, follicle stimulating hormone; LH, luteinizing hormone; HDL, 
high-density lipoprotein; LDL, low density lipoprotein.   
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3.5 Discussion 
There exist multiple lines of evidence from in vitro assays that TBPH and TBB might disrupt 
endocrine functions.  Although in vitro assays are useful for screening of chemicals that might 
have endocrine disrupting effects, these preliminary tests cannot accurately represent the 
complexity of an in vivo system and it is necessary to perform definitive tests to determine 
whether chemicals affect the reproductive capacity of organisms.  The current investigation is the 
first in vivo determination of endocrine disruption in fish exposed to the NBFRs TBPH/TBB.   
3.5.1 Fecundity 
Exposure to the mixture of TBPH/TBB impaired reproductive function of medaka. Cumulative 
fecundity of Japanese medaka exposed to the greatest concentration of TBPH/TBB was inhibited 
by 32%, but no significant effects of the lesser dose of the mixture were observed (Figure 3.1)   
Changes in fecundity can be quantified as an integrative measurement endpoint for 
exposure to endocrine disrupting chemicals and provide a holistic measure of endocrine function.  
For example, the androgen 17β-trenbolone, two imidazole-type fungicides, prochloraz and 
ketoconazole, or the aromatase inhibitor fadrozole, inhibited cumulative fecundity of Japanese 
medaka102-104.  Similar alterations in fecundity were observed in zebrafish (Danio rerio) exposed 
to DEHP, the structural analogue of TBPH51.  Production of eggs by females exposed to the 
control diet was variable but similar to numbers reported in other studies110. Furthermore, a 
profile analysis which contrasts patterns of daily deposition of eggs among different treatment 
groups revealed significant differences between medaka exposed to the solvent control and 
medaka exposed to the greatest concentration of the mixture of TBPH/TBB (Figure C3.S1.).  
The profile analysis also illuminated the timeline of inhibition of deposition of eggs and 
differences in the overall pattern of fecundity.  A within-group analysis of fecundity indicated 
that daily deposition of eggs by females exposed to the greatest concentration of the mixture 
changed across time (Figure C3.S2A.).  Specifically, there appear to be two distinct phases of 
deposition of eggs, an initial toxic insult phase where deposition was significantly inhibited, and 
a compensatory phase where deposition recovered but remained lesser than initial numbers.   
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3.5.2 Abundances of transcripts 
In teleost fishes, regulation of sexual reproduction is dependent on a complex signaling pathway 
mediated by the HPGL axis.  The hypothalamus is a major site of initiating events and regulatory 
feedback of the HPGL signaling network as the organ integrates several endogenous and 
exogenous signals such as E2, T, photoperiod, and temperature.  Gonadotropin-releasing 
hormones (GnRHs) synthesized in the hypothalamus in response to signaling events interact with 
GnRH receptors (GnRHRs) in the pituitary gland to regulate the synthesis and release of 
gonadotropin hormones, follicle stimulating hormone (FSH) and luteinizing hormone (LH).  
FSH and LH consist of a non-covalently linked glycoprotein-hormone α-subunit (GTHα) and a 
specific β-subunit (FSHβ or LHβ)111.  Male and female medaka exposed to the greater dose of 
TBPH/TBB demonstrated global down-regulation of mRNA of GnRHs (cGnRH II, sGnRH), 
GnRHRs (GnRH RI/II/III), and subsequent gonadotropin subunits, GTHα and LH-β (Table 3.2) 
which might have resulted in lesser synthesis and concentrations of FSH and LH in blood 
plasma.  Although abundances of transcripts of many genes were not statistically different in 
medaka exposed to the mixture of TBPH/TBB compared to medaka exposed to the control diet, 
patterns of expression suggest that exposure to these compounds caused down-regulation of gene 
expression along the HPGL axis.  Gonadotropins interact with gonadotropin receptors, FSHR 
and LHR, in gonads and initiate the release of second messenger molecules that regulate 
expression and activity of enzymes that catalyze the synthesis of sex hormones112.  Interactions 
between gonadotropins and their receptors might have implications in the present study as 
expression of FSHR and LHR were significantly down-regulated in female and to a lesser extent 
in male medaka, which might provide another line of evidence of the potential decrease of 
gonadotropin hormones, FSH and LH.  Alternatively, lesser abundances of transcripts of 
GnRHRs might have been caused by direct effects of the mixture on expression of these genes. 
Exposure to the mixture of TBPH/TBB might have disrupted steroidogenesis.  
Significantly lesser abundances of transcripts of activin BA, CYP17 and 3β-HSD in male 
medaka might have inhibited synthesis of T.  In female medaka, although there were no 
statistically significant effects on abundances of transcripts that encode enzymes of 
steroidogenesis, the trend of lesser abundances of several transcripts suggests that synthesis of 
E2 might have been impaired.  If synthesis of E2 was impaired this effect might explain the 
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lesser fecundity by females exposed to the greatest concentration of the mixture of TBPH/TBB. 
Effects of the mixture on abundances of transcripts that encode enzymes of sex hormone 
steroidogenesis are similar to a previous study in which abundances of transcripts of CYP17  
were lesser in a porcine primary testicular model exposed to 0.005 mg/L TBB, but not TBPH100. 
In contrast, the abundance of transcripts of CYP17 was greater in marine medaka and the 
Chinese rare minnow exposed to DEHP, a structural analogue of TBPH49, 113.  The mechanism(s) 
of effects on steroidogenesis is not known, but exposure to the mixture of TBPH/TBB might 
have disrupted the activation of GnRHRs by GnRH and altered subsequent signal transduction 
cascades which affect expression of key steroidogenic enzymes including CYP11A, StAR, 3β-
HSD, CYP19A and CYP17111, 114.  Previous in vitro experiments have supported the observation 
that expression of CYP17, CYP21A  and CYP11A, 3β-HSD, CYP19A are significantly altered 
following exposure to TBB and TBPH, respectively100.  Alternatively, patterns of expression of 
genes involved in steroidogenesis in response to exposures to (anti)estrogenic and/or 
(anti)androgenic compounds might give insight to mechanisms of endocrine disrupting effects of 
TBPH/TBB. For example, expression of CYP17 and 3β-HSD102, and HDLR, CYP17, activin 
BA, HMGR, and StAR was lesser in medaka exposed to the androgen, 17β-trenbolone104 which 
is similar to the profile of expression in medaka exposed to  the mixture of TBPH/TBB.  
Any effects the mixture of TBPH/TBB might have had on steroidogenesis might have 
been caused, at least in part, by disruption of the metabolism of cholesterol.  Among those 
proteins that play important roles in sex hormone steroidogenesis are those that function in the 
synthesis and transport of cholesterol.  HMGR is the rate-limiting enzyme in the mevalonate 
pathway that is important for the synthesis of cholesterol; HDLR is a receptor protein which is 
essential to shuttle cholesterol to the cell from high density lipoproteins that transport cholesterol 
through blood; and StAR performs the rate limiting step in steroidogenesis of transporting 
cholesterol from the outer to inner mitochondrial membrane.  Therefore, any alterations to the 
expression of genes encoding proteins involved in the synthesis and transport of cholesterol 
might increase or decrease the synthesis of E2 and T.   In the current study, abundances of 
transcripts of HDLR and HMGR were lesser in male medaka exposed to the mixture of 
TBPH/TBB, while abundances of transcripts of HDLR and StAR were lesser in female medaka.   
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Effects of the greatest concentration of the mixture of TBPH/TBB on reproductive 
capacity of Japanese medaka might be related to effects on sex hormone receptor proteins.  
Estrogen and androgen receptors are ligand-activated transcription factors that interact with 
endogenous sex hormones to propagate endocrine signals.  However, these receptor proteins can 
also interact with xenoestrogens and xenoandrogens, leading to disruption of endocrine 
functions. Sex steroid receptor proteins are important regulators of the HPGL axis, and in vitro 
investigations using the YES and YAS assays have demonstrated weak antagonistic effects of 
TBPH and TBB on human hERα and hARα, respectively99.  However, because of differences in 
physiology of the ERs/ARs in humans and fishes, and differing complexities of the test systems, 
these results of the YES/YAS assays should be used only as an indicator of potential endocrine 
disrupting effects of TBPH/TBB. Teleost fishes have at least three estrogen receptors (ERα, 
ERβ1, and ERβ2) with differential tissue distributions115, though only two have been included in 
the current rendition of the HPGL axis.    
Exposure to the greatest concentration of the mixture of TBPH/TBB had a significant 
effect on the expression of ERβ and ARα. Significantly lesser abundances of transcripts of these 
receptors in brains from male medaka, but not brains from female medaka, suggest that effects 
were sex-dependent.  Lesser abundances of transcripts of ERβ and ARα in brains from male 
medaka corresponded with the pattern of global down-regulation of gene expression in brains 
from male medaka (GnRHs, GnRHRs, GTHα, LH-β).  ERs and ARs in the hypothalamus and 
pituitary interact with sex hormones as part of negative and positive feedback pathways and 
directly or indirectly regulate expression of gonadotropins and the subsequent production of sex 
hormones107, 111, 116.  Furthermore, estrogen response elements (EREs) in the promoter region of 
ER genes auto-regulate their expression117. Therefore, lesser abundances of transcripts of the 
genes that encode these receptor proteins might be indicative of lesser concentrations of E2 in 
blood plasma or direct interaction of the mixture of TBPH/TBB with receptors, an effect which 
was observed in vitro99. 
Effects of the mixture of TBPH/TBB on abundances of transcripts of sex hormones 
receptors in livers were sex-specific.  However, in contrast to brain, abundances of transcripts of 
ERβ and ARα were significantly lesser in livers from female medaka but were not different in 
livers from male medaka.  In contrast to effects on ERβ, abundances of transcripts of ERα were 
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not significantly affected in female medaka exposed to the mixture of TBPH/TBB. There exists a 
complex interplay between ERα and ERβ and the current dogma suggests that ERα contributes 
almost exclusively to the induction of vitellogenesis through interactions with EREs in the 
promoter of the VTG gene102, 118, whereas ERβ might function as a modulator of the expression 
of ERα 115.  Furthermore, several studies have demonstrated that increased expression of hepatic 
ERα is correlated to the induction of vitellogenesis119, 120.  Though correlative relationships of 
induction exist between ERα and vitellogenesis, several investigations have also shown that 
expression of the VTG gene is not completely dependent on increases in the transcriptional 
activity of the ERα gene.  In these studies, the increase in transcription of VTG required only 
basal or minimal concentrations of ERα, though prolonged induction of vitellogenesis was 
hypothesized to require increases in ERα transcripts117, 121.  Patterns of gene expression in female 
medaka exposed to TBPH/TBB, which include the induction of VTG II, baseline transcript 
abundances of ERα, and lesser abundance of ERβ, a gene which likely does not affect 
vitellogenesis, corresponds to current knowledge regarding complex exchanges and endocrine 
disruption of ERs. 
Greater expression of VTG is a sensitive biomarker of exposure to compounds that are 
agonists of ERs.  Greater abundances of transcripts of VTG II and CHG H in female medaka 
indicate greater concentrations of E2 or activation of ER by the mixture of TBPH/TBB. 
However, the lesser abundances of transcripts of genes in the brain and gonads suggest that 
steroidogenesis might have been suppressed in these individuals, and therefore the greater 
abundances of transcripts of VTG II and CHG H might be due to activation of ER by the 
mixture99.  Additionally, the lack of greater abundances of transcripts of VTG II and CHG H in 
male medaka suggests that effects of TBPH/TBB on ER signaling might be sex specific. Several 
other biomarkers of exposure to agonists of the ER including greater expression of CHG HM, 
CHG L, and VTG I were not induced in medaka exposed to the mixture of TBPH/TBB.  
However, VTG genes are differentially responsive to estrogens, and VTG II has been found to be 
more sensitive to estrogenic effects than VTG I119.   
3.5.3 Conclusions 
The NBFRs TBPH and TBB are endocrine disrupting compounds.  Lesser fecundity and altered 
expression of genes in medaka exposed to 1422:1474 μg/g food, w/w of a mixture of TBPH/TBB 
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are evidence of this effect.  Effects of exposure to the mixture were sex-specific and altered 
expression profiles of key genes across signal initiation events in the brain, steroidogenesis in the 
gonad, and biomarkers of estrogenic effects in livers of female medaka.  The global down-
regulation of abundances of transcripts across all tissues of the HPGL axis is a unique signature 
of endocrine disruption resulting from exposures to TBPH/TBB which has manifested as 
inhibition of fecundity in female medaka.  Fecundity is an integrated measure of endocrine 
disruption and has implications for population level effects as reductions in egg production could 
significantly alter population size and affect the survivability of the species.   
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4 CHAPTER 4: EFFECTS OF THE BROMINATED FLAME 
RETARDANT TBCO ON FECUNDITY AND PROFILES OF 
TRANSCRIPTS OF THE HPGL-AXIS IN JAPANESE MEDAKA 
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PREFACE 
Chapter 2 demonstrated that TBCO did not activate the AhR, but elicited effects in EDC 
screening assays.  TBCO produced antiandrogenic effects in the YAS assay and altered 
concentrations of the steroid hormone, E2, in the H295R assay system.  Following the positive 
responses of TBCO in the in vitro screening level assessment, the goal of Chapter 4 was to 
characterize whole-organism endocrine-related adverse effects and mechanisms of action.  In-
depth characterization of adverse effects and mechanisms of action was critical to increase 
knowledge regarding the profile of toxicity of TBCO, to inform more accurate assessments of 
risk. This chapter was included in the first phase of this research program, the characterization of 
potential toxicities of TBPH, TBB, and TBCO. 
 The content of Chapter 4 was reprinted (adapted) from Aquatic Toxicology, 
(10.1016/j.aquatox.2015.01.018) D.M.V. Saunders, M. Podaima, Steve Wiseman, J.P. Giesy, 
“Effects of the brominated flame retardant TBCO on fecundity and profiles of transcripts of the 
HPGL-axis in Japanese medaka” 160, 180-187. Copyright 2015, with permission from Elsevier. 
Author Contributions: 
David M.V. Saunders (University of Saskatchewan) conceived, designed, and managed the 
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Michelle Podaima (University of Saskatchewan) provided laboratory assistance with fish culture, 
maintenance and in vivo exposure. 
Drs. Steve Wiseman and John P. Giesy (both at University of Saskatchewan) provided 
inspiration, scientific input, and guidance, commented on and edited the manuscript, and 
provided funding for the research. 
 
 
 
 
72 
 
4.1 Abstract 
The novel brominated flame retardant, 1,2,5,6-tetrabromocyclooctane (TBCO) is an additive 
flame retardant which is marketed under the trade name Saytex® BCL-48. TBCO has recently 
been investigated as a potential alternative to the major use brominated flame retardant, 
hexabromocyclododecane (HBCD), which could have major implications for significant 
increases in amounts of TBCO used. Yet there is a lack of information regarding potential 
toxicities of TBCO. Recently, results of in vitro experiments have demonstrated the potential of 
TBCO to modulate endocrine function through interaction with estrogen and androgen receptors 
and via alterations to the synthesis of 17-β-estradiol and testosterone. Further research is required 
to determine potential endocrine disrupting effects of TBCO in vivo. In this experiment a 21-day 
fecundity assay with Japanese medaka (Oryzias latipes) was conducted to examine endocrine 
disrupting effects of TBCO in vivo. Medaka were fed a diet containing either 607 or 58 μg 
TBCO/g food, wet mass (wm). Fecundity, measured as cumulative deposition of eggs and 
fertilization of eggs, as well as abundances of transcripts of 34 genes along the hypothalamus–
pituitary–gonadal–liver (HPGL) axis were measured as indicators of holistic endocrine 
disruption and to determine mechanisms of effects, respectively. Cumulative fecundity was 18% 
lesser by medaka exposed to 58 μg TBCO/g, wm food. However, fecundity of medaka exposed 
to 607 μg TBCO/g, wm food was not significantly different from that of controls. Organ-specific 
and dose-dependent alterations to abundances of transcripts were observed in male and female 
medaka. A pattern of down-regulation of expression of genes involved in steroidogenesis, 
metabolism of cholesterol, and regulatory feedback mechanisms was observed in gonads from 
male and female medaka which had been exposed to the greater concentration of TBCO. 
However, these effects on expression of genes were not manifested in effects on fertilization of 
eggs or fecundity. In livers from male and female medaka exposed to the lesser concentration of 
TBCO greater expression of genes that respond to exposure to estrogens, including vitellogenin 
II, choriogenin H, and ERα, were observed. The results reported here confirm the endocrine 
disrupting potential of TBCO and elucidate potential mechanisms of effects which include 
specific patterns of alterations to abundances of transcripts of genes in the gonad and liver of 
medaka. 
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4.2 Introduction 
Brominated flame retardants (BFRs) are compounds that are added to consumer and industrial 
products to inhibit the propagation of fire. More than 175 brominated compounds are listed as 
flame retardants2, including tetrabromobisphenol A (TBBPA), Deca-technical mixtures of 
polybrominated diphenyl ethers (PBDEs), and hexabromocyclododecane (HBCD). In 2001, 
these three compounds comprised approximately 59% (TBBPA), 26% (DecaBDE), and 8% 
(HBCD) for a combined 93% of the global market of BFRs33. Because of concerns about 
persistence, bioaccumulation, and toxicity (PBT) several governmental agencies and NGOs have 
reviewed the PBT profile and uses of HBCD122-124. HBCD is scheduled to be phased-out of 
European markets by 2015 and from North American markets in the near future31. However, to 
maintain compliance with consumer product flammability standards, replacement compounds 
such as novel brominated flame retardants (NBFRs) must be identified. Consequently, the uses 
and PBT profiles of potential replacement compounds have been reviewed. Assessments of 
alternatives to HBCD have included reports from the U.S. EPA Office of Pollution Prevention 
and Toxics, Design for the Environment (DfE), and Lowell Center for Sustainable Production33, 
125. These reports have investigated several BFR alternatives that are promising substitutes for 
HBCD. 
HBCD is used predominantly in building materials since the compound is mainly added 
to two insulating foams, extruded polystyrene (XPS) and expandable polystyrene (EPS). 
Increased demand for HBCD33, which is fueled in part by growth of the construction sector, 
would also have implications for production volumes of any replacement compound. 1,2,5,6-
Tetrabromocyclooctane (TBCO), which is marketed as Saytex® BCL-48, is an additive NBFR 
that has been investigated as an alternative to HBCD33, 125. Although the thermal stability of 
TBCO does not meet the operating temperature requirements for the manufacture of XPS foam, 
the compound might be incorporated into EPS foams and other materials to which HBCD is 
currently added125. Alternatives assessment reports have attempted to identify key health and 
environmental concerns for potential alternative products since the replacement compound 
should have lesser adverse effects on the health of humans and wildlife. Currently, there is little 
information regarding concentrations of TBCO in the environment or the compound’s PBT 
profile. Thus, there is a lack of adequate information to include TBCO in an alternatives 
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assessment of HBCD. To date only three studies have attempted to detect TBCO in 
environmental matrices126-128, and a single study investigated degradation of TBCO in the 
environment129. In an extensive assessment of potential effects on the environment that was 
conducted by the Environment Agency’s Science Group of the United Kingdom55, TBCO met 
EU criteria as a potential aquatic hazard, and met PBT criteria, specifically due to a large 
potential for persistence and bioaccumulation. Based on QSAR modeling, TBCO was classified 
as a potential acute toxicant to aquatic organisms with a predicted LC50 of <1 mg/L. That report 
also classified TBCO as having a low critical-tonnage, the amount of chemical which would 
have to be on the market to produce concern for an aquatic or terrestrial environment, and the 
compound has been identified as a priority for further substance-specific review. 
There is insufficient toxicity data to properly assess the safety of TBCO as a replacement 
for HBCD. To date, there are only two studies of toxicity of TBCO, both of which investigated 
sub-lethal endpoints99, 100. TBCO was shown, by use of the yeast estrogen/androgen screening 
assays (YES/YAS), to be an antagonist of the human estrogen- and androgen-receptors 
(hERα/hARα). TBCO weakly antagonized the hERα, but antagonized the hARα in a dose 
dependent fashion with a maximal concentration of 300 mg/L resulting in a 74% inhibition of 
activity. In the same study, concentrations of 17β-estradiol (E2) were 3.3-fold greater in a 
H295R cellular assay system exposed to 15 mg/L of TBCO. In a second investigation, synthesis 
of testosterone (T) and E2, possibly because of greater expression of enzymes of steroidogenesis, 
was greater in porcine primary testicular cells exposed to 3.0 mg/L (2.1-fold) and 0.03 mg/L 
(5.9-fold), respectively100. 
Additional studies are required to augment existing aquatic toxicity data regarding TBCO 
for further alternatives assessments and to determine whether the compound has endocrine 
disrupting effects in an in vivo system. Therefore, in the present investigation an OECD 21-day 
short term fecundity assay101 with medaka (Oryzias latipes) was used to quantify effects of 
TBCO on reproduction. Additionally, abundances of transcripts of 34 genes along the 
hypothalamic–pituitary–gonadal–liver (HPGL) axis were quantified to determine potential 
mechanisms of effects. 
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4.3 Materials and methods 
4.3.1 Chemicals and reagents 
1,2,5,6-Tetrabromocyclooctane (TBCO) and 6-fluoro-2,2′,4,4′-tetrabromodiphenyl ether (F-
BDE-47) were obtained from Specs (Delft, SH, Netherlands) and AccuStandard (Connecticut, 
U.S.), respectively. All solvents including acetone, hexane, and dichloromethane (DCM) were of 
analytical grade and obtained from Fisher Scientific (Ontario, Canada). 
4.3.2 Animal care 
Embryos of Japanese medaka (O. latipes) were obtained from the aquatic culture unit at the US 
Environmental Protection Agency Mid-Continent Ecology Division (Minnesota, U.S.) and were 
shipped to the Aquatic Toxicology Research Facility (ATRF) at the University of Saskatchewan. 
Medaka were maintained in 30 L tanks under static-renewal conditions (27 °C 16:8 light/dark) 
and fed to satiation with flaked food and Artemia 3-times daily. All handling of fish and 
exposures were in accordance with protocols approved by the University of Saskatchewan 
Committee on Animal Care and Supply and Animal Research Ethics Board (UCACS-AREB; # 
200090108). 
4.3.3 Exposure protocol 
Fish food was spiked with TBCO according to methods described previously130. Briefly, 
commercial flaked food (Nutrafin Basix Staple Food) was ground and spiked with a 150 mL 
solution of 2.34 x 10−3 M or 2.34 x 10−4 M TBCO in acetone, to make 1000 μg TBCO/g, wm 
food (greater dose), or 100 μg TBCO/g, wm food (lesser dose). Containers containing spiked 
food were shaken for 30 min to ensure thorough mixing of food and chemicals and subsequently 
air dried for 7 hr in a dark fume hood. A similar protocol was used to prepare the acetone-spiked 
control food. Concentrations of TBCO were based on previous in vitro studies of endocrine 
disruption99, 100. 
Exposure protocols were adapted from the fish short term reproductive assay, OECD test 
229101. Medaka (14-wk-old) which ranged in mass from 0.3 to 0.6 g, live mass were randomly 
assigned to 10 L tanks under flow-through conditions. Eight males and eight females were 
placed into each tank and acclimated at 25 ± 2 °C with a 16:8 light/dark cycle and fed to satiation 
for 7-days prior to initiation of experiments. No mortalities were observed during the acclimation 
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period. Fish were exposed to either dose (lesser/greater) of TBCO or the solvent control (acetone 
prepared food) for 21-days. Fish were fed approximately 5% of body mass per day, and food was 
administered twice daily. At each 24 hr interval, total eggs from each tank were collected and 
counted and the number normalized to number of female medaka. Each treatment had four 
replicates. No mortalities were observed during the exposure period. Eggs that were collected at 
days 7, 14, and 21 were visualized by use of a dissecting microscope to assess success of 
fertilization. At termination of the 21-day experiment, fish were euthanized by cervical 
dislocation. Masses of whole body, livers and gonads were recorded to determine hepatic 
somatic index (HSI) and gonadal somatic index (GSI). Livers, brains (including pituitary), and 
gonads from each fish were frozen in liquid nitrogen and stored at −80 °C for quantification of 
abundances of transcripts. 
4.3.4 Chemical analysis 
Three replicates of each food type were homogenized with clean sodium sulphate and a mortar 
and pestle. Stainless steel extraction cells (33 mL) were packed with 1 g of fish food and an in-
cell absorbent (activated alumina) to remove lipids (20:1, absorbent:lipid ratio)106 then extracted 
by use of pressurized liquid extraction (ASE 200, Dionex, California, U.S.). Cells were extracted 
with a 1:1 solution of hexane and DCM at a temperature of 100 °C and 1500 psi for 10 min. The 
resulting extract was diluted 10x and 50 ng of F-BDE-47 was added as an internal standard. 
Three laboratory blanks and matrix spikes (spiked with 100 μg of TBCO) were extracted for 
quality assurance purposes. 
Extracts were analyzed for TBCO by use of an Agilent (California, U.S.) 7890A gas 
chromatograph (GC) system coupled to an Agilent 5975C mass spectrometer (MS) operating in 
the electron impact ionization mode (EI). One microliter samples were injected at an injection 
port temperature of 280 °C in the splitless mode. Chromatographic separation was achieved with 
a 15 m x 250 μm i.d. Rtx-1614 fused silica capillary GC column, which had a 0.1 μm film 
thickness (Restek Corporation, Pennsylvania, U.S.). The carrier gas was helium at a constant 
flow of 1.5 mL/min. The following GC oven temperature program was used: 100 °C for 1 min, 5 
°C/min to 190 °C for 2 min, 20 °C/min to 220 °C for 2 min, and 40 °C/min to 300 °C for 4 min. 
The GC/MS transfer line was maintained at 280 °C. Selected ion monitoring of m/z 267/187 and 
343/234 was used for quantification/confirmation of TBCO and F-BDE-47. TBCO was 
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quantified by use of the internal standard method using F-BDE-47. TBCO was not detected in 
blank samples. The mean and standard error of the mean for TBCO recovery in the matrix spikes 
was 87 ± 0.12%. 
4.3.5 Gene selection and graphical model 
A total of 34 genes, which represent key signaling pathways in the brain, gonad, and liver, genes 
in steroidogenesis, and biomarkers of exposure to estrogens in the HPGL axis of Japanese 
medaka were selected for study based on previous results102-104, 107, 130. Primers were based on 
sequences available in the NCBI GeneBank database and were designed by use of NCBI Primer-
Blast software. Sequences of nucleotide primers and efficiencies are given in the appendix 
(Table C4.S1.). 
Graphical models depicting abundances of transcripts of 34 genes across the HPGL axis 
were produced by use of GenMapp 2.0 (Gladstone Institutes, California, U.S.) and were 
constructed and maintained by Dr. Xiaowei Zhang (Nanjing University, JS, China). Criteria for 
inclusion in the model were (a) ≥2-fold change in abundances of transcripts to represent 
physiological relevance, and (b) statistically significant changes in abundances of transcripts 
(Figure 2 and Figure 3). 
4.3.6 Quantitative real-time PCR 
Total RNA was extracted from livers, brains, and gonads by use of the RNeasy Plus Mini Kit 
(Qiagen, Ontario, Canada) according to the protocol provided by the manufacturer. 
Concentrations of RNA were determined by use of a NanoDrop ND-1000 spectrophotometer 
(Nanodrop Technologies, Delaware, U.S.) and stored at −80 °C. First strand cDNA was 
synthesized from 1 μg of RNA and by use of the QuantiTect Reverse Transcription Kit (Qiagen) 
according to the protocol provided by the manufacturer. 
Real-time quantitative PCR (qPCR) was performed according to previously published 
methods130. Amplification of a single PCR product was confirmed by melt curve analysis and 
target gene transcript abundance was quantified by use of the ddCt method by normalizing to 
abundance of transcripts of the RPL-7 housekeeping gene.  
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4.3.7 Statistical analysis 
Statistical analysis was conducted by use of SPSS statistics software (V.20). Normality of data 
was determined by use of the Kolmogorov–Smirnov test and homogeneity of variance was 
determined by use of Levene’s test. Unless otherwise noted, data was analyzed by use of analysis 
of variance (ANOVA), followed by Tukey’s test. Differences in daily production of eggs, within 
groups, was determined by use of a repeated-measures ANOVA. If assumptions of sphericity 
were violated a Greenhouse–Geisser correction was applied. Further, post hoc tests were 
corrected by use of a Bonferroni adjustment. Due to the conservative nature of the Bonferroni 
adjustment, data points were pooled according to data trends and statistical differences which 
were assessed by pairwise comparisons. All post hoc comparisons in repeated measures analysis 
were made to group 1 which represented the initial conditions of egg deposition in the 
experiment. Profile analyses were performed by use of a MANOVA test. A probability level of p 
≤ 0.05 was considered significant except in cases of Bonferroni adjustments. All data are shown 
as mean ± standard error of mean (S.E.M.). 
4.4 Results 
4.4.1 Concentrations of chemicals in food 
Concentrations of TBCO differed from the reported nominal concentrations in two of three food 
types (Table 4.1). The measured concentration of TBCO was 58% and 61% of the desired 
nominal concentration in both types of spiked food. Concentrations of TBCO in food spiked with 
clean acetone were less than method limits of detection. 
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Table 4.1. Concentrations of TBCO in three diets used in the 21-day fecundity assay.  
Concentrations of TBCO are presented as mean ± standard error (μg/g, wm food).  Three 
replicates were extracted and analyzed for each food type. 
Feed [nominal] TBCO  
Control ND 
1000 μg/g, wm food 607±65.2 
100 μg/g, wm food 57.7±4.95 
ND: below limit of detection  
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4.4.2 Chemical-induced effects on fecundity of medaka 
There were no significant differences in HSI or GSI of male or female medaka exposed to either 
concentration of TBCO compared to medaka exposed to the solvent control (Table C4.S2.). 
Fertility of male fish was not significantly affected since the proportion of fertilized eggs 
collected at days 7, 14, and 21 were not different between fish exposed to either concentration of 
TBCO or the solvent control. 
Exposure to TBCO affected fecundity of medaka. There were significant differences in 
cumulative production of eggs between female medaka exposed to 58 μg TBCO/g, wm food and 
solvent controls, but there were no differences observed between medaka exposed to the greater 
concentration of TBCO and solvent controls (Figure 1). Numbers of eggs produced relative to 
solvent control were 95% ± 6.2 and 82% ± 4.0 by female fish exposed to greater and lesser 
concentrations of TBCO, respectively. Further statistical analyses were conducted to augment 
findings of the cumulative fecundity analysis. Profiles of daily production of eggs were 
significantly different between fish exposed to the control and the lesser concentration of TBCO 
but not the greater concentration of TBCO (Figure C4.S2.). A within-group repeated measures 
analysis also revealed significant differences in daily deposition of eggs over time by fish 
exposed to the lesser concentration of TBCO (Figure C4.S3A.), but not the greater concentration 
of TBCO or the solvent control. Across 21-repeated measures, a post hoc analysis with a 
Bonferroni adjustment was prohibitively conservative. To accommodate the conservative nature 
of the Bonferroni adjustment, time points were grouped according to statistical differences in 
daily deposition of eggs (Figure C4.S3B.). Pooled group 1 represented the initial period of 
deposition of eggs and was set at 100% fecundity. Statistically significant differences between 
initial depositions of eggs, group 1, and all subsequent groups (2–4) were observed. 
 4.4.3 Gene expression profiles 
Abundances of transcripts of genes of the HPGL axis were quantified in male and female 
medaka exposed to the greater and lesser concentrations of TBCO. There were no statistically 
significant changes in abundances of transcripts in brains from male or female medaka exposed 
to either concentration of TBCO (Table 4.2). 
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Figure 4.1.  Cumulative production of eggs (fecundity) by medaka exposed to the greater 
concentration of the TBCO (607 µg/ g food, w/w), the lesser concentration of TBCO (58 µg/g 
food, w/w) and solvent control.  The values represent the mean cumulative number of eggs per 
female over a 21-day period.  The experiment included 4 replicate tanks, and each contained 8 
female/male medaka.  Asterisks indicate a significant difference (p < 0.05) when compared to the 
control group. 
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Table 4.2. Response profiles of genes of the hypothalamic-pituitary-gonadal-liver 
(HPGL) axis in Japanese medaka exposed to the greater (607 μg/g food) and lesser 
(58 μg/g food) concentrations of TBCO.  Transcript responses are expressed as fold 
change compared to corresponding solvent controls 
 Male  Female 
Tissue Gene High Dose Low Dose  High Dose Low Dose 
  
Brain ERα -2.37 1.11  -3.62 -1.09 
 ERβ -2.12 1.13  -2.14 -2.07 
 ARα -1.99 1.70  -3.24 1.03 
 Neuropep Y -6.91 -1.28  1.13 1.37 
 cGnRH II 1.22 2.71  2.13 1.45 
 mfGnRH 3.33 1.49  5.39 2.72 
 sGnRH -4.92 1.40  -9.30 -1.51 
 GnRH RI 11.51 1.10  -1.82 -3.73 
 GnRH RII -1.05 1.79  1.36 2.23 
 GnRH RIII 3.46 1.42  4.67 1.69 
 GTHa -2.69 -8.55  -6.63 1.56 
 LH- β -1.39 -16.15  -3.48 1.49 
 CYP19B -5.45 1.61  1.13 1.70 
  
Gonad ERα -5.19** -4.35**  -6.72* 1.71 
 ERβ -14.77** -1.44  -6.22* 1.12 
 ARα -2.45* -2.36**  -8.94*** 1.89 
 FSHR -2.49 -1.19  1.55 1.00 
 LHR -1.06 -3.60  -2.25 -2.16 
 HDLR -19.10** -1.21  -21.20* -1.45 
 LDLR -1.63 -1.59  -12.13* 2.92 
 HMGR -16.27** -1.09  -7.37 1.47 
 StAR -16.37* 3.19  -16.26* -4.79 
 CYP11A -1.53 1.04  1.60 1.01 
 CYP17 -13.63** -1.65  -2.71 -1.07 
 CYP19A 1.33 -7.76  1.47 -1.53 
 20β-HSD -3.00 -3.66  -1.75 1.00 
 Inhibin A -6.04 -20.82*  -8.03* 2.01 
 Activin BA 1.52 -18.70*  -12.94* 1.64 
  
Liver ERα 8.79 6.31  -10.09 11.83* 
 ERβ -5.23 -1.33  1.93 -16.86* 
 ARα -14.22 -7.63  -26.81 -12.06 
 VTG I 1.60 3.82  2.32 5.04 
 VTG II 1.75 12.99  -1.95 18.37* 
 CHG H -1.75 1.45  2.59 8.40* 
 CHG HM 1.97 5.87*  3.44 2.46 
 CHG L 1.70 13.70  -1.77 2.86 
 CYP3A 2.54 28.29**  -5.46 -2.03 
 Annexin max2 -2.52 -2.77  -1.01 -8.32* 
Animal replicate (n = 4-6). * p < 0.05; ** p < 0.01; *** p < 0.001 
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Exposure to TBCO affected expression of genes in gonads from male and female 
medaka. Some effects of TBCO on expression of genes in gonads were concentration-dependent. 
Abundances of transcripts of HDLR, StAR, and ERβ were significantly lesser in gonads from 
male and female fish exposed to the greater concentration of TBCO but not the lesser 
concentration of TBCO (Table 4.2 and Figures 4.2, 4.3). Some effects of TBCO on expression of 
genes were sex-specific. Abundances of transcripts of HMGR and CYP17 were lesser only in 
gonads from male medaka whereas the abundance of transcripts of LDLR was lesser only in 
gonads from female medaka (Table 4.2 and Figures 4.2, 4.3). Some effects of TBCO on gene 
expression were neither sex dependent nor concentration dependent. Abundances of transcripts 
of ERα and ARα were significantly lesser in males exposed to either concentration of TBCO and 
in females exposed to the greater concentration of TBCO (Table 4.2 and Figures 4.2, 4.3). 
Abundances of transcripts of Inhibin A and Activin BA were significantly less in males exposed 
to the lesser concentration of TBCO and in females exposed to the greater concentration of 
TBCO (Table 4.2 and Figures 4.2, 4.3). 
TBCO affected abundances of transcripts of several genes in livers from male and female 
medaka exposed to the lesser concentration, but not the greater concentration, of TBCO (Table 
4.2). Abundances of transcripts of ERα, VTG II, and CHG H were significantly greater, while 
ERβ and Annexin max2 were significantly lesser in female medaka exposed to the lesser 
concentration of TBCO (Figure 4.2). Abundances of transcripts of CHG HM and CYP3A were 
significantly greater in male medaka exposed to the lesser concentration of TBCO (Figure 4.2). 
The pattern of gene expression in livers from male and female medaka exposed to the lesser 
concentration of TBCO was very similar, though many alterations to abundances of transcripts 
were not statistically significant (Table 4.2).  
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Figure 4.2. Graphical representation of the transcript response profile of the HPGL-axis in 
Japanese medaka exposed to the lesser concentration of TBCO (58 µg/ g food).  Gene expression 
data are represented as striped colour sets with notches denoting sex of fish. Eight colours were 
used to represent different fold-change thresholds.  Criteria not met denotes a lack of statistical 
difference (p < 0.05) or lack of physiological relevance (< ±2-fold change).  E2, 17β-estradiol; T, 
testosterone; KT, 11-ketotestosterone; FSH, follicle stimulating hormone; LH, luteinizing 
hormone; HDL, high-density lipoprotein; LDL, low density lipoprotein.   
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Figure 4.3. Graphical representation of the transcript response profile of the HPGL-axis in 
Japanese medaka exposed to the greater concentration of TBCO (607 µg/ g food).  Gene 
expression data are represented as striped colour sets with notches denoting sex of fish. Eight 
colours were used to represent different fold-change thresholds.  Criteria not met denotes a lack 
of statistical difference (p < 0.05) or lack of physiological relevance (< ±2-fold change).  E2, 
17β-estradiol; T, testosterone; KT, 11-ketotestosterone; FSH, follicle stimulating hormone; LH, 
luteinizing hormone; HDL, high-density lipoprotein; LDL, low density lipoprotein.   
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4.5 Discussion 
TBCO is currently a low-production NBFR which has been assessed as a potential aquatic 
hazard with low-critical tonnage. Furthermore, TBCO is a potential replacement compound for 
HBCD, and due to the pending phase out of HBCD from global markets, the production volume 
of TBCO might drastically increase in the near future, which might increase risk to the 
environment including aquatic systems. It is of great importance to understand the persistence, 
bioaccumulation and toxic effects of TBCO prior to potential increases in production volumes. 
This investigation is an initial in vivo assessment of the endocrine disrupting potential of TBCO 
in a standard laboratory fish and is critical to generate meaningful data for risk and alternatives 
assessments. 
4.5.1 Fecundity 
Exposure to TBCO impaired reproductive performance of female medaka. Cumulative fecundity 
of medaka exposed to the lesser concentration of TBCO was inhibited by 18%, but no significant 
effects were observed in medaka exposed to the greatest concentration of TBCO (Figure 4.1). 
Similar disparities of effects on fecundity between fish exposed to the greater and lesser 
concentrations of TBCO were revealed by use of profile analyses and within-group repeated 
measures analyses. The profile analyses, which contrasts patterns of daily deposition of eggs 
among different treatment groups, revealed significant differences between medaka exposed to 
the lesser concentration of TBCO and controls, but not between medaka exposed to the greater 
concentration of TBCO and controls (Figure C4.S2.). The within-group repeated-measures 
analysis of fecundity showed that daily deposition of eggs by medaka exposed to the lesser 
concentration of TBCO changed over the duration of the study. This effect was not observed in 
medaka exposed to the greatest concentration of TBCO or controls (Figure C4.S3.). Furthermore, 
there were two distinct phases of deposition of eggs by medaka exposed to the lesser 
concentration of TBCO, an initial toxic insult phase where deposition was significantly inhibited, 
and a compensatory phase in which deposition slightly recovered but remained lesser than initial 
numbers (Figure C4.S3.). 
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4.5.2 Abundances of transcripts 
Differences between effects of the greater and lesser concentrations of TBCO on fecundity might 
have been caused by differences in effects on expression of genes of the HPGL axis. Abundances 
of transcripts of several genes across the HPGL axis were altered in medaka exposed to either 
concentration of TBCO, but profiles of gene expression were unique between the two 
concentrations. With the exception of the brain, in which changes in gene expression were not 
significant, effects on gene expression were organ specific (Table 4.2). Based on the number of 
statistically significant changes in expression, gonad was the most sensitive tissue in males and 
in females exposed to the greater concentration of TBCO. But it is not known if changes in 
abundance of transcript in gonads from males exposed to TBCO affected fecundity of females. 
Livers from female medaka exposed to the lesser concentration of TBCO were more sensitive 
than gonads. These organ specific alterations might help to explain differences in inhibition of 
fecundity between medaka exposed to the lesser and greater concentrations of TBCO and have 
identified liver as the target tissue of effect. 
Abundances of transcripts of several genes were significantly altered in gonads from 
male and female medaka exposed to the greater concentration of TBCO and in male medaka 
exposed to the lesser concentration of the compound. Abundances of transcripts of StAR, HDLR, 
HMGR, and LDLR, which are important for the synthesis and transport of cholesterol, were 
lesser in either male or female medaka exposed to the greater concentration of TBCO (Figure 
4.3). Because cholesterol is the precursor of sex hormones, any significant alterations to 
abundances of transcripts encoding proteins involved in synthesis and transport of cholesterol 
might affect concentrations of T or E2. Several studies that utilized in vitro assays have shown 
that exposure to TBCO caused alterations to concentrations of T and E2. Concentrations of E2 
increased in H295R cells exposed to 15 mg/L TBCO99, while concentrations of T and E2 were 
significantly greater in primary porcine testicular cells exposed to 0.03 mg/L TBCO100. 
Additionally, genes involved in sex hormone steroidogenesis and regulatory networks in the 
HPGL axis, including CYP17, Inhibin A, Activin BA, ERα, ERβ, and ARα were down-regulated 
in male and/or female medaka exposed to the greatest concentration of TBCO (Figure 4.3). In 
vitro assessments of the endocrine disrupting effects of TBCO have shown alterations to 
abundances of transcripts of several genes involved in steroidogenesis, including CYP17 and 
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CYP21A100, and antagonistic interaction of TBCO with the human ERα and ARα99. Significant 
alterations to the expression of genes involved in steroidogenesis and regulatory networks might 
disrupt reproductive performance in fish by affecting homeostasis of sex hormones and altering 
normal functions of the HPGL axis. Yet female medaka exposed to the greater concentration of 
TBCO did not demonstrate inhibition of fecundity or altered patterns of deposition of eggs, and 
there were no adverse effects on fertility of males. In this experiment, fecundity was assessed as 
an integrated measure of endocrine function, but concentrations of sex hormones were not 
measured. The pattern of lesser abundances of transcripts in gonads from medaka exposed to the 
greater concentration of TBCO would likely lead to reductions in concentrations of sex 
hormones. However, several compensatory networks present in the HPGL axis might have offset 
this effect thereby preventing effects on fecundity. 
Abundances of transcripts of several genes were altered in livers from female medaka 
exposed to the lesser concentration of TBCO, which might have caused the lesser cumulative 
deposition of eggs. Furthermore, there were no significant alterations to abundances of 
transcripts in livers from male or female medaka exposed to the greater concentration of TBCO 
and no inhibition of cumulative deposition of eggs was observed. These results support the 
proposed link between altered expression of genes and inhibition of fecundity and provide a 
mechanistic explanation of effects on apical endpoints. Female medaka exposed to the lesser 
concentration of TBCO had significantly greater abundances of transcripts of ERα but lesser 
abundances of transcripts of ERβ (Figure 4.2). Current dogma suggests that activation of ERα by 
E2 stimulates vitellogenesis whereas ERβ might solely function as a modulator of expression of 
ERα. Several studies have demonstrated that increased expression of hepatic ERα is correlated to 
the induction of vitellogenesis119, 120, 131 whereas expression of ERβ might be down-regulated by 
estrogenic compounds115, 131. A pattern of up-regulation of expression was observed in genes 
regulated by ERs and involved in vitellogenesis, which include VTGs and CHGs, though only 
VTG II and CHG H were significantly increased. However, VTG genes are differentially 
responsive to estrogens, and VTG II has been shown to be more sensitive to estrogenic effects 
than VTG I119. Because expression of VTGs and CHGs occurs in response to E2, greater 
abundances of these transcripts is likely a response to xenoestrogens or elevated concentrations 
of endogenous E2132. A similar pattern was observed in male medaka exposed to the lesser 
concentration of TBCO but the effects were not statistically significant (Table 4.2). It is 
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interesting to note that female medaka which presented inhibition of fecundity also presented 
increases in expression of VTG and CHG, two gene groups which are associated with production 
of eggs. Incongruities between gene expression and fecundity can likely be attributed to the 
complexity of HPGL signaling and regulatory networks, and timing of spawning patterns. The 
pattern of greater expression of ERα and lesser expression of ERβ is consistent with patterns of 
gene expression in response to xenoestrogens or endogenous E2 and, paired with increases in 
biomarkers of estrogenic exposure, provide further evidence for estrogenic effects of TBCO. 
4.5.3 Conclusions 
The NBFR, TBCO, is an endocrine disrupting compound and might alter estrogen signaling. 
Lesser fecundity observed in medaka exposed to the lesser concentration of TBCO, and patterns 
of gene expression that mimicked patterns of expression known to be caused by exposure to 
(xeno)-estrogens are evidence of this effect. Alterations to abundances of transcripts in medaka 
which experienced inhibition of fecundity occurred almost exclusively in the liver and were 
associated with vitellogenesis. In contrast, alterations to abundances of transcripts in medaka that 
experienced no inhibition of fecundity occurred almost exclusively in gonads and were 
associated with sex hormone steroidogenesis and metabolism of cholesterol. Differences in 
inhibition of fecundity experienced between dosing groups was likely attributable to different 
patterns of altered expression of genes. 
Although there is little research regarding the toxicity of TBCO, the compound has been 
designated as a potential aquatic hazard, as having low critical-tonnage, and is an option to 
replace HBCD, a high production volume chemical124. Current research into the PBT 
characteristics of TBCO might represent a unique opportunity for researchers to accurately 
assess risk prior to incidences of environmental contamination or toxic insult.  
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5 CHAPTER 5: DETECTION, IDENTIFICATION, AND 
QUANTIFICATION OF HYDROXYLATED BIS(2-ETHYHEXYL)-
TETRABROMOPHTHALATE ISOMERS IN HOUSE DUST 
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PREFACE 
Following the determination of endocrine disrupting effects of TBPH, TBB, and TBCO in 
Chapters 2, 3, and 4, environmental concentrations of these NBFRs were required to define more 
accurate assessments of exposure and eventually inform assessments of risk. The objective of 
Chapter 5 was to develop a novel and improved analytical method by use of a newly acquired 
ultra-high resolution mass spectrometer (Q Exactive Orbitrap instrument) and determine 
concentrations of TBPH, TBB, and TBCO in dust collected from ECEs.  Yet, upon analysis of 
analytical standards of TBPH and TBB, several unknown compounds were observed.  Further 
investigation of the technical products Firemaster® 550 and BZ-54 confirmed the presence of 
these unknown contaminants.  The amended objective of this chapter was to identify these novel 
compounds in analytical standards and technical products and investigate their presence and 
quantities in dust from ECEs. Though the hydroxylated contaminants of both TBPH and TBB 
were characterized in standards and environmental samples, the investigation of hydroxylated 
TBB was not included in this thesis.  This chapter was included in the second phase of this 
research program, the characterization of exposure to TBPH and TBB in the indoor environment. 
The content of Chapter 5 was reprinted (adapted) from Environmental Science & 
Technology, (10.1021/es505743d)  H. Peng*, D.M.V. Saunders*, J. Sun, G. Codling, S. 
Wiseman, P.D. Jones, J. P. Giesy, “Detection, identification, and quantification of hydroxylated 
bis(2-ethylhexyl)-tetrabromophthalate isomers in house dust” 49, 2999-3006. Copyright 2015, 
with permission from the American Chemical Society.  
Author Contributions: 
* Indicates co-first authorship.  Dr. Peng Hui and David Saunders were listed in alphabetical 
order. 
David M.V. Saunders (University of Saskatchewan) conceived, designed, and managed the 
experiment, generated and analyzed the data, prepared all figures, and drafted the manuscript. 
Dr. Hui Peng (University of Saskatchewan) designed the experiment, helped with data analysis 
and preparation of figures, and co-drafted the manuscript. 
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Dr. Jianxian Sun (University of Saskatchewan) laboratory aid in the preparation and processing 
of environmental samples. 
Dr. Gary Codling (University of Saskatchewan) provided technical support for analytical 
instrumentation. 
Drs. Steve Wiseman, Paul D. Jones, and John P. Giesy (all at University of Saskatchewan) 
provided inspiration, scientific input, and guidance, commented on and edited the manuscript, 
and provided funding for the research. 
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5.1 Abstract 
Ultra-High Resolution LC/mass spectrometry (LC-UHRMS; Thermo Fisher Q-Exactive) was 
used to identify two novel isomers of hydroxylated bis(2-ethylhexyl)-tetrabromophthalate (OH-
TBPH) which were unexpectedly observed in a commercial standard of TBPH. By combining 
ultra-high resolution (UHR) mass spectra (MS1), mass errors to theoretical [TBPH-Br+O]− were 
2.1 and 1.0 ppm for the two isomers, UHR-MS2 spectra and NMR analysis; the structures of the 
two compounds were identified as hydroxylated TBPH with a hydroxyl group on the aromatic 
ring. Relatively great proportions of the two isomers of OH-TBPH were detected in two 
technical products, Firemaster® 550 (FM-550; 0.1% and 6.2%, respectively) and Firemaster® BZ 
54 (BZ-54; 0.1% and 7.9%), compared to a commercial standard (0.4% and 0.9%). To 
simultaneously analyze OH-TBPH isomers and TBPH in samples of dust, a method based on 
LC-UHRMS was developed to quantify the two compounds, using negative and positive ion 
modes, respectively. The instrumental limit of detection for TBPH was 0.01 μg/L, which was 
200–300 times better than traditional methods (2.5 μg/L) based on gas chromatography–mass 
spectrometry. The analytical method combined with a Florisil cleanup was successfully applied 
to analyze TBPH and OH-TBPH in 23 indoor dust samples from Saskatoon, Saskatchewan, 
Canada. Two OH-TBPH isomers, OH-TBPH1 and OH-TBPH2, were detected in 52% and 91% 
of dust samples, respectively. Concentrations of OH-TBPH2 (0.35 ± 1.0 ng/g) were 10-fold 
greater than those of OH-TBPH1 (0.04 ± 0.88 ng/g) in dust, which was similar to profiles in FM-
550 and BZ-54. TBPH was also detected in 100% of dust samples with a mean concentration of 
733 ± 0.87 ng/g. A significant (p < 0.001) log–linear relationship was observed between TBPH 
and OH-TBPH isomers, further supporting the hypothesis of a common source of emission. 
Relatively small proportions of OH-TBPH isomers were detected in dust (0.01% ± 0.67 OH-
TBPH1 and 0.1% ± 0.60 OH-TBPH2), which were significantly less than those in technical 
products (p < 0.001). This result indicated different environmental behaviors of OH-TBPH and 
TBPH. Detection of isomers of OH-TBPH is important, since compounds with phenolic groups 
have often shown relatively greater toxicities than non-hydroxylated analogues. Further study is 
warranted to clarify the environmental behaviors and potential toxicities of OH-TBPH isomers. 
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5.2 Introduction 
Brominated flame retardants (BFRs) have caused concern to regulatory agencies and the general 
public133, particularly regarding polybrominated diphenyl ethers (PBDEs), which were the most 
widely used BFRs134. Previous studies have reported that PBDEs are ubiquitous in the 
environment135-137, bioaccumulated into organisms138-140, and can cause toxicity141-143. Since 
2004, due to these concerns, production and sales of two major commercial PBDE products, 
Penta- and Octa-BDEs, have been voluntarily withdrawn or banned in some parts of the world144. 
Following the phase-out of PBDEs, the BFR industry has begun to use alternative brominated 
compounds to replace PBDEs. Investigations of the behaviors of these alternative BFRs and 
assessment of their potential health and ecological risk is thus of special interest. 
Firemaster® 550 (FM-550) and Firemaster® BZ-54 (BZ-54) are two PBDE replacement 
mixtures, both of which contain 2-ethylhexyl-2,3,4,5-tetrabromo-benzoate (TBB) and bis(2-
ethylhexyl)-tetrabromophthalate (TBPH). The percentage of TBPH in FM-550 and BZ-54 is 
15% and 30%, respectively30. Since TBPH is a brominated analogue of bis(2-
ethylhexyl)phthalate (DEHP), a well-studied compound that has exhibited a range of 
toxicities145-147, concerns are emerging regarding the potential health risks of TBPH. For 
example, metabolic pathways for TBPH similar to those of DEHP have been observed. In vitro 
metabolism of TBPH has resulted in production of a monoester metabolite, mono-(2-ethyhexyl) 
tetrabromophthalate (TBMEHP)78. Furthermore, hepatotoxic effects and interaction with the 
peroxisome proliferator activated receptor (PPAR), known effects of DEHP, have also been 
elicited by the monoester metabolite of TBPH54. A recent study, using in vitro cellular assays, 
has also reported the antiestrogenic potency of TBPH99. In addition to potential toxicities, results 
of previous studies have demonstrated the widespread presence of TBPH in house dust38, air9, 
sediment148, and tissues of wildlife149. Of particular importance, a recent study has reported the 
presence of TBPH in blood serum and milk of nursing women, which indicates its potential risk 
to the health of humans, particularly infants150. Since TBPH has been detected at relatively great 
concentrations in dust (geometric mean (GM) concentration was 234 ng/g, dry mass (dm)), 
which was comparable to concentrations of hexabromocyclododecane (HBCD; GM was 354 
ng/g) in the same samples from the United States, indoor dust ingestion is expected to be one of 
95 
 
the primary routes of exposure38. Three other studies have also found TBPH in house dust from 
California and Norway at similar concentrations, ng/g, dm56, 151, 152.  
The study reported here developed a sensitive liquid chromatography ultrahigh resolution 
mass spectrometry (LC-UHRMS) method to analyze TBPH in dust samples collected from 
houses in Saskatoon, Saskatchewan (SK), Canada. Using UHRMS, two isomers of hydroxylated 
TBPH (Figure 5.1) in commercial standards and technical products were unexpectedly detected. 
Finally, the UHRMS method combined with a Florisil cartridge cleanup was used to 
simultaneously analyze TBPH and OH-TBPH isomers in 23 dust samples from eight homes in 
Saskatoon, SK, Canada. 
5.3 Materials and methods 
5.3.1 Chemicals and reagents 
Native TBPH standard (purity, 98.1%) was purchased from AccuStandard (Connecticut, U.S.), 
and its surrogate, mass-labeled standard d34,
13C6-TBPH (purity, >98%) was purchased from 
Wellington Laboratories Inc. (Ontario, Canada). Commercial standards of TBPH (purity, >95%) 
were purchased from Waterstone Technology (WST; Indiana, U.S.), and BZ-54 and FM-550 
technical products were gifts from the Heather Stapleton Research Group at Duke University, 
Nicholas School of the Environment. OH-TBPH2 was purified by use of the HPLC fraction from 
BZ-54 technical products. Florisil (6 cm3, 1 g, 30 μm) solid-phase extraction (SPE) cartridges 
were purchased from Waters (Massachusetts, U.S.). Ammonia solution (28–30%) was purchased 
from Alfa Aesar Chemical Industries (Ward Hill, Massachusetts, U.S.). Dichloromethane 
(DCM), methanol, and acetone were all “omni-Solv” grade and were purchased from EMD 
Chemicals (New Jersey, U.S.). 
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Figure 5.1. Chemical structures of TBPH and two identified OH-TBPH isomers. 
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5.3.2 Purification of OH-TBPH by HPLC fractionation 
HPLC fractionation was used to isolate OH-TBPH from technical product BZ-54 which 
contained only TBB and TBPH compared to FM-550. Fractions were collected at 2-min interval 
from 0 min to 120 min, and then OH-TBPH2 in each fraction was quantified by use of UHPLC-
Q Exactive after 10,000-fold dilution with a mixture of methanol and acetone (v/v, 1:1). 
Fractions which contained OH-TBPH2 were collected and combined, and then evaporated. 
Fractionation was conducted by use of a Betasil C18 column (5 μm; 22.1 mm x 150 mm; 
Thermo Fisher Scientific) which was maintained at 30 °C.  The flow rate and the injection 
volume were 6 mL/min and 100 μL, respectively. Mixture of methanol and ultrapure water (v/v, 
8:2) containing 0.1% NH4OH (v/v) was used as mobile phase. After purification, the OH-
TBPH2 was characterized by 1H NMR spectra (Figure C5.S4.). The purified OH-TBPH2 (0.1 
mg/L) was also characterized using UHPLC-Q Exactive with full scan range from m/z 200-2000. 
The intensity of OH-TBPH2 was 100-folds higher than TBPH, indicated the relatively high 
purity of the OH-TBPH2 standard (Figure C5.S4.). 
5.3.3 Collection of dust 
Twenty-three samples of dust were collected from eight houses (2–3 dust samples per house) 
across Saskatoon, SK, Canada from May to August, 2013. Dust was collected by use of a Eureka 
Mighty-Mite vacuum cleaner (model 3670)38, 153 into a cellulose extraction thimble (Whatman 
International, Pennsylvania, U.S.) which was inserted between the vacuum tube extender and 
suction tube and was secured by use of a metal hose clamp. Extraction thimbles were Soxhlet-
extracted with DCM for 2 hr prior to use. The equivalent of the entire floor-surface area was 
sampled in each room. All sampling components upstream of the extraction thimble were 
cleaned after each sampling event. 
5.3.4 Sample pretreatment and analysis 
Approximately 0.1 g, dm of dust was transferred to a 15 mL centrifuge tube. Twenty microliters 
(20 μL) of 1 mg/L mass-labeled internal standard d34, 13C6-TBPH, and 5 mL of methanol were 
added to the house dust samples for extraction. Samples were vigorously shaken (Heidolph Multi 
Reax Vibrating Shaker, Brinkmann) for 30 min followed by sonication for an additional 30 min, 
and the methanol extract was separated by centrifugation at 1669g for 10 min and transferred to a 
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new tube. The extraction was repeated using 5 mL of DCM. The methanol and DCM extracts 
were combined and blown to dryness under a gentle stream of nitrogen. Extracts were dissolved 
in 500 μL of DCM and loaded onto Florisil cartridges, which had been sequentially conditioned 
by 6 mL of acetone and DCM. TBPH was eluted from the Florisil cartridges using 5 mL of 
DCM. Following a washing rinse of 4 mL of acetone, OH-TBPH isomers were eluted to a new 
tube using 5 mL of methanol/DCM mixture (v/v, 1:1). Final extracts were blown to dryness 
under a gentle stream of nitrogen and reconstituted with 200 μL of acetone for analysis. 
5.3.5 Instrumental analysis 
Aliquots of extracts were analyzed using a Q Exactive mass spectrometer (Thermo Fisher 
Scientific) interfaced to a Dionex UltiMate 3000 ultra high-performance liquid chromatography 
(UHPLC) system (Thermo Fisher Scientific). Separation of TBPH and OH-TBPH was achieved 
with a Betasil C18 column (5 μm; 2.1 mm × 100 mm; Thermo Fisher Scientific) with an 
injection volume of 5 μL. Ultrapure water (A) and methanol containing 0.1% NH4OH (v/v) (B) 
were used as mobile phases. Initially, 20% B was increased to 80% in 3 min, then increased to 
100% at 8 min and held static for 19.5 min, followed by a decrease to initial conditions of 20% B 
and held for 2 min to allow for column re-equilibration. The flow rate was 0.25 mL/min. The 
column and sample chamber temperatures were maintained at 30 and 10 °C, respectively. Data 
were acquired using full scan mode and selected ion monitoring (SIM). Briefly, MS scans (200–
2000 m/z) were recorded at resolution R = 70 000 (at m/z 200) with a maximum of 3 × 106 ions 
collected within 200 ms, based on the predictive automated gain control. SIM scans were 
recorded at a resolution R = 70 000 (at m/z 200) with a maximum of 5 × 104 ions collected within 
200 ms, based on the predictive automated gain control, with isolation width set at 2.0 m/z. For 
MS2 identification, selected ions were fragmented in the collision cell utilizing higher-energy 
collisional dissociation (HCD). MS2 scans with a target value of 1 × 105 ions were collected with 
a maximum fill time of 120 ms and R = 35 000 (at m/z 200). The general mass spectrometry 
settings applied for negative ion mode were as follows: spray voltage, 2.7 kV; capillary 
temperature, 375 °C; sheath gas, 46 L/hr; auxiliary gas, 11 L/hr; probe heater temperature, 375 
°C. The general mass spectrometry settings applied for positive ion mode were as follows: spray 
voltage, 3.0 kV; capillary temperature, 400 °C; sheath gas, 46 L/hr; auxiliary gas, 15 L/hr; probe 
heater temperature, 350 °C. 
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5.3.6 Quality assurance/quality control 
Minor contamination of TBPH was detected during sample processing, so procedural blank 
experiments were performed along with each batch of samples. Standards were reinjected after 
four to six injections of samples, and acetone was injected after each standard injection to 
monitor background contamination. Due to minor background contamination, the method 
detection limit (MDL) for TBPH, defined as 3 times the procedural blanks, was 1.1 ng/g, dm. As 
for OH-TBPH without background contamination, its MDLs were calculated based on the peak-
to-peak noise of the baseline near the analyte peak obtained by analyzing field samples on a 
minimum value of signal-to-noise of 3, and was 0.01 ng/g, dm. Compound-specific matrix 
spiking recoveries were calculated by spiking standards into samples of dust that contained the 
least concentrations of TBPH (n = 3). Standards were spiked at 500 ng TBPH/g and 10 ng OH-
TBPH/g, dm. Recoveries from dust were 75 ± 12% and 86 ± 10% for TBPH and OH-TBPH, 
respectively. Quantification of TBPH was conducted by internal calibration curve by use of 
internal standard d34, 
13C6-TBPH, for which recoveries from dust averaged 82 ± 27%. 
Concentrations of OH-TBPH were calculated without internal standard since recoveries were 
>80% and stable among recovery samples. Due to the lack of OH-TBPH1 standard, its 
concentrations were quantified using purified OH-TBPH2 standard. External calibration curves 
of target analytes were calculated for TBPH, 0, 49, 98, 195, 391, 781, 1563, 3125, 6250, 12 500, 
25 000, 50 000, and 100 000 pg/mL and for OH-TBPH, 0, 63, 125, 250, 500, and 1000 pg/mL. 
Both calibration curves showed strong linearity (correlation coefficients >0.99). 
5.3.7 Data analysis 
Statistical analyses were carried out using SPSS 19.0. Values less than the MDLs were replaced 
by MDL/2. Normal distributions of chemical concentrations were assessed using the Shapiro-
Wilk test, and a log-transformation was used to ensure the normality of the distribution of data. 
All 23 dust samples from eight homes were treated as independent data and were included in the 
log-regression analysis. Differences with p < 0.05 were considered significant. 
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5.4 Results and discussion 
5.4.1 Observation and chemical structure identification of OH-TBPH in TBPH standards 
The primary purpose of the study was to develop a LC-UHRMS method based on the LC-Q 
Exactive platform that could be used to quantify TBPH in environmental samples. Unexpectedly, 
three separate peaks were observed when ions were extracted at m/z 640.9946 (10 ppm window) 
from full scan mass spectra (200–2000 m/z) from the commercial TBPH standards in negative 
ion mode (Figure 5.2A). Based on full scan mass spectra, the m/z values for the three peaks were 
640.9949, 640.9946, and 640.9948, with mass errors of 2.1, 1.0, and 1.9 ppm, respectively 
(Figure 5.2D) compared to the theoretical m/z value (640.9936; [TBPH-Br+O]−) as reported 
previously154. Based on the results of the UHRMS data and the isotopic distribution pattern, the 
three peaks likely had the same formula, C24H35Br3O5, which could have been isomers or adducts 
of TBPH with the same protonated ion. The HPLC mobile phases were optimized, and the first 
two peaks (peak a and peak b) were eluted from the HPLC column earlier (5.85 and 6.92 min) 
with 0.1% NH4OH as an additive in methanol compared to pure methanol (12.5 min, Figure 
C5.S1.), whereas the retention time of the third peak (c) remained unchanged (15.9 min). These 
results indicated that the first two peaks were likely acidic compounds, and their retention on 
C18 columns would likely be reduced with the use of basic mobile phases. To further identify 
the peak associated with TBPH, retention times of the identified peaks were compared to those 
of PBDEs under the same HPLC conditions; retention times of most PBDEs were 5–15 min 
(data not shown), which were earlier than the third peak (c) but later than peaks a and b. 
Considering that the log KOW of TBPH (11.95) is greater than those of PBDEs (6.3–6.58 and 
6.29 for Penta- and Octa BDE) and that the retention of compounds on C18 columns is 
correlated with KOW values
155, 156, peak c was thought to most likely be TBPH. To further 
confirm this hypothesis, two strategies were used: (i) confirmation of the third peak with highly 
purified native and mass-labeled TBPH standards—the third peak (c) was specifically observed 
while peaks a and b were detected only at lesser intensities (Figure C5.S2.)—and (ii) analysis of 
the commercial standard in positive ion mode to detect TBPH adducts that were theoretically 
possible. The m/z of the amino adduct of TBPH ([TBPH+NH4]
+, which was 719.9534 with 0.42 
ppm mass accuracy) was only observed at a retention time similar to that of peak c (15.9 min) 
(Figures 5.3A, 5.3C).  
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Figure 5.2. Chromatogram of extracted ions with m/z 640.9946 (10 ppm window) for (A) 
commercial standard (B) FM-550 technical product (C) BZ-54 technical product using Q 
Exactive in negative ion mode. (D) Mass spectra of OH-TBPH. (E) Product ion mass spectra of 
ion at m/z 640.9946. (a) OH-TBPH1, (b) OH-TBPH2, (c) TBPH. 
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Together, these four lines of evidence, alterations of retention times using basic mobile phases, 
retention times relative to PBDEs, relatively greater proportions in highly purified standards, and 
observation of ions of adducts in positive ion mode, were consistent with the third peak (c) at 
15.9 min being TBPH. To further confirm the structure, high resolution MS2 spectra (R = 35 000 
at m/z 200) were analyzed in positive ion mode at 30–50 eV. As shown in Figure 5.3D, typical 
fragment ions of TBPH were observed with a mass error less than 10 ppm. The fragment ions 
clearly showed that TBPH precursor ions were fragmented at the alkyl side chains, while 
cleavage of the C–O bond yielded a predominant product ion at m/z 464.6611. Such routes of 
cleavage were similar to those of phthalates, which also produced a phthalic anhydride fragment 
when using collision induced dissociation (CID)157, in triple quadruple mass spectrometry mode, 
despite the fact that HCD was used to fragment ions in the Q Exactive instrument. 
To evaluate chemical structures of the two unknown peaks a and b, the Q Exactive was 
used in negative ion mode to obtain ultrahigh-resolution (R = 35 000 at m/z 200) product ion 
spectra. Several product ions with m/z at 245.1179, 326.7484, 404.9526, and 484.8787 were 
observed (Figure 5.2E). The structures of the product ions were evaluated based on elemental 
composition with a mass error of 0.4, 1.5, 0.7, and 1.0 ppm, respectively. Patterns of peaks 
associated with products of fragmentation were more complex than that of TBPH, and the 
addition of a hydroxyl substituent to the aromatic ring was observed for each of the four 
predominant fragments. To avoid the possibility that the addition of the hydroxyl moiety was due 
to a substitution reaction during negative ionization, as has previously been reported for 
brominated compounds158, OH-TBPH was also analyzed in positive ion mode. When analyzed in 
positive ion mode, a sodium adduct of OH-TBPH ([M + Na]+; m/z value of 666.9861 and mass 
error of 0.75 ppm) was observed (Figure C5.S3.). Based on all of this information, it was clear 
that the first two peaks were hydroxylated derivatives of TBPH with formulas C24H35Br3O5 and 
with hydroxylation at the aromatic ring which formed a phenolic group. To further confirm the 
chemical structures of the compounds, 1H NMR was used to characterize the structures of OH-
TBPH2 purified from the BZ-54 technical product using HPLC (Figure C5.S4.). A chemical shift 
characteristic of a phenolic group with carboxylic acid ester substituent was observed in the 
purified OH-TBPH2 standard at 8.6 ppm (Figure C5.S4.). Isomers of OH-TBPH were identified 
in purified standards of TBPH and technical products and had similar product ion spectra with 
TBPH; therefore, we proposed structures of these two novel compounds as shown in Figure 5.1. 
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To further investigate the widespread presence of OH-TBPH isomers as by-products of 
TBPH, we also determined OH-TBPH isomers in other standards. In addition to the commercial 
TBPH standard, OH-TBPH isomers were also observed in purified TBPH standards from 
AccuStandard and in technical materials. Percentages of OH-TBPH in the native standard from 
AccuStandard were <0.1% (Figure C5.S2.). Furthermore, small proportions, <0.1%, of mass-
labeled OH-TBPH (d17, 
13C6–OH-TBPH) were detected in the mass-labeled TBPH standard from 
Wellington Laboratories Inc. This result indicated potential widespread occurrence of isomers of 
OH-TBPH as byproducts in TBPH standards. These results indicated that OH-TBPH might also 
be present in technical products. To confirm this hypothesis, technical products, BZ-54 and FM-
550, which, along with the flame retardant product, DP-45, are two of three potential major 
sources of TBPH in the environment30, were analyzed for OH-TBPH. Isomers of OH-TBPH 
were detected in both BZ-54 and FM-550, but profiles of relative concentrations of the OH-
TBPH isomers (Figures 5.2B, 5.2C) were different from those of the commercial TBPH 
standard. The relative contributions of OH-TBPH1, OH-TBPH2, and TBPH were 0.4%, 0.9%, 
and 98.7%, respectively, in the commercial standard, while their relative contributions were 
0.1%, 6.2%, and 93.7% in FM-550 and 0.1%, 7.9%, and 92.0% in BZ-54 with relatively greater 
amounts of OH-TBPH2. The presence of isomers of OH-TBPH in FM-550 and BZ-54 technical 
products suggests potential emissions to the environment. 
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Figure 5.3. Chromatogram of extracted ions with m/z 640.9946 and m/z 723.9486 (10 ppm 
window) for (A) FM-550 technical product (B) house dust using Q Exactive (SIM) in both 
negative ion mode and positive ion mode. (C) Mass spectra of TBPH in positive ion mode. (D) 
Product ion mass spectra of ion at m/z 723.9486 in positive ion mode. 
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5.4.2 Development of analytical methods to measure TBPH and OH-TBPH in dust 
To measure TBPH and OH-TBPH isomers in house dust, a LC-UHRMS method based on the Q 
Exactive Orbitrap was developed for simultaneous analysis of both compounds. A single study 
had previously reported a method for quantification of TBPH by use of LC-APCI (−)154, while 
most studies have used GC-MS148, 156. In the current study, the Q Exactive operated in ESI (+) 
showed greater sensitivity for TBPH compared to analyses with ESI (−) or APCI (−) (>100 fold). 
An ammonium adduct of TBPH ([TBPH+NH4]
+) was detected while [TBPH+H]+, which was the 
expected ion in positive ion mode, was not observed even with 0.1% formic acid in methanol as 
the mobile phase. The IDL of the newly developed LC-UHRMS method was calculated to be 
0.01 μg/L for TBPH, which was roughly 200- to 300-fold more sensitive than that of the LC-
APCI (−) method (3.3 μg/L) and GC-MS method (2.5 μg/L; Table 5.1)54, 154. The [M + Na]+ ion 
of OH-TBPH isomers was observed in positive ion mode, but the sensitivity was >50 fold less 
than ions produced in negative ion mode. Finally, a LC-HRMS method based on the Q-Exactive 
platform was established for simultaneous analysis of TBPH and isomers of OH-TBPH in both 
negative and positive ion modes. The greater sensitivity of the newly developed method for 
TBPH is important due to the low concentrations anticipated in human tissue (ND-164 ng/g lipid 
weight (lw) in human serum). The detection frequencies in humans are relatively low (<60%)150, 
and information on concentrations of TBPH in these samples is limited. 
 
 
 
 
 
 
 
 
 
106 
 
 
 
 
 
 
 
 
 
Table 5.1. Instrumental detection limits (IDLs, μg/L), method detection limits (MDLs, 
ng/g, dm) and recoveries (n=3) of OH-TBPH isomers and TBPH of different methods 
 IDLs 
 (GC-MS)a 
IDLs  
(LC-QE) 
MDLs 
(GC-MS)b 
MDLs 
(LC-QE) 
Recoveries 
(n=3) 
TBPH 2.5 0.01 4 1.1d 75±12% 
OH-TBPHc - 0.005 - 0.01 86±10% 
a data from reference78 
b data from reference78 
c IDLs, MDLs and recoveries were just calculated for OH-TBPH2, due to the lack of standards 
for OH-TBPH1. 
d MDL was relatively high compared to IDL since minor background contamination of TBPH 
was detected in procedural blanks. 
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To simultaneously analyze TBPH and OH-TBPH in house dust, a sequential liquid 
extraction method was developed by using methanol and DCM to extract polar OH-TBPH and 
nonpolar TBPH, respectively. To assess recoveries of the liquid extraction method, 500 μg/L of 
TBPH and 5 μg/L OH-TBPH were spiked into samples of house dust and left to equilibrate for 
24 hr at room temperature. Extracts were diluted 20-fold with acetone and analyzed by LC-
UHRMS directly without further sample pretreatment. Recoveries for TBPH and OH-TBPH, 
using the liquid extraction method, were 92 ± 5% and 95 ± 6%, respectively. Since matrix effects 
can be problematic in LC–MS/MS analysis, an SPE method was developed to clean extracts of 
samples. Several solvent mixtures for elution of OH-TBPH and TBPH from Florisil cartridges 
were tested. DCM was chosen to elute TBPH from the cartridge, while acetone, which could not 
elute OH-TBPH, was used to rinse potential interferences. Finally, OH-TBPH was eluted using a 
mixture of methanol/DCM (v/v, 1:1; Figure C5.S5.). The use of methanol as an elution solvent 
was different from cleanup methods for other phenolic compounds such as estrogens, which are 
generally eluted from Florisil using a mixture of acetone and DCM159. Thus, the use of acetone 
as a rinse prior to elution of OH-TBPH allowed removal of most of the yellow or blue 
interferences in extracts of house dust. Potential effects of matrices were also evaluated by 
spiking 1000 μg/L TBPH and 10 μg/L OH-TBPH into final extracts before analysis by Q 
Exactive LC-UHRMS. Suppression of signals of TBPH and OH-TBPH (n = 3) were minor at −5 
± 3% and −10 ± 6%, respectively. Finally, based on sample pretreatment methods, the recoveries 
for TBPH and OH-TBPH were 76 ± 12% and 86 ± 10%, respectively (Table 5.1). 
5.4.3 Concentrations and profiles of TBPH and OH-TBPH in house dust 
The newly developed methods were applied to quantify OH-TBPH and TBPH in 23 samples of 
house dust. Two OH-TBPH isomers were both detected in house dust (Figure 5.3B; Table 5.2), 
with detection frequencies of 52% and 91%, respectively. Use of SIM mode was necessary to 
detect OH-TBPH in house dust, since no peaks related to OH-TBPH were detected when using 
full scan mode (Figure C5.S6A.). This was likely due to the dynamic range of the Q Exactive 
and co-elution of numerous compounds that interfered with OH-TBPH. In the analysis of OH-
TBPH, intensities of total ions were 1.5 × 1010 at a retention time similar to that for OH-TBPH 
and were much greater than those of OH-TBPH (<105 in SIM mode; Figure C5.S6.). Thus, OH-
TBPH could not be detected in full scan mode because maximum injected ions, based on 
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predictive automated gain control, were limited to 3 × 106. During analysis by SIM, total injected 
ions were limited to a narrow isolation window (2.0 m/z), which greatly increased the number of 
injected ions for targeted chemicals. Therefore, SIM was used to analyze OH-TBPH and TBPH 
in house dust in subsequent experiments. 
Profiles of relative concentrations of TBPH and OH-TBPH isomers in dust were 
compared to technical products to evaluate their potential emission source. As expected, the 
greater proportion of OH-TBPH2 compared to OH-TBPH1 in dust samples was similar to 
proportions in BZ-54 and FM-550 but different from the commercial TBPH standard in which 
proportions were roughly equal. Concentrations of OH-TBPH2 (GM ± GSD, 0.35 ± 1.0 ng/g, 
dm) were 10-fold greater than those of OH-TBPH1 (0.04 ± 0.88 ng/g, dm) in house dust (Table 
5.2). TBPH was also detected in all samples of house dust with an average concentration, 734 ± 
0.87 ng/g, dm. Concentrations of TBPH were comparable to dust samples from the UK (mean 
value was 381 ng/g, dm) but greater than dust samples from California (mean value 260 ng/g, 
dm)56, 58. It should be noted that the maximum detected concentration of TBPH in this study was 
22251 ng/g, dm, several fold greater than previously reported maximum concentrations in dust 
from houses in the United Kingdom (6175 dm) and California (3800 ng/g dm)56, 58. In this study, 
dust samples were collected in 2013 and were more recent than those in previous studies. Since 
previous reports have shown trends of increasing concentrations of TBPH in house dust over 
time151, greater concentrations of TBPH in more recent samples were expected in this study. In 
fact, in a more recent study by Stapleton et al., concentrations of TBPH (maximum concentration 
20960 ng/g, dm) were similar to concentrations reported here160. In addition, as shown in Figure 
5.4, relatively great concentrations of TBPH and OH-TBPH isomers were detected in three 
samples from the same home. Information provided in a brief survey showed that the house was 
constructed in 2004, and most electronics and furniture were recently purchased. Furthermore, 
several pieces of furniture with TB 117 labels were discovered in the home. The newly built 
house, recently purchased consumer items, and adherence to Californian furniture flammability 
standards might have contributed to the relatively great concentrations of TBPH in this home.  
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Table 5.2. Concentrations of OH-TBPH and TBPH (ng/g, dm) in samples of house dust from 
Saskatoon, Saskatchewan, Canada. 
 GM±GSD Min Max Detected%b Contribution%c 
TBPH 734±0.87 15 22251 100 99.9 
OH-TBPH1  0.04±0.88 <0.01a 7.3 52% 0.01 
OH-TBPH2 0.35±1.0 <0.01 27 91% 0.1 
a the concentration was lower than MDL (0.01 ng/g, dm). 
b detection frequencies of TBPH and OH-TBPH isomers in dust samples. 
c relative contribution to the sum concentrations of TBPH and OH-TBPH isomers.  
 
 
 
 
 
 
 
 
 
110 
 
 
 
 
 
 
 
Figure 5.4. Concentrations of TBPH (A), OH-TBPH1 (B) and OH-TBPH2 (C) in 23 dust 
samples from 8 houses. Dotted lines were used to separate house dust samples among different 
houses. The samples between the two red dotted lines were from a house built in 2004, which 
had greater concentrations of TBPH and OH-TBPH isomers. 
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Isomers of OH-TBPH were not detected in two samples of house dust, and concentrations 
of TBPH in these samples were also small (74 ng/g and 158 ng/g). Furthermore, a log–linear 
regression analysis showed a significant relationship between concentrations of TBPH and OH-
TBPH isomers (r2 = 0.67 for OH-TBPH1 and r2 = 0.50 for OH-TBPH2, p < 0.001 for both; 
Figure 5.5A), which, when paired with evidence of similar isomer profiles in dust and technical 
products, indicated common sources of OH-TBPH and TBPH. However, it should be noted that 
the percentage of isomers of OH-TBPH contributing to the sum of concentrations of OH-TBPH 
and TBPH in samples of dust were relatively small (0.01% ± 0.67 and 0.1% ± 0.60). Percentages 
of OH-TBPH in house dust were less than in BZ-54 (0.1% and 7.9%), FM-550 (0.1% and 6.2%), 
and the commercial standards (0.4% and 0.9% respectively; p < 0.001; Figure 5.5B), while 
relative contributions of TBPH in samples of house dust (99.9% ± 0.0) were significantly greater 
than in the technical product and commercial standard (p < 0.001). The relatively low 
contributions of OH-TBPH might be due to different physical–chemical properties and 
environmental fates during application, or mechanical or chemical emissions from products to 
the environment. Alternatively, the sample number for technical products was limited, and the 
proportions of OH-TBPH might vary among different manufacturers. 
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Figure 5.5. (A) Log−linear regression between concentrations of TBPH and OH-TBPH in 23 
dust samples. (B) Comparison of relative contributions of TBPH and OH-TBPH isomers in dust 
samples, commercial standard, BZ-54 technical product, and FM-550 technical product. The y 
axis indicates the log-transformed percentages of TBPH and OH-TBPHs in different samples. 
Colors differentiate dust samples or standard. Chinastd indicates the commercial TBPH standard 
produced in China. A t-test was used to evaluate statistical difference. ***p < 0.001. 
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5.4.4 Implications 
Detection of OH-TBPH contamination in analytical standards, technical products, and 
environmental dust samples is of great importance due to differences in the physical–chemical 
properties between TBPH and OH-TBPH and the implications for bioavailability and toxicity. 
For example, the toxic potency of OH-TBPH likely differs from that of TBPH as the addition of 
a phenolic group, as observed with OH-PBDEs, has been shown to increase the toxic potency of 
compounds161. Increased toxicities might be due to structural similarities to endogenous 
compounds including 17-β-estradiol, triiodothyronine, or thyroxine, and/or greater binding 
affinities with important receptors or transport proteins162. In addition, because of its extreme 
hydrophobicity (estimated log KOW, 11.95), bioavailability of TBPH is likely relatively limited
29, 
156. The substitution of bromine for the hydroxyl group of OH-TBPH would lead to a lesser log 
KOW, estimated at 9.56 (ChemDraw Ultra 8.0), and thus greater bioavailability. Therefore, the 
addition of a phenolic group, potential increased toxic potency, and increased bioavailability of 
OH-TBPH might lead to greater concerns about risks posed to the environment and human 
health. 
 
 
 
 
 
 
 
 
 
 
 
114 
 
 
 
 
 
 
 
 
 
 
6 CHAPTER 6: CONCENTRATION, SEASONALITY AND 
BIOACCESSIBILITY OF NOVEL BROMINATED FLAME RETARDANTS 
IN DUST FROM CHILDCARE FACILITIES IN SASKATOON, SK, 
CANADA 
 
 
 
 
 
 
 
 
 
115 
 
PREFACE 
Following the detection and identification of novel hydroxylated isomers of TBPH (and TBB) in 
Chapter 5, further assessments of environmental concentrations and factors of exposure were 
necessary.  The objective of Chapter 6 was to determine concentrations of TBPH, TBB, OH-
TBPH1, OH-TBPH2, and ƩOH-TBBs in dust from ECEs to determine if children were exposed 
to greater amounts of these NBFRs in this environment. Other factors of exposure including 
seasonality of concentrations and microenvironment specific parameters which might lead to 
greater concentrations in dust, were assessed. Finally, bioaccessibility was calculated to estimate 
bioavailability of the compounds, a parameter which is important to accurate assessments of risk.  
This chapter was included in the second phase of this research program, the characterization of 
exposure to TBPH and TBB in the indoor environment. 
The content of Chapter 6 is in preparation for submission for publications as  D.M.V. 
Saunders, H. Peng, J. Sun, Wiseman, J. P. Giesy, “Concentration, seasonality, and 
bioaccessibility of novel brominated flame retardants in dust from childcare facilities in 
Saskatoon, Saskatchewan, Canada”. 
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experiment, generated and analyzed the data, prepared all figures, and drafted the manuscript. 
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6.1 Abstract 
The novel brominated flame retardants (NBFRs) bis(2-ethylhexyl)-tetrabromophthalate (TBPH 
or BEH-TEBP) and 2-ethylhexyl-tetrabromobenzoate (TBB or EH-TBB) have been detected at 
some of the greatest concentrations in indoor dust from early childhood environments (ECEs) in 
Canada, the U.S., and Europe, though relatively few investigations have been conducted in 
Canada.  Recently, hydroxylated isomers of these compounds, OH-TBPHs and OH-TBBs have 
been identified and quantified in indoor dust from Canada.  Young children in the cold Canadian 
climate spend great proportions of time indoors, specifically in ECEs (i.e. day care centers) and 
are likely exposed to relatively great quantities of these compounds. Though increased exposure 
of children to these NBFRs is likely due to differences in behaviours (hand-to-mouth, hygiene), 
the greater concentrations of these contaminants in dust from ECEs has not been thoroughly 
assessed.  In this study, concentrations of TBPH, TBB and their OH-isomers in specific 
microenvironments which contained permutations of greater/lesser amounts of children’s 
products and foot-traffic were assessed in dust from several day care centers in Saskatoon, 
Saskatchewan, Canada.  Further, seasonal differences in concentrations of NBFRs and 
bioaccessibilities were investigated.  Day care centers in Saskatoon had some of the greatest 
concentrations of these NBFRs, globally; TBPH 734±0.87; TBB 992±0.82; OH-TBPHs 
0.04±0.88 to 0.81±0.75; OH-TBBs 0.30±0.78 (GM±GSD, ng/g, dm).  Though no significant 
seasonal differences were observed between summer and winter or TBPH or TBB, a non-
statistically significant trend of increased concentrations of the OH-isomers was observed during 
the colder season (increases of 143-425%).  Microenvironments in ECEs with greater numbers of 
toys and greater foot-traffic had greater concentrations of all NBFRs in winter, though no 
differences were observed in summer.  Bioaccessibilities of TBPH, TBB, OH-TBPHs, and OH-
TBBs in dust from day care centers were, 23, 53, 30, and 70%, respectively.  The bioaccessibility 
of OH-TBBs was significantly greater than that of TBB which indicated that greater quantities of 
OH-TBBs would likely be absorbed.  Results of the study presented here demonstrate that ECEs 
from Saskatoon, SK, Canada have some of the greatest concentrations of these NBFRs reported 
to date, which might be due, in part, to greater abundances of children’s products.  Furthermore, 
bioaccessibilities of these compounds are low to moderate, but OH-TBBs are likely more 
bioavailable. 
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6.2 Introduction 
Bis(2-ethylhexyl)-tetrabromophthalate (TBPH or BEH-TEBP) and 2-ethylhexyl-
tetrabromobenzoate (TBB or EH-TBB ) are novel, additive brominated flame retardants 
(NBFRs) that are components of the flame retardant mixture Firemaster® 550 (FM-550) and BZ-
54 which are replacements for the Penta-mixtures of polybrominated diphenyl ethers (PBDEs).  
Recently novel, hydroxylated isomers of TBPH and TBB have also been detected in FM-550 and 
BZ-54 technical products163, 164. As major replacements, FM-550 and BZ-54 are added to 
numerous consumer products, and specifically to flexible polyurethane foam.  Polyurethane 
foams are widely used in children’s products and furniture for juveniles and components of FM-
550 have been detected at approximately 4.2% by weight in foam of some couches41. Additive 
flame retardants are known to migrate from consumer products to the surrounding environment 
through chemical (volatilization), direct contact with dust, or via mechanical (abrasion) 
processes.  Several studies have documented relatively great concentrations of TBPH and TBB 
in dust165, 166 and two recent studies have quantified their hydroxylated isomers (OH-
TBPHs/TBBs) in the same matrix163, 164. Furthermore, due to the phase-out of Penta-BDE 
mixtures and the partial discontinuation of production of a prominent organophosphate flame 
retardant (TDCPP), concentrations of these compounds might increase in indoor environments. 
Changes in use of these major BFRs will likely increase use of FM-550 in consumer products.  A 
recent investigation which approximately coincided temporally with the phase out of Penta-BDE 
mixtures, detected an approximate 2-fold increase in concentrations of TBPH and TBB in indoor 
dust in the U.S. collected from 2006-201156.   
Indoor dust is considered a major route of exposure to brominated flame retardants 
(BFRs) and results of pharmacokinetic models have suggested that as much as 82% of total 
exposures might be via dust57.  Because young children exhibit behaviours that increase the 
likelihood of exposure, they have greater potential for exposure to BFRs than do adults. Young 
children wash their hands less than adults and exhibit greater exploratory behaviours which 
include, greater hand-to-mouth activities and greater associations with floors/surfaces.  Children 
generally have greater body burdens of BFRs than do adults71-73. For example, in a paired study 
of young U.S. children and their mothers, children had approximately 2.8-times greater 
concentrations of total PBDEs in blood167. This trend regarding greater body burdens of BFRs in 
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children has also been observed with NBFRs, including TBB.   Recently, tetrabromobenzoic acid 
(TBBA) was identified as a metabolite of TBB detected in urine and validated as a marker of 
exposure to the compound 168. In a subsequent study of paired children and adults, TBBA was 
detected in 27% of adults and 70% of children which suggested greater exposures to children169.  
In North America, children spend a great proportion of time away from home. Some 
young children spend as much as 50 h per week in childcare and preschool centres75. In Canada 
in 2011, 60% of all parents relied on some sort of childcare for children aged 2-4 yrs170. Due to 
the exploratory and clumsy nature of young children, products manufactured for use by children 
contain great quantities of polyurethane foam which might have been treated with FM-550.  
There is generally a direct relationship between the number of children in child care facilities and 
number of products for children.  For example, a home with one child might have a single piece 
of furniture designed for juveniles, but a day care center might have several times more to 
facilitate concurrent use by children. This greater density of products designed for children might 
result in greater loadings of BFRs to the indoor environment and subsequently, greater exposure 
of children.   
Exposure to TBPH and TBB might have implications for normal development of 
children. For example, a recent study has shown that prenatal exposure to several components of 
the Penta-BDE mixture, which are endocrine disrupting compounds (EDCs), were significantly 
associated with lower IQ and more hyperactivity of children171. TBPH, TBB and OH-
TBPHs/TBBs likely are EDCs and might also adversely affect normal endocrine functions 
during key phases of early childhood development. In several studies, TBPH and TBB have been 
shown to interact antagonistically with the human estrogen receptor (ERα) and androgen 
receptor (ARα), alter sex hormone concentrations in in vitro cellular assays, and significantly 
alter fecundity and transcript abundances of genes associated with the highly conserved, hepatic-
pituitary-gonadal-liver axis in Japanese Medaka99, 130, 172. Additionally, a study using rats showed 
that exposure to FM-550 resulted in obesogen-like effects and the mixture potentially contributed 
to an observed metabolic syndrome52. Also, the hydroxylated isomers, OH-TBBs, likely have 
endocrine disrupting effects. In a recent study, OH-TBB was detected as a strong agonist of the 
peroxisome proliferator-activated receptor gamma (PPARγ) and a weak agonist of the ER164.  
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TBPH and TBB are hydrophobic compounds with theoretical Log Kows of 11.95 and 
8.75, respectively (estimated by use of KOWWIN, CLOGP, and Chemsketch programs), and 
might not be readily available for absorption or distribution, though the Log Kows of the 
hydroxylated isomers are less (9.56 for OH-TBPH and 6.8 for OH-TBB) which might 
significantly alter bioavailability.  One of the first exposure studies with FM-550, which used 
fathead minnows, calculated uptake to be 1% of daily dosage of TBPH or TBB, though uptake 
was not calculated for hydroxylated isomers29. A more recent study calculated bioaccessibility of 
TBPH and TBB from dust, by use of a colon extended physiologically-based extraction test (CE-
PBET)173. The study concluded that approximately 25% and 50% of TBPH and TBB, 
respectively, were bioaccessible from dust, though there was no information regarding 
bioaccessibilities of OH-TBPHs/TBBs.  
In this study, samples of dust from government licensed day care centers across 
Saskatoon, SK, Canada were collected in winter and summer and analyzed for TBPH, TBB and 
their hydroxylated isomers OH-TBPHs/TBBs.  Dust was collected from three distinct 
environments in each day care center with permutations greater/lesser foot-traffic and 
greater/lesser numbers of children’s products.  Comparisons of concentrations of compounds in 
these environments could help to determine if increased amounts of children’s products increase 
concentrations of NBFRs in dust. Concentrations of these compounds in samples collected 
during summer or winter months were also compared to deduce potential seasonal changes to 
concentrations of indoor contaminants. Any differences between seasons might have 
implications for exposures of humans, since Canadians spend approximately 97% of the day 
indoors during the winter174. Finally, bioaccessibilities of TBPH/TBB and OH-TBPHs/TBBs 
were assessed by use of a Tenax (TA) enhanced CE-PBET model.  These tests generated data 
regarding uptake of the novel, potential EDCs, OH-TBPHs/TBBs. Young children are a 
susceptible population, and this study will help to more precisely evaluate risk of exposure of 
NBFRs to children via ingestion of dust. 
6.3 Materials and methods 
6.3.1 Chemicals and reagents 
Native standards of TBPH and TBB were purchased from AccuStandard (Connecticut, U.S.), 
and their surrogates, mass labelled, d34, 13C6-TBPH and d17, 
13C6-TBB were purchased from 
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Wellington Laboratories Inc. (Ontario, Canada). Procedures for the purification of OH-
TBPHs/TBBs from BZ-54 technical mixture are included in our previous studies163, 164.  
Dichloromethane (DCM), acetone, and methanol were purchased from EMD Chemicals (New 
Jersey, U.S.) and an ammonia solution (28-30%) was purchased from Alfa Aesar Chemical 
Industries (Massachusetts, U.S.).  Florisil, solid-phase extraction cartridges (6cc, 1 g, 30 μm) 
were purchased from Water (Massachusetts, U.S.). 
6.3.2 Collection of dust samples 
Forty-six (46) samples of dust were collected from 14 day care centers in Saskatoon, SK, 
Canada, from May 2013 to April 2014.  This represented approximately 18% of licensed day 
care homes in the Saskatoon area. Ethical approval of all research and procedures has been 
awarded by the University of Saskatchewan Behavioural Research Ethics Board (Beh-REB).  
Dust was collected by use of a Eureka Might-Mite vacuum cleaner (model 3670) and stored at -
20 ºC. The components upstream of the vacuum collection vessel were thoroughly cleaned 
between sampling events. The entire procedure for dust collection has been described in our 
previous publications163, 164. 
6.3.3 Pretreatment of dust  
Approximately 0.1 g of dust was transferred to a 15 mL tube and 20 μL of each, 1 mg/L mass- 
labeled internal standards d34, 13C6-TBPH and d17, 
13C6-TBB, and 10 mL methanol were added. 
Samples were shaken vigorously (Heidolph Multi Reax Vibrating Shaker, Brinkmann) for 30 
min then sonicated for an additional 30 min. Dust was separated from the methanol by 
centrifugation at 1669 g for 10 min and the methanol was transferred to a new tube.  The 
extraction procedure was repeated with 10 mL DCM.  The methanol and DCM extracts were 
combined and blown to dryness under a stream of nitrogen.  Extracts were dissolved in 500 μL 
of DCM and loaded onto Florisil cartridges, which had been conditioned by use of 6 mL acetone 
and DCM.  TBPH, TBB, and the OH-isomers were eluted from Florisil cartridges by use of 5 mL 
DCM and a mixture of DCM/methanol (v/v, 1:1).  Extracts were blown to dryness under a 
stream of nitrogen and reconstituted with 200 μL acetone for analysis. 
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6.3.4 Pretreatment of Tenax  
The Tenax envelope, with approximately 0.3 g Tenax, was transferred to a 15 mL centrifuge tube 
and 20 μL of each, 1 mg/L mass- labeled internal standards d34, 13C6-TBPH and d17, 13C6-TBB, 
and 10 mL hexane were added. Samples were shaken vigorously (Heidolph Multi Reax 
Vibrating Shaker, Brinkmann) for 30 min, sonicated for an additional 30 min, then the hexane 
was transferred to a new tube.  The extraction procedure was repeated with 10 mL acetone.  The 
hexane and acetone extracts were combined and blown to approximately 1 mL under a stream of 
nitrogen.  Extracts were loaded onto Florisil cartridges, which had been conditioned by use of 6 
mL acetone and hexane.  TBPH, TBB, and the OH-isomers were eluted from Florisil cartridges 
by use of 6 mL hexane and 6 mL acetone.  Extracts were blown to dryness under a stream of 
nitrogen and reconstituted with 200 μL acetone for analysis. 
6.3.5 Pretreatment of gastro-intestinal fluid  
A sub-sample of total incubation fluid (30 mL), 20 μL of each, 1 mg/L mass- labeled internal 
standards d34, 13C6-TBPH and d17, 
13C6-TBB, and 20 mL DCM were added to a 50 mL 
centrifuge tube. The mixture was shaken vigorously (Heidolph Multi Reax Vibrating Shaker, 
Brinkmann) for 30 min then sonicated for an additional 30 min.  Following sonication, the 
mixture was stored at 4 ºC to allow for separation of DCM and GI-fluid.  The GI-fluid and DCM 
were separated and DCM transferred to an evaporation tube and blown to complete dryness 
under a stream of nitrogen.  The Extract was dissolved in 500 μL DCM and loaded onto Florisil 
cartridges, which had been conditioned by use of 6 mL DCM.  TBPH, TBB, and the OH-isomers 
were eluted from Florisil cartridges by use of 5 mL DCM and a mixture of DCM/methanol (v/v, 
1:1).  Extracts were blown to dryness under a stream of nitrogen and reconstituted with 200 μL 
acetone for analysis. 
6.3.6 Instrumental analysis 
Instrumental analysis of the four target analytes has been described in our previous papers163, 164. 
Extracts were analyzed using a Q Exactive ultrahigh resolution mass spectrometer (Thermo 
Fisher Scientific) interfaced to a Dionex UltiMate 3000 ultra-high-performance liquid 
chromatography (UHPLC) system (Thermo Fisher Scientific).  Separation of the compounds was 
conducted by use of a Betasil C18 column (5 μm; 2.1 mm x 100 mm; Thermo Fisher Scientific) 
122 
 
with an injection volume of 5 μl.  Ultrapure water (A) and methanol containing 0.1% NH4OH 
(v/v) (B) were used as mobile phases.  Initially 20% of B was increased to 80% in 3 min, then 
increased to 100% at 8 min and held static for 19.5 min, followed by a decrease to initial 
conditions of 20% B and held for 2 min to allow for equilibration.  The flow rate was 0.25 
mL/min.  Temperatures of the column and sample chamber were maintained at 30 °C and 10 °C, 
respectively.  Data were acquired by use of selected ion monitoring (SIM) with an APCI or ESI 
ionization source. SIM mode was used to monitor the four target compounds to expand dynamic 
range. Briefly, MS scans (200-2000 m/z) were recorded at resolution R=70,000 (at 200 m/z) with 
a maximum of 3×106 ions collected within 200 ms (100 ms; APCI), based on the predictive 
automated gain control.  SIM scans were recorded at a resolution of R=70,000 (at 200 m/z) with 
maximum of 5×104 ions collected within 200 ms (80 ms; APCI), based on the predictive 
automated gain control, with isolation width set at 2.0 m/z.  For ESI, the general mass 
spectrometry settings applied for negative ion mode were as follows: spray voltage, 2.7 kV; 
capillary temperature, 375 °C; sheath gas, 46 L/h; auxiliary gas, 11 L/h; probe heater 
temperature, 375 °C. The general mass spectrometry settings applied for positive ion mode were 
as follows: spray voltage, 3.0 kV; capillary temperature, 400 °C; sheath gas, 46 L/h; auxiliary 
gas, 15 L/h; probe heater temperature, 350 °C. For APCI, the applied general mass spectrometric 
settings for APCI source were as follows: discharge current, 10 µA; capillary temperature, 225 
°C; sheath gas, 20 L/h; auxiliary gas, 5 L/h; probe heater temperature, 350 °C. 
6.3.7 Design of the Tenax bead incubation envelope 
A previous study which added TA beads to the CE-PBET demonstrated the necessity of use of 
an incubation apparatus to isolate TA from dust samples173. In this experiment, Tenax beads (60-
80 mesh, Supelco) were sieved through 100 mesh and cleaned by sonication by use of 
acetone:hexane (1:1, v/v).  To limit loss of TA and the contamination of dust samples during 
incubation, an envelope was designed to isolate TA while allowing uninhibited flow of gastro-
intestinal (GI) fluids, see appendix (Figure C6.S1).  100 mesh stainless steel was cut to 
approximately 9 x 6 cm (length x width) and rolled to create hollow cylinders.  One end of the 
cylinder was folded and affixed with copper wire to form a TA pocket in the hollow cylinder. TA 
was weighed (0.3 g) and inserted into the hollow portion of the cylinder while the other end was 
folded and affixed with copper wire.  To test their effectiveness to contain TA beads, several 
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envelopes were inserted and submerged in hexane:acetone, and sonicated/shaken for 30 min 
(n=4).  Few TA beads were observed in the liquid or attached to the exterior of the envelope. 
6.3.8 Tenax enhanced bioaccessible extraction 
Methods used in this study were adapted from a recently developed in vitro CE-PBET technique 
and from an additional TA bead assisted method173, 175. Three surrogate GI fluids including 
stomach (pH 2.5), small intestine (pH 7.0), and colon (pH 6.5) were prepared, in the fed state, 
according to a previous study175. Concentrations of target compounds in samples of dust were 
determined prior to incubation to allow for mass balance analysis following in vitro digestion. 
OH-TBB isomers were not detected in the standard reference dust (SRM 2585; National Institute 
of Standards and Technology (NIST), Maryland, U.S.), so standards were spiked with 1 ng/g 
dust and homogenized to ensure complete mixing.  Approximately 0.1 g of dust collected from 
day care centers or reference dust (SRM) and 0.3 g TA (in the prepared envelope) were added to 
50 mL glass centrifuge tubes containing 45 mL of the pre-warmed, simulated stomach media and 
incubated at 37 ºC for 1 hr with constant agitation, to simulate peristaltic movement of the 
human gastro-intestinal tract.  A sequential system, where dust was exposed to the three 
compartments in succession was employed. Following a 1 hr incubation period, bile salts (bovine 
and ovine, Sigma-Aldrich), pancreatin (porcine, Sigma-Aldrich), and sodium bicarbonate (to 
adjust to pH 7.0), were added to create the simulated intestinal media. Following incubation for 4 
hr, the TA envelope was removed and dust was separated from the intestinal medium via 
centrifugation at 1000 g for 8 min.  The TA envelope was re-added to the centrifuge tube 
containing dust, along with 45 mL of colon fluid, and incubated for 8 hr.  Following incubation, 
the TA envelope was rinsed with deionized water to remove dust and both (dust & water) were 
added to colon fluid. Following this procedure, dust and fluid were separated as detailed above.  
Approximately 69% and 60% of dust was recovered following incubation in the CE-PBET and 
TA enhanced CE-PBET, respectively, and 95% of TA was recovered (Figure C6.S2). 
6.3.9 Quality control 
Minor contamination of TBPH was detected during processing of dust from day care centers, so 
procedural blank samples were included.  Standards were typically re-injected after four to six 
injections of samples, and acetone was injected following each standard injection.  Due to minor 
background contamination, the method detection limit (MDL) for TBPH in dust was 1.1 ng/g, 
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dm.  No background contamination was detected for OH-TBPHs, TBB, or OH-TBBs. MDLs for 
these three compounds in dust were 0.01 ng OH-TBPH/g, dm, 0.12 ng TBB/g, dm and 0.005 ng 
OH-TBB/g, dm. Previous studies have investigated potential matrix effects by use of ESI or 
APCI163, 164. Recoveries of analytes were determined by spiking standards into samples of dust, 
TA, and the three GI media (n=12) prior to extraction.  Concentrations of standards spiked into 
dust and TA, were 500 ng TBPH/g, dm, 500 ng TBB/g, dm, 5 ng OH-TBPHs/g, dm and 5 ng 
OH-TBBs/g, dm and 1 ng TBPH/TBB/OH-TBPHs/OH-TBBs/mL in GI fluid.  Recoveries from 
dust, TA, and GI fluid ranged from 70-105% for TBPH, 65-94% for TBB, 83-101% for OH-
TBPHs, and 85-115% for OH-TBBs.  TBPH and TBB were quantified by use of internal 
standards, d34, 13C6-TBPH and d17, 
13C6-TBB for which recoveries in dust, TA, and GI fluids 
were 82-95%., and 79-101%, respectively. Concentrations of OH-TBPHs and OH-TBBs were 
quantified without the use of internal standard due to the lack of commercial internal authentic 
standards and because recoveries were > 80% and stable across replicate recovery samples.  
Concentrations of both OH-TBPH1 and OH-TBPH2 were quantified by use of purified OH-
TBPH2 standard, as described previously163. Concentrations of OH-TBBs were quantified by use 
of purified OH-TBBs standard, though, due to the lack of separation of the three OH-TBB 
isomers, total peak abundances were used for quantification. External calibration curves showed 
strong linearity for all four compounds (r2 > 0.99), during the concentration series 0, 49, 98, 195, 
391, 781, 1563, 3125, 6250, 12 500, 25 000, 50 000, and 100 000 pg/mL (TBPH/TBB) and 0, 63, 
125, 250, 500, and 1000 pg/mL (OH-TBPHs/OH-TBBs). 
6.3.10 Data analysis 
Bioaccessibility was calculated by use of Equation 6.1173. 
Bioaccessibility = 1 – (NBFRs remaining in dust following incubation/Sum of NBFRs measured 
in dust, Tenax and digestive fluid)…………………………………………………………...(6.1)    
Statistical analyses were completed by use of SPSS 19.0 software. Values less than MDLs were 
replaced by MDL/2.  Contributions of individual compounds to sum of target analytes in dust 
were calculated as previously described163, 164. Concentrations were assessed using the Shapiro-
Wilk test to determine if they followed a normal probability function.  If the frequency 
distribution of a set of concentrations was not normally distributed, a log-transformation was 
used to ensure normality of distributions of values.  When comparing bioaccessibility or 
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concentrations of compounds among samples/seasons, a paired t-test analysis was used.  
Differences with p < 0.05 were considered significant. 
6.4 Results and discussion 
6.4.1 Concentrations of NBFRs and their hydroxylated isomers in dust from day care 
centers 
Concentrations of TBPH and TBB are consistently the greatest in indoor dust from the U.S. and 
Canada. Although there are numerous studies regarding concentrations of a range of legacy and 
novel flame retardants (FRs) in the U.S., Europe, and China, there have been fewer studies 
conducted in Canada.  In this study, concentrations of TBPH, TBB and their hydroxylated 
isomers, OH-TBPH1, OH-TBPH2, and ƩOH-TBBs in dust from day care centers across 
Saskatoon, SK, Canada were among the greatest reported for these compounds.  TBPH and TBB 
had geometric mean concentrations of 734 and 992 (ng/g, dm), respectively, in summer while 
OH-TBPH1, OH-TBPH2, and ƩOH-TBBs had greatest geometric mean concentrations of 0.17, 
0.81, and 0.30 (ng/g, dm), respectively, in winter (Table 6.1).  Concentrations of TBPH were 
similar, though generally greater, than those previously reported for dust from academic 
environments and homes in the U.S. and Canada41, 160, 165, 176, while concentrations of TBB were 
similar, though generally greater, than those reported for dust in homes from the U.S. and 
Canada41, 165. Concentrations of the hydroxylated isomers have only been reported previously by 
our group163, 164. These isomers were initially detected in analytical standards and technical 
mixtures such as Firemaster® 550 and BZ-54, but were later confirmed in dust from day care 
centers.  Though the relative contributions of OH-TBPH1, OH-TBPH2, and ƩOH-TBBs in FM-
550 were approximately 0.1, 7.9, and 0.8%, their relative contributions in dust ranged from 0.01-
0.13% OH-TBPH1/2, and 0.18-0.24% ƩOH-TBBs. Differences in relative contributions between 
technical mixtures and environmental samples might be due to differences in environmental 
partitioning to air or dust and in size of dust particles. OH-TBPH1, OH-TBPH2, and ƩOH-TBBs 
were detected in approximately 48, 84 and 88% of samples collected during winter, which were 
similar to frequencies of detection for TBPH (100%) and TBB (100%), though frequencies for 
OH-TBPH1 were significantly fewer.  Reduced frequency of detection, lesser relative 
contributions, and lesser concentrations of OH-TBPH1 in dust indicate the compound is likely a 
very minor contaminant in technical mixtures of the flame retardant. Concentrations observed in 
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these ECEs are among the greatest reported, which indicates that products in these environments 
contain greater quantities of NBFRs or there are greater amounts of products which contribute to 
the concentrations detected in dust. 
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Table 6.1. Concentrations of TBPH, OH-TBPH, TBB, and ƩOH-TBB (ng/g, dm) in samples of 
dust collected from daycare centers in summer or winter of 2013 and 2014, respectively. 
  TBPH OH-TBPH1 OH-TBPH2 TBB ƩOH-TBB 
S
u
m
m
er
d
,e
 GM ± GSD 734 ± 0.87 0.04 ± 0.88 0.35 ± 1.0 992 ± 0.82 0.21 ± 1.33 
Min. 15 <0.01a <0.01a 25 <0.01a 
Max. 22251 7.3 27 37975 91 
Det. Freq. b 100%  52% 91% 100% 91% 
Contributionc 99.9% 0.01% 0.1% 99.8% 0.18 
       
W
in
te
r 
GM ± GSD 627 ± 0.66 0.17 ± 0.71 0.81 ± 0.75 841 ± 0.76 0.30 ± 0.78 
Min. 105 <0.01a <0.01a 22 <0.01a 
Max. 19345 7.8 15.8 43035 87 
Det. Freq. b 100% 48% 84% 100% 88% 
Contributionsc 99.8% 0.04% 0.13% 99.8% 0.23% 
aThe concentration was less than the MDL (0.01 ng/g).  
bDetection frequencies in samples of dusts. 
 cRelative contribution to the sum of concentrations of TBPH or TBB and their OH-isomers. 
d,eConcentrations of TBPH and TBB and their OH-isomers in samples collected from summer were 
reported in our previous studies163, 164. 
*Indicates a statistically significant difference between samples from summer and winter (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
128 
 
Children in the U.S. and Canada generally spend a great proportion of their time in early 
childhood environments (ECEs) and schools, while dust from these environments might contain 
relatively greater concentrations of BFRs than in homes.  Though greater concentrations of BFRs 
in certain environments might be an important determinant of overall exposure of children to 
BFRs, relatively few assessments of concentrations of TBPH or TBB have been conducted on 
dusts from ECEs or primary schools. One such assessment in California, U.S., reported mean 
concentrations of TBPH and TBB of 431 and 1062 ng/g, dm, respectively, which is significantly 
less than reported here but greater than concentrations detected in homes in California75. Several 
other investigations have reported greater concentrations of BFRs including PBDEs (PentaBDE 
mixture) and hexabromocyclododecane (HBCD) in ECEs and schools relative to other 
environments including houses, cars, and apartments70, 177-180. These relatively great 
concentrations in dust might have originated from a greater number of children’s products in 
these environments.  For example, a screen of children’s products collected from 2000 to 2010 
detected components of the Firemaster® 550 mixture in 17% and tris(1,3-dichloro-2-propyl) 
phosphate (TDCIPP) in 36% of products. Indeed, in a study of  metabolites of organophosphate 
flame retardants (OPFRs) in urine, children who possessed > 16 children’s products had 6.8 
times greater concentrations and those infants which attended day care centers had 3.7 times 
greater concentrations of metabolites of some OPFRs181. A potential conclusion which can be 
inferred from these findings is that increased concentrations of FRs in dust might be partially due 
to the increased density of children’s products in these environments and might be a relevant 
factor in the greater exposure of children to FRs. 
6.4.2 Differences of concentrations of NBFRs and their hydroxylated isomers in dusts from 
specific microenvironments 
Day care centers and other ECEs have relatively greater densities of children’s products than 
homes and these products can contain significant amounts of legacy BFRs and NBFRs. 
Therefore, it was hypothesized that the greater number of children’s products might lead to 
greater concentrations of these NBFRs in dust from ECEs, which would, in turn, result in greater 
exposures of children to BFRs.  In this study, concentrations of compounds in dust from three 
microenvironments which represented permutations of greater/lesser numbers of children’s 
products (toys/furniture) and more/less human activity and foot-traffic were investigated. The 
microenvironments were designated as higher traffic-higher toys (HT-HT), higher traffic-lower 
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toys (HT-LT), and lower traffic-lower toys (LT-LT). Microenvironments designated as 
higher/lower foot-traffic were major play/activity rooms or rooms with lesser foot-traffic 
(sleeping rooms), respectively, where microenvironments designated as higher/lower toys 
contained relatively greater amounts of children’s products (storage or major activity rooms) and 
fewer children’s products (sleep or craft rooms). By comparing concentrations of these NBFRs 
in dust from microenvironments which contain higher/lower number of children’s products, 
information regarding potential sources of the compounds and increased risk of exposure might 
be inferred. Results of other studies have shown that high foot-traffic rooms can contain greater 
concentrations of BFRs in dust153,  which indicates that human activity, including air movement 
and transfer of dust, might alter concentrations of NBFRs in microenvironments.   
In each day care center sampled during winter, dust from HT-HT microenvironments 
consistently had greatest concentrations of TBPH, TBB, OH-TBPH1, OH-TBPH2, and ƩOH-
TBBs (Figures 6.1, 6.2). In assessments of TBPH, TBB and ƩOH-TBBs, concentrations in dust 
collected in winter from the HT-HT environments were greater than concentrations in the HT-LT 
and LT-LT environments while concentrations of OH-TBPH1 were greater in HT-HT than in 
HT-LT and concentrations of OH-TBPH2 were greater in the HT-HT than in LT-LT (Figures 
6.1, 6.2).  Greater concentrations of these FRs in the HT-HT environment could indicate that 
relatively more children’s products might contribute to greater concentrations in dust, although it 
has also been previously described that high foot-traffic areas can contain greater concentrations 
of BFRs in dust.  For example, in homes from Boston, concentrations of PentaBDEs and 
DecaBDEs were 72 and 97% greater in dust collected from the main living room than the 
bedroom153.  Though higher foot-traffic in the area might contribute to concentrations of FRs in 
dust, there were no differences in concentrations of any compound in dust between the HT-LT 
and LT-LT microenvironments.  These environments have similar numbers of children’s 
products, but vary in intensities of human foot-traffic, which indicates that foot-traffic is not a 
major contributor to increased concentrations of NBFRs in dust. Differences in concentrations of 
OH-TBPH1 or OH-TBPH2 in microenvironments might also indicate that foot-traffic is not a 
major factor affecting concentrations of NBFRs. The common factor between 
microenvironments in which differences in concentrations of the hydroxylated isomers were 
detected was ‘lower toys’, no discernable pattern was observed for ‘traffic’ as a contributing 
factor.  These microenvironments had similar numbers of electronics and furniture, though 
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considerable uncertainty exists in any analysis of contributing factors because NBFRs are added 
to numerous consumer products including flooring, electronics and insulating foams. The myriad 
of uses coupled with inconsistent masses applied and lack of information regarding types of FRs 
incorporated into the product can create difficulties in ascribing singular sources (children’s 
products) as sole contributors to NBFRs in dust.  These inconsistencies have been discussed in 
previous reports which encountered difficulties in relating concentrations of FRs in dust to 
numbers of furniture or electronics182, 183. Based on data derived from winter samples, 
microenvironments which contain more children’s products generally have greater 
concentrations of NBFRs in dust and while the volume of foot-traffic might also contribute to 
these increased concentrations, a significant difference in concentrations of NBFRs were not 
detected between environments which varied only in the ‘traffic’ parameter (HT-LT vs. LT-LT).   
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Figure 6.1. Mean concentrations of TBPH (A), OH-TBPH1 (B), and OH-TBPH2 (C) in dust from 
daycares across Saskatoon, SK, Canada (n=10).  Dust was collected from higher traffic-higher toy 
environments (HT-HT), lower traffic-lower toy environments (LT-LT), and higher traffic-lower 
toy environments (HT-LT). Samples were collected in summer of 2013 and winter of 2014 (n=10, 
per room type/season). Error bars represent standard deviation, lower case letters represent 
statistically significant differences, p < 0.05. 
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Figure 6.2. Mean concentrations of TBB (A) and ƩOH-TBBs (B) in dust from daycares across 
Saskatoon, SK, Canada (n=10).  Dust was collected from higher traffic-higher toy environments 
(HT-HT), lower traffic-lower toy environments (LT-LT), and higher traffic-lower toy 
environments (HT-LT). Samples were collected in summer of 2013 and winter of 2014 (n=10, per 
room type/season). Error bars represent standard deviation, lower case letters represent statistically 
significant differences, p < 0.05. 
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6.4.3 Seasonal differences in concentrations of NBFRs and hydroxylated isomers in dust 
Seasonal differences in concentrations of NBFRs in indoor dust are particularly important in 
colder climates, where people spend a great proportion of time indoors. Significant variability in 
concentrations of NBFRs among seasons could alter assessments of risk as exposure 
concentrations during cold seasons could be higher relative to warmer periods177. In particular, 
young children spend great proportions of time indoors, up to 97% in Canada174, during the 
winter months, which might increase risk associated with these indoor contaminants.   
Means of concentrations, frequencies of detection, and relative contributions of none of 
the compounds were statistically different between seasons, though a trend of increased 
concentrations of the hydroxylated isomers, OH-TBPH1, OH-TBPH2, and ƩOH-TBBs in winter 
was observed (Table 6.1).  Concentrations of OH-TBPH1, OH-TBPH2, and ƩOH-TBBs were 
425%, 231%, and 143% greater in winter than in summer. Furthermore, no seasonal differences 
were detected in comparison of microenvironments, which was expected as the amount of 
children’s products and furniture were not significantly altered between the two sampling periods 
(Figures 6.1 and 6.2). Seasonality of concentrations of NBFRs in dust can be attributed to 
numerous phenomena including migration from consumer products177, 184. The processes are 
functions of specific physical-chemical properties including log Kow, volatility, and molecular 
weight (MW)182. For example, BDE-209 (log Kow, 12.11; vapour pressure, 6.22x10
-10 Pa; MW, 
959.17; EpiWeb 4.1) likely migrates from products via mechanical abrasion as it has a high log 
Kow and low vapour pressure, where triphenyl phosphate (TPP) (log Kow, 4.70; vapour pressure, 
8.37x10-4 Pa; MW, 326.29; EpiWeb 4.1) another FR and major component of the Firemaster® 
550 mixture, has a greater vapour pressure and lesser log Kow and generally would migrate from 
products via volatilization-adsorption.  Processes by which chemicals migrate from products 
partially dictates where a chemical will partition in the environment.  For example, BDE-209 
would likely remain adsorbed to abraded particles and incorporate into dust185, while TPP would 
preferentially partition to the air-phase (vapour and particles).  These mechanisms also dictate 
emissions of NBFRs, where TBPH, TBB, OH-TBPHs, and OH-TBBs have physical-chemical 
properties similar to BDE-209 and components of the PentaBDE mixture (BDE-47/99/153).  As 
such, the NBFRs would likely remain adsorbed to abraded particles in dust and follow similar 
seasonal trends as BDEs-47/99/153/209. In previous studies of seasonality, concentrations of 
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PBDEs (47/99/153/209) in dust did not significantly change between cold and warm seasons153, 
186, 187. For example, in one of the most in-depth and robust studies of seasonal variations of FRs, 
concentrations of PBDEs (47/99/153/209) and NBFRs (TBPH/TBB) remained stable between 
the summer and winter months, though a clear seasonal effect was observed in concentrations of 
OPFRs184. Increased concentrations of OPFRs in winter months are likely due to greater 
volatilities as compounds which partition to air would be affected by lower air flow and filtration 
in buildings, where this effect would be minor for non-volatile or lesser for semi-volatile 
compounds. Indeed, most investigations of seasonal differences of less volatile compounds 
indicate that introduction of new consumer products or changes in cleaning behaviours, instead 
of seasonal differences of heat and air flow, are important parameters for changes to 
concentrations in dust188. The lack of seasonal differences in concentrations of NBFRs and some 
PBDEs in dust is similar to results observed in this study, though increases in concentrations in 
winter months of the OH-isomers were not significant, the observed patterns could be due to 
greater volatility, lower MW and lower log Kow of the compounds relative to TBPH and TBB.  
Results of this study indicate that seasonality would not significantly alter assessments of risk for 
these NBFRs, though great variability in concentrations have been observed in repeated samples, 
so several sampling events would likely be required for accurate estimations of concentrations in 
dust. 
6.4.4 Bioaccessibilities of NBFRs and their hydroxylated isomers in standard reference dust 
and dust collected from day care centers 
In general, humans are exposed to NBFRs via three pathways, dermal absorption, inhalation, and 
ingestion.  Due to the physical-chemical characteristics of TBPH and TBB, inhalation and 
ingestion are likely the major routes of exposure to these indoor contaminants.  Though precise 
routes of exposure for TBPH and TBB are unclear, recent studies have shown that the dermis 
likely provides a significant barrier for hydrophobic compounds including TBPH and TBB, thus 
epidermal exposure is likely not a major route of concern189, 190. To properly assess exposure via 
ingestion the concentrations of target compounds in the exposure vector and their bioavailability 
must be accurately described. But, in vivo determinations of bioavailability are difficult and carry 
ethical and economic considerations associated with the use of animals.  Thus, bioavailability 
data is seldom integrated into assessments of exposure when calculating risks.  The surrogate 
measure, bioaccessibility via the in vitro CE-PBET method avoids these concerns and represents 
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an accurate estimation of in vivo bioavailability which can be integrated into these 
assessments173.   
Significant differences in bioaccessibilities were detected for all compounds when TA 
was/not added to the CE-PBET test system (Figure 6.3).  For example, in the system enhanced 
with TA, bioaccessibilities of TBPH and TBB were 33 and 59%, respectively, while in the 
system lacking TA they were 3 and 12%, respectively.  Results of previous studies have shown 
that predictions of in vitro bioaccessibility of PBDEs have been more similar to in vivo values 
with the use of a TA enhanced system173. This is likely because TA acts as a sorption sink to 
remove NBFRs mobilized into the GIT fluid from dust particles by mimicking the lipid 
membrane of intestinal cells191. As such, TA helps to maintain a desorption gradient between 
dust and the GIT fluid which would likely be observed in the gastro-intestinal system.  
Bioaccessibilities of TBPH, TBB, OH-TBPHs, and OH-TBBs from standard reference dust and 
dust collected from day care centers in winter and summer, were assessed with the system 
enhanced with TA.  The NBFRs were detected in all samples, though OH-TBBs were not 
detected in the SRM and standards were subsequently spiked into the material. Bioaccessibilities 
of TBPH and OH-TBPHs in SRM and dust collected from day care centers in summer and 
winter ranged from 33-38% and 23-30%, respectively (Figures 6.3, 6.4; Table C6.S2). These 
values are similar to those from a previous study - 25% for TBPH - that used the TA assisted 
CE-PBET method.  They were also similar to bioaccessibilities of PBDEs with similar physical-
chemical characteristics as TBPH and OH-TBPHs; BDE-209 = 28% and 5-14% and BDE-153 = 
28-34%173, 192. Bioaccessibilities of TBB and OH-TBBs in SRM and dust collected from day care 
centers in summer and winter were moderate, and ranged from 53-59% and 70-72%, respectively 
(Figures 6.3, 6.4; Table C6.S2).  These values were similar, though greater than those from a 
previous study which used the TA assisted CE-PBET method. Bioaccessibility of TBB was 48% 
and was generally greater than bioaccessibilities of PBDEs with similar physical-chemical 
characteristics; BDE-153 = 55% and 28-34%, BDE-47 = 74% and 23-25%, and BDE-99 = 65% 
and 15-23%173, 192. No seasonal differences of bioaccessibility were observed for any compounds 
for dust collected in winter vs. summer (Figure 6.4).  Differences of bioaccessibilities between 
studies could likely be explained by differences in composition of dust (organic content), the 
state of the in vitro model (fed vs. unfed) and use of TA as a sorptive sink.  This study supports 
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the values of bioaccessibilities of TBPH and TBB reported in the only other assessment in the 
literature173, and is the  first to calculate bioaccessibilities of OH-TBPHs and OH-TBBs.  
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Figure 6.3.  Bioaccessibilities of TBPH, TBB and their OH-isomers (ƩOH-TBPH1/2 and ƩOH-
TBBs) in reference dust (n=4). Bioaccessibilities were tested with and without Tenax enhancement 
and compared to data from a previous in vitro study173. Error bars represent standard deviation, 
lower case letters represent statistically significant differences, p < 0.05. 
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Figure 6.4. Bioaccessibilities of TBPH, TBB and their OH-isomers (ƩOH-TBPH1/2 and ƩOH-
TBBs) in dust (n=14) collected in the summer of 2013 and winter of 2014 from daycares in 
Saskatoon, SK, Canada. Bioaccessibilities of TBPH and TBB were compared to data from a 
previous in vitro study173. Error bars represent standard deviation, lower case letters represent 
statistically significant differences, p < 0.05. 
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There were significant differences in bioaccessibilities of TBB and OH-TBBs from SRM 
and dust collected from day care centers, though no differences were observed between TBPH 
and OH-TBPHs (Figures 6.3, 6.4).  Further, no differences in bioaccessibilities between TBB 
and OH-TBBs were observed in the CE-PBET system which did not integrate TA. This indicates 
that performance of the system was enhanced with the addition of TA.  Molecular weight, 
solubility, and log Kow are likely important factors which influence the bioaccessibility of 
compounds. Previous studies have shown a significant relationship between bioaccessibility and 
values of log Kow, where bioaccessibility decreased as values of log Kow increased, though 
bioaccessibilities of compounds with log Kows ≥ 8 were generally similar173, 193. This phenomena 
was also observed in this study, as bioaccessibilities of TBPH and OH-TBPH, which have 
similar log Kow values of 11.95 and 9.56, respectively, were not significantly different. 
Bioaccessibilities of these compounds were similar to those of BDE-209 and BDE-153, which 
have log Kow values of 12.11 and 8.55, respectively.  Differences in bioaccessibilities of TBB 
and OH-TBBs is likely due to differences in log Kows. Specifically, the log Kows of TBB and OH-
TBB are close to the asymptotic region of the relationship between bioaccessibility and log Kow, 
where TBB > 8 > OH-TBB, which indicated that OH-TBB would likely be more bioaccessible 
than TBB. This increase in bioaccessibility of the OH-isomer is important to note because an 
increased amount of the compound will likely reach the systemic circulation, and the addition of 
a phenolic group generally increases the toxic potency of a chemical as observed with OH-
PBDEs161. For example, in our recent study, OH-TBB demonstrated greater estrogenic response 
and induced greater PPARγ activity than native TBB in in vitro cellular assays164. The increased 
bioaccessibility of OH-TBB and increased toxic potency highlights the potential for increased 
risk to children.  
6.4.5 Conclusion 
This study was one of the first to quantify the NBFRs TBPH and TBB and their hydroxylated 
isomers, OH-TBPH1, OH-TBPH2, and ƩOH-TBBs in dust from early childhood environments. 
This study was also the first to investigate the seasonality of these compounds in dust from these 
environments and bioaccessibilities in an in vitro model.  Results show that day care centers 
from Saskatoon, SK, Canada have some of the greatest concentrations of TBPH and TBB 
observed to date.  This finding is concerning as these NBFRs have been shown to disrupt 
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endocrine functions which are important to normal development. As the majority of young 
children in Canada attend some version of an ECE, they might be exposed to increased 
concentrations of these NBFRs during a susceptible period of development.    
Seasonal differences between concentrations of these NBFRs were minimal which might, 
in part, be due to their process of migration from consumer products. In our previous studies, 
which were the first to detect, identify, and quantify the OH-isomers of TBPH and TBB163, 164, 
we proposed they might be more bioaccessible than the natural compounds due to their lower log 
Kows. In this study we observed that OH-TBBs, though not OH-TBPHs, were indeed more 
bioaccessible than the native compounds. The increased bioaccessibility of these OH-isomers 
(OH-TBBs) is important as it has recently been shown that the compound has greater endocrine 
disrupting potency than the native TBB164, and is more likely to enter systemic circulation and 
adversely affect normal endocrine functions in the developing child. 
In an effort to obtain broad distribution of samples and appropriate sample sizes to 
determine seasonal and microenvironment specific differences in concentrations, approximately 
60% of provincially licensed day care centers in Saskatoon, SK, Canada were canvassed for 
inclusion in this study.  However, participation among day care centers was limited as there were 
perceived stigma related to scientific studies and implications for viability of small businesses.  
Participation by licensed day care centers was recorded at approximately 18%.  Though a larger 
sample size would have helped to more accurately described trends in seasonal variation and 
differences in microenvironments, the study was successful with the acquired samples.  
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7 CHAPTER 7: GENERAL DISCUSSION 
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7.1 History and project rationale 
7.1.1 Regulations, the use of BFRs, and research regarding Firemaster® 550 
In 1972 the California Bureau of Electronic and Appliance Repair, Home Furnishing and 
Thermal Insulation responded to increases in devastating home fires by implementing a 
residential flammability standard known as Technical Bulletin 117 (TB 117).  The terms of this 
standard required that fill materials in upholstered consumer products, including polyurethane 
foams (PUF), were able to withstand 12 s of open flame before ignition, in theory reducing the 
time to combustion of the material.  Though this local standard was implemented in California, it 
has affected exposure to BFRs internationally.  Due to the size and prominence of the 
Californian economy, manufacturers integrated this standard into most products destined for 
North American markets. At the initiation of this PhD program, most household furniture 
investigated in Saskatoon, SK, Canada contained the TB 117 label.   
In recent years, there has been controversy regarding the TB 117 standard.  Many 
scientists and engineers have noted that TB 117 was ineffective, specifically in the 12 s smoulder 
test which used naked polyurethane foam exposed to a candle sized flame. This standard did not 
represent a realistic scenario as fires generally started on the outer fabric which covered the PUF.  
Once contacted, the PUF would likely be exposed to flame significantly greater than those 
generated by a candle.  In fire retardancy tests of PUF generated in the 1980s, researchers funded 
by manufacturers of BFRs claimed that the addition of FRs provided residents a 15-fold increase 
in time to escape residential fires.  It was later exposed that concentrations of FRs used in these 
tests were significantly greater than those found in consumer products. Recently, scientists, 
regulators, media, and concerned citizens have questioned the use of chemical FRs, due to their 
associated toxicities, and have attempted to amend TB 117.  In 2013, following a polarizing 
campaign which saw chemical manufacturers create fake citizen awareness groups and purchase 
false congressional testimony from a highly regarded specialist (who later relinquished their 
medical license), the California state government updated their fire safety standards. The new 
California standard, TB-117-2013, did not ban the use of BFRs, but it no longer required their 
use in upholstered furniture and suggested the use of smolder-resistant fabrics.  This decision has 
the potential to significantly alter exposure to BFRs and NBFRs in North America as several 
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major retailers including Wal-Mart, Ashley Furniture, and Ikea have committed to eliminate 
BFRs and NBFRs from products. 
Initially, compliance with TB 117 was partially achieved by application of flame 
retardant compounds such as PBDEs and OPFRs to consumer products. Studies which 
demonstrated their persistence in the environment, bioaccumulation potential, and toxicities lead 
to the phase-out of some of these compounds from U.S., European, and Canadian markets. 
Following the phase out of the Penta-BDE formulations, the FR mixture, FM-550, which 
contained TBPH and TBB was one of the primary replacements and their volumes of production 
have likely increased31. In 2011, when this program of study was initiated, there were six studies 
which characterized the presence and behaviour of TBPH and TBB in the environment36, 38, 41, 43, 
149, 194, and no studies which focused on toxicities of these compounds. In the two subsequent 
years, several investigations of toxicity, including the study presented in Chapter 2, were 
published29, 52, 53, 78, 99.  These studies demonstrated potential endocrine disrupting effects, 
potential for DNA damage resulting from exposure to FM-550 or the individual components of 
the mixture, and characterized in vitro metabolism.  Though these initial studies highlighted 
some of the potential toxicities of components of FM-550, further assessments of concentrations 
in the environment and toxic profiles of these compounds were greatly important.  
7.1.2 History of research regarding TBCO 
When this program was initiated in 2011 there were only three studies which had investigated 
the presence of TBCO in the environment126, 127, 195, and though the compound had met EU 
criteria as a potential aquatic hazard, there were no assessments of its potential toxicities.  TBCO 
was a low production volume chemical with great potential. The compound was structurally 
similar to HBCD, one of the major-use legacy BFRs, and had been identified by the U.S. EPA 
Design for the Environment program as a potential replacement. In 2001, use of HBCD 
comprised approximately 8% of the global market, but due to its toxicity, persistence in the 
environment, and bioaccumulation potential, the compound was added to the Stockholm 
Convention on POPs in 2014 and was phased out of use in European markets. Use of TBCO as a 
major or minor replacement of HBCD would greatly increase the compound’s production 
volume and risk of exposure of humans and aquatic wildlife.  
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7.1.3 Project rationale  
Information in the published literature regarding concentrations in the indoor-outdoor 
environment and potential toxicities of TBPH, TBB, and TBCO was sparse. Due to their 
inclusion as major and potential replacement compounds of legacy BFRs, production volumes of 
these chemicals were likely to increase.  Thus, the rationale for this program of research was to 
increase knowledge of toxicities and concentrations of these compounds in the indoor 
environment.  Such knowledge would improve assessments of risk and alternative assessments 
of these compounds.  For this purpose, toxicity profiling similar to the U.S. EPA Endocrine 
Disruptor Screening Program was used.  Screening level in vitro assessments of the compounds 
were conducted by use of a range of cellular assay systems (Chapter 2). Initial positive results 
indicated that further studies were required, thus, small fish models were used to characterize 
potential endocrine disrupting effects and elucidate mechanisms of action (Chapters 3 and 4). 
Following assessments of toxicities, concentrations of these compounds in dust from ECEs were 
determined and potential modulating factors of these concentrations and bioaccessibilities of the 
compounds were investigated (Chapters 5 and 6).  
7.2 Toxicities of novel brominated flame retardants 
7.2.1 Screening level in vitro assessments of endocrine disrupting effects of TBPH and TBB  
The few initial assessments of toxicities of TBPH and TBB showed potential endocrine 
disrupting effects of these compounds (Chapter 2).  Following these results, several in vitro 
studies were conducted to further verify and characterize toxicities of these compounds.  
Concurrent investigations into metabolism of TBPH and TBB were conducted as the mono-ester 
metabolite of DEHP, the non-brominated analogue of TBPH, was considered to be the 
toxicologically active form of the compound79.  In tissue preparations of fish, rats, and humans, 
TBB was rapidly metabolized to form 2,3,4,5-tetrabromobenzoic acid (TBBA), while TBPH was 
metabolized to form mono(2-ethylhexyl)-2,3,4,5-tetrabromophthalate (TBMEHP).  Due to 
potential toxicities of these metabolites, some investigations have focused on these compounds29, 
52, 78.  The (anti)-estrogenic, (anti)-androgenic, and (anti)-thyroidal activities of TBPH, TBB and 
their metabolites TBBA and TBMEHP were assessed in numerous cellular assay systems at 
concentrations which ranged from 1 to 3000 μM.  In corroboration of results from Chapter 2, 
studies showed that TBPH and its mono-ester metabolite, TBMEHP interacted with hormone 
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receptors to cause anti-androgenic and anti-thyroidal effects196; both compounds caused anti-
estrogenic and anti-androgenic effects and inhibited deiodinase activity54, 197; and TBPH 
modulated levels of E2 and T in a porcine mixed cell model100; though TBPH did not cause 
(anti)-estrogenic or (anti)-androgenic effects at similar concentrations in the MCF-7 or 
YES/YAS cellular assay systems53, 198.  TBPH and TBMEHP were potent agonists of the 
pregnane X receptor (PXR), while TBPH also elicited antagonistic effects199.  
Similar to results presented in Chapter 2, TBB and its metabolite TBBA interacted with 
hormone receptors to cause anti-androgenic and anti-thyroidal effects196; TBBA elicited anti-
estrogenic and anti-androgenic effects in the YES/YAS assay system though no effects were 
observed for TBB197; TBB and TBBA were potent agonists of the pregnane X receptor (PXR) 
which caused significant increases in transcript abundances of CYP3A4199; though TBB did not 
modulate concentrations of E2 and T in a porcine mixed cell model100.  Further, TBB, TBBA, 
and TBPH did not interact with the PPARα or PPARγ receptors in vitro200-202, though TBMEPH 
caused moderate activity of both receptor sub-types and induced adipocyte differentiation while 
ƩOH-TBBs elicited strong activity of PPARγ54, 164, 202, 203.  As observed in the screening level 
assessment of TBPH and TBB in Chapter 2, these compounds and their metabolites affected 
activities of several nuclear receptors which function within the endocrine system, and 
modulated concentrations of steroid hormones within these cellular assays.  But, it is also 
important to note that there were several contradictory reports of these effects, which is common 
for compounds tested with different in vitro assay systems at varying concentrations.  Cellular 
assay systems were created from diverse tissues and can vary greatly in their sensitivities, 
physiologies, and metabolism. For example, the MCF-7 cell line originated from mammary 
epithelium tissue which naturally express the hER and other cellular tools of the ER activation 
pathway, whereas YES/YAS were derived from yeast which contained a transfected receptor 
(hER/hAR), express none of the inherent enzymes associated with the ER activation pathway, 
and contain a cell wall which might alter absorption of chemicals relative to mammalian derived 
cellular systems81.   
Though in vitro assay systems are accepted tools for screening level assessments of 
toxicity, as exemplified in the U.S. EPA EDSP, there remains questions of confidence in results 
generated from these tests. Further, not all compounds which elicit responses in these in vitro 
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assays are EDCs and assessments beyond the limited complexity of in vitro binding assays are 
required. In vitro systems are inherently simple and cannot represent the complexity of an in vivo 
system which integrates dynamic networks of processes which are tightly regulated and 
controlled to maintain homeostasis.  There are numerous examples of chemicals which interact 
with specific molecular endpoints in the endocrine system but have no adverse effects on tissue 
or the whole organism; vertebrate networks such as the endocrine system are incredibly adaptive 
to maintain function.  Thus, further assessments of the endocrine disrupting toxicities of these 
NBFRs were conducted in in vivo model systems (Chapters 3,4).   
7.2.2 In vivo assessments of endocrine disrupting effects of TBPH, TBB and TBCO 
Fish models have been used extensively in screening programs of endocrine disruption, in part 
due to the significant conservation of basic aspects of the endocrine system between vertebrates.  
Thus, our assessment of these NBFRs used a small fish model to test fecundity and fertility to 
determine effects on the whole organism and identify mechanisms of toxic effect (Chapters 3,4).  
Exposure to a mixture of TBPH/TBB or TBCO resulted in a decrease in cumulative fecundity of 
32% for the TBPH/TBB mixture, and 18% for TBCO, though neither exposure resulted in 
modulation of fertility130, 172.  Analysis of 34 genes across the HPGL-axis did not provide a 
specific mechanism of effect for the TBPH/TBB mixture, though a pattern of global down-
regulation of transcripts of upstream signals including gonadotropin releasing hormones, 
gonadotropin releasing hormone receptors, and brain ER/AR was observed. No compelling 
mechanism of toxic effect was observed from the analysis of transcript abundances of the HPGL-
axis of fish exposed to TBCO, though sex and organ specific differences were noted.  In female 
fish increased expression of genes that responded to exposure to estrogens, which included 
vitellogenin II, choriogenin H, and ERα, were observed. This indicated that TBCO might have 
caused increased production of E2. This hypothesis was supported by the 3.3-fold increase in 
production of E2 observed in the H295R assay following exposure to TBCO99 (Chapter 2).  The 
studies conducted in Chapters 3 and 4 supported the hypotheses that TBPH, TBB, and TBCO 
were endocrine disrupting compounds, and though the mechanisms of toxicity were not fully 
elucidated, significant alterations to expression of genes across the HPGL-axis were observed.  
 Several investigations have attempted to characterize toxicities of FM-550 and its 
components in in vivo systems. Components of the FM-550 mixture including TBPH, TBB, 
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triphenyl phosphate (TPP), and a complex mixture of ortho-, meta, and para- substituted isomers 
of mono-, di-, tri-, and tetra isopropylated triaryl phosphates (ITPs) were tested for 
developmental toxicity in a zebrafish embryo model204.  In this screening level assessment, 
exposure of TBPH or TBB up to 10 μM resulted in no significant effects on embryonic survival 
or development, whereas exposure to the phosphate components resulted in effects on cardiac 
function during embryogenesis.  In a separate study which investigated the neurobehavioural 
effects of the FM-550 mixture, chronic exposures of 0.01 to 1.0 mg/L FM-550 in developing 
zebrafish or acute exposures of 1.0 to 3.0 mg/L FM-550 in adolescent zebrafish caused 
hypoactivity and a significant reduction in social behaviour, though within 1-week of acute 
exposure, effects were completely attenuated205.  This was one of the first studies which 
investigated potential neurobehavioural effects of FM-550 and reported that the mixture might 
cause persistent alterations to social behaviour. This study also found that exposures during 
susceptible periods of development were likely more harmful than acute exposures during 
adolescence.      
Due to the similarity of the mono-ester metabolite of TBPH to the bioactive metabolite of 
DEHP (MEHP), the toxicities of TBMEHP were assessed in pregnant rats54. Rats were treated by 
gavage with 200 or 500 mg/kg of TBMEHP on gestational days 18 and 19, and dams and fetuses 
were evaluated for toxicity.  The 48 hr exposure of TBMEHP produced hypothyroidism and 
decreased concentrations of serum T3, produced an increase in maternal hepatotoxicity, and an 
increase in multinucleated germ cells (MNGs) in fetal testes. These effects were similar to those 
observed following exposure to MEHP88.  The increase in MNGs was likely an indication of 
effects on the seminiferous cords which can cause anti-androgenic effects and developmental 
toxicity206.  The lack of inhibition of production of T was dissimilar to previous studies where 
TBPH was shown to antagonize the AR in vitro and modulate concentrations of T in the H295R 
assay99.  In our study regarding toxicities of the mixture of TBPH/TBB in fish, we did not 
observe hepatotoxic effects.  There were no significant differences in the HSI of exposed and 
control fish, and though that simple measurement is generally indicative of hepatic health, we did 
not conduct confirmatory histological studies. Further, hepatotoxicity of DEHP is likely caused 
by activation of the PPARα207, an activity which has been confirmed for TBMEHP54. 
Differences in hepatotoxicity between our assessment of fish and assessment in rats could be due 
to direct exposure of TBMEHP vs. exposure to TBPH (and subsequent metabolism to TBMEHP) 
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or due to the known PPAR agonistic effects of the OPFR components of FM-550.  In a separate 
study, the FM-550 mixture was fed to pregnant rats at 100 or 1000 μg/day until the 8th 
gestational day52.  Exposure to FM-550 caused increased concentrations of serum thyroxine in 
dams and induced metabolic syndrome, advanced female puberty, weight gain, cardiac 
hypertrophy, and altered exploratory behaviours in offspring. These effects indicated that 
perinatal exposure might affect normal development and alter adipogenic pathways. Effects on 
development might be mediated through disruption of endocrine function including modulation 
of concentrations of hormones or antagonism of hormone receptors, which has been 
characterized for TBPH, TBB, and their metabolites.  Weight gain and metabolic syndrome 
could be attributed to activation of PPARs, as they are known to affect adipocyte differentiation 
and deposition and might contribute to phenotypes of metabolic syndrome208.  TBMEHP, ƩOH-
TBBs, and the phosphate ester components of the FM-550 mixture have been shown to activate 
PPARs in in vitro experiments54, 164, 201.  Though many of these in vivo assessments highlighted 
the endocrine disrupting effects of the FM-550 mixture, it was impossible to determine if effects 
were attributable to TBPH or TBB.  Indeed, effects including cardiotoxicity, hepatoxicity and 
activation of the PPARs observed in these assessments have previously been attributed to several 
components of the FM-550 mixture52, 54, 204. As such, it was difficult to confirm results from our 
previous in vivo assessments.   
There are limited studies which have investigated toxicities of TBCO, and though it is a 
low production volume chemical, its potential as a replacement for HBCD justified prescriptive 
assessments of potential toxicity.  The initial in vitro assessment (Chapter 2) indicated the 
compound might have endocrine disrupting effects, which was confirmed in a subsequent in vivo 
study (Chapter 4).  Further characterization of this potential aquatic hazard has focused on early 
life stage exposures to fish.  Early stages of development are likely the most sensitive to toxic 
effects and represent an important period for which to assess toxicity of chemicals.  Embryos of 
Japanese medaka were exposed with 10 to 1,000 μg/L TBCO from 2 hr post fertilization until 1-
day post-hatch, and both time to- and success of- hatch were impaired209. Modulation of the 
transcriptome and proteome of medaka exposed to 100 μg/L TBCO was investigated to 
determine potential causes of toxic effects.  Medaka exposed to TBCO produced lesser 
abundances of proteins involved in pathways associated with embryo development and hatching 
which could explain effects on time to hatch, with lower success.  Further analysis of the 
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transcriptome and proteome revealed potential impairment of visual performance and contraction 
of cardiac muscle which was confirmed in separate exposures by use of targeted bioassays.  
Targeted analysis of several genes from the HPGL-axis showed significant up-regulation of VTG 
II, CHG-H, and the AR, a similar pattern of gene expression observed in our previous study172.  
This study represented the only other investigation of toxicity of TBCO in an in vivo system. The 
results confirmed the modulation of transcripts or proteins across the HPGL-axis and identified 
disruption of normal development and hatching, which were regulated by the endocrine system.  
The study confirmed TBCO as a potential endocrine disrupting compound and demonstrated 
significant impairment in the development of cardiac muscle and vision.  Further research is 
required to characterize toxic effect and mechanisms of action of TBCO.   
7.2.3 Epidemiological studies of legacy BFRs and potential for ‘read-across’ 
There is significant structural similarity between the NBFRs, TBPH, TBB and TBCO, and the 
legacy compounds, PBDEs, DEHP, and HBCDs to appropriately use a qualitative ‘read-across’ 
approach to inform potential toxicities of these chemicals. This is a particularly useful method 
because it can address gaps in data for these compounds as there are currently few investigations 
regarding their toxicities.  The ‘read-across’ approach has been utilized in the high production 
volume chemical program under the U.S. EPA, and has been adopted by REACH as a method to 
screen chemicals.  Legacy BFRs including PBDEs and HBCD as well as DEHP are known 
endocrine disrupting compounds with effects similar to those predicted for TBPH, TBB, and 
TBCO. For example, rats exposed to Octa-BDEs experienced significant modulation of the 
thyroid system210 whereas both TBPH and TBB interacted antagonistically with the thyroid 
receptor196.  DEHP is a reproductive toxicant, as it causes lesions in the testis, decreases rates of 
pregnancy, and increases rates of miscarriage211. DEHP’s active metabolite, MEHP is also an 
endocrine disrupting compound, as it has decreased serum concentrations of E2, decreased 
activity of aromatase and inhibited cellular signaling of FSH46, 212.  Though these specific effects 
have not been thoroughly tested for TBPH, TBB, or TBCO, studies have shown that they might 
have similar toxicities as they interact with the thyroid hormone receptor, modulate 
concentrations of E2, affect transcript abundances of FSH, and impair fecundity of fish99, 130, 172, 
196.  Epidemiological investigations have highlighted the population level effects of PBDEs and 
DEHP, but these studies require strong evidence of molecular toxic effects. There have been 
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relatively few targeted studies of TBPH, TBB, or TBCO to facilitate these large scale 
assessments. Thus, it might be useful to review epidemiological studies of compounds with 
similar structures or molecular effects.  For example, an epidemiological study of MEHP, a 
compound with a similar structure to TBB and TBMEHP, showed a negative association 
between concentrations of MEHP and concentrations of serum T3 in the U.S. population213. 
Modulation of the thyroid system via the TR receptor has been described for TBB and 
TBMEHP196.  Numerous studies have linked behavioural alterations in children to elevated 
concentrations of BFRs in serum, an effect which has been observed in rats and fish exposed to 
the FM-550 mixture52, 205. For example, prenatal exposure to several components of the Penta-
BDE mixture were significantly associated with lower IQ and greater hyperactivity of 
children171.  The Center for the Health Assessment of Mothers and Children of Salinas 
(CHAMACOS) completed a longitudinal birth cohort study of families in California and found 
that both prenatal and childhood exposure to PBDEs were associated with impaired attention and 
cognition. Children at age 7 were found to have deficits in verbal IQ and issues with attention 
and perceptual reasoning214.  Neurodevelopmental, behavioural, and reproductive effects have 
been linked to endocrine disruption during early stages of development215. Unfortunately, this 
stage of development corresponds with elevated body burdens of (N)BFRs including PBDEs and 
TBB relative to adolescents or adults169, 216, 217.  TBPH, TBB, and TBCO are likely endocrine 
disrupting compounds but researchers have inchoate knowledge of their effects. From the 
investigations outlined above, these compounds have similar potential for population level 
effects as BFRs and DEHP.  Yet, physiological or molecular effects of a compound alone do not 
define its toxicity.  The exposure and toxicokinetics of compounds are important to determine 
potential risk to human and ecological health.    
7.3 Exposure to novel brominated flame retardants 
7.3.1 Routes of exposure 
Humans are exposed to NBFRs via three pathways, dermal absorption via direct contact with 
products or dust which contain NBFRs, inhalation of NBFRs in the gaseous phase or associated 
with small particles, and ingestion of food or dust which contain NBFRs.  The dermal absorption 
of TBPH, TBB and HBCD, a surrogate for TBCO, has recently been investigated.  TBPH, TBB, 
and HBCD were applied to a human skin ex vivo model and though significant amounts were 
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recovered in the upper skin layers, relatively little of the compounds penetrated the skin190.  A 
significant relationship between penetration of compound and log Kow was observed, where a 
greater log Kow resulted in less penetration into the skin. This might be important for exposure to 
OH-TBBs and OH-TBPHs which have lower log Kow than TBPH and TBB.  The dermal 
absorption of TBPH and TBB were also tested in human and rat skin ex vivo systems189.  In this 
study, human skin absorbed approximately 24% of TBB, while only 0.2% penetrated the tissue, 
where rat skin was slightly more permeable as 2% of TBB penetrated the tissue. Further, TBB 
was metabolized to TBBA in these ex vivo systems.  Approximately 12% of TBPH was absorbed 
into human skin, while rat skin was significantly more permeable and absorbed 41% of TBPH, 
though < 0.01% of the compound penetrated the tissue in the rat or human systems.  Overall, < 
1% of TBPH or TBB was estimated to reach the systemic circulation via dermal absorption, 
which indicated that the dermis provided a significant barrier for these highly lipophilic 
compounds189, 190. Dermal absorption might account for some exposure to these NBFRs, though 
it likely does not represent a major pathway of exposure for humans.  It is important to note that 
exposure via dermal absorption is likely attenuated via hand-washing, as such, total exposure of 
children is likely more affected by this route than adolescents or adults. 
Exposure to NBFRs via inhalation is possible via two sources, the gaseous phase and 
small particles suspended in air.  The low vapour pressure and relatively high log Kow of TBPH 
and TBB indicated that these compounds would likely remain in dust, as they would 
preferentially migrate from consumer products via mechanical abrasion processes and become 
incorporated into the dust matrix.  Exposure to these NBFRs via inhalation would likely be via 
small particles as the compounds would preferentially partition to this phase.  For example, 
compounds with similar physical-chemical properties such as Penta-Hepta BDEs, and BDE-209 
have been predicted to remain almost exclusively in the particle phase; 60-90% for Penta-Hepta 
BDEs, and 100% for BDE-209218.  TBPH and TBB have been detected in respirable (< 4 μm) 
and inhalable (> 4 μm) fractions of air166.  These NBFRs were major contributors to ƩFRs 
(approx. 60%) detected in respirable fractions.  Further analysis of the inhalable particulate 
fraction of air showed a 10-fold increase in concentrations of these NBFRs, which indicated that 
these compounds were generally associated with larger particles.  This association would result 
in exposure via absorption of NBFRs in the mucus membranes of the respiratory and digestive 
tracts as these large particles would not likely penetrate deep into the lung166. TBCO, OH-TBBs, 
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and OH-TBPHs have lower log Kows and greater vapour pressures than TBPH and TBB and 
might have greater fractions which partition to the respirable particle phase.  Inhalation of 
particles contaminated with TBPH, TBB, or TBCO is likely a relevant vector of exposure, 
though due to the large particle size, a fraction of this exposure would occur in the digestive 
tract.   
 Ingestion is a major route of exposure to BFRs, and most studies to date have focused on 
ingestion via diet or indoor dust210.  Ingestion via diet was predicted to be a main route of 
exposure for some BFRs, such as PBDEs219.  Yet, there is little information regarding 
concentrations of NBFRs in food and exposure to humans. TBPH and TBB have been detected 
in food from an e-waste site in Eastern China220.  The study examined meat from pork and 
several avian and aquatic species and detected the greatest concentration of TBB in fish (62.2 
ng/g, lw), though the main source of exposure to TBPH and TBB was via pork (34% and 54% 
for adults and children, respectively). Of the NBFRs tested, TBB followed by TBPH had the 
greatest estimated exposure from diet for both children and adults (18.9 ng/kg/day and 8.03 
ng/kg/day, respectively).  This was the first account of these NBFRs in food though it might not 
represent a representative scenario as animals were cultured near highly contaminated sites of e-
waste recycling.  The authors also noted that no regulatory health based limit values existed for 
consumption of TBPH or TBB, perhaps reflecting the limited information regarding toxicity and 
estimates of exposure via food.  An investigation of serum concentrations in Swedish mother-
toddler pairs, and exposure via diet and dust did not detect TBPH or TBB in any dietary items 
from Sweden, though the compounds were detected at relatively moderate concentrations in 
indoor dust221.  Thus, indoor dust was considered to be the primary route of exposure for TBPH 
and TBB.  In 2012, the European Food Safety Authority conducted a meta-analysis regarding 
concentrations of legacy and novel BFRs in European diets, but could not find information 
regarding dietary exposure to TBPH, TBB, or TBCO222.  Though few studies have attempted to 
detect TBPH, TBB or TBCO in the diet, due to their detection in wildlife the compounds are 
likely present in food. Ingestion of dust is likely a major route of exposure of TBPH and TBB 
and might be more important than dietary routes in children compared to adults.  
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7.3.2 Toxicokinetics and human exposure 
Ingestion of indoor dust contaminated with NBFRs is likely a major route of exposure for 
humans.  As such, it was important to characterize potential metabolism, bioaccessibility and 
bioaccumulation of these compounds, as the toxicokinetics of ingested chemicals would affect 
risk to human health.  In vitro and in vivo assessments of metabolism of TBPH and TBB have 
identified two major metabolites, TBBA and TBMEHP52, 54, 78. Two recent studies have 
investigated the disposition and metabolism of TBPH and TBB in rats and mice223, 224.  Within 
24 hr of oral exposure of radio-labelled TBPH, rats eliminated approximately 75% of the 
unchanged compound in feces, though bioaccumulation was observed in liver and adrenals 
following a prolonged (10-day) exposure.  Further, a significant increase in dose (100-fold) of 
orally administered TBPH did not alter metabolism or uptake, though when administered 
intravenously TBPH was eliminated as a mixture of parent and metabolite compounds.  These 
results indicated that TBPH was poorly absorbed in the GIT and supported results presented in 
Chapter 6 which tested bioaccessibility of TBPH in vitro.  These studies supported the findings 
that the CE-PBET system was an accurate measure of bioavailability of TBPH in rats and mice. 
Bioaccessibility was predicted at 23% while bioavailability from the GIT was observed at 
approximately 25%. Following a single oral exposure of radio-labelled TBB, rats eliminated 
greater than 90% of the compound as metabolites (TBBA, TBBA-sulfate, TBBA-glycine) in 
urine and feces, while less than 1% of the total dose remained in tissues at 72 hr post exposure223. 
At greater doses (100 to 1000-fold), the main route of elimination shifted from urine to feces 
which indicated lesser absorption from the gut.  At lower exposure doses, TBB was rapidly 
absorbed from the gut with a half-life of approximately 4 hr and an absorption of approximately 
85%. Further, limited bioaccumulation of TBB was observed at all doses, which indicated a low 
likelihood of bioaccumulation upon chronic exposure223.  These results indicated that TBB was 
readily bioavailable in the GIT, though the assessment presented in Chapter 6 indicated a 
moderate bioaccessibility of 53%. Differences between in vivo and in vitro results were likely 
due to methods of delivery of TBB. The purpose of the in vivo assessment was to determine 
toxicokinetic characteristics of TBB, thus rats were exposed by gavage with a liquid formulation, 
where the in vitro system was seeded with TBB adsorbed to dust to determine bioaccessibility 
from this matrix. To date, no studies have examined the toxicokinetics of OH-TBPHs or OH-
TBBs. Though these compounds were minor contaminants in FR technical formulations and 
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indoor dust, our recent assessments indicated that OH-TBBs would likely be more bioaccessible 
than TBB (Chapter 6).  Further, it would be interesting to identify metabolites of these 
compounds as current studies indicate that esterase enzymes hydrolyze TBPH and TBB, where 
the substitution of a Br atom with a hydroxyl substituent might present a favourable site for 
conjugation.   
Few studies have detected TBPH, TBB, or TBCO in humans. TBPH and TBB were 
detected in 94 and 98% of hair samples, in 86 and 96% of fingernail samples, and 16 and 92% of 
serum samples, respectively, from participants from Indiana, U.S.225.  TBPH was also detected in 
50% of samples of feces from children in Sweden, though TBB was not detected226. Analysis of 
feces might be a useful tool to monitor exposure to TBPH as a large proportion of TBPH was 
excreted, unchanged via this matrix224. TBPH and TBB were detected in 17 and 57% of serum 
samples from nursing women in Quebec, Canada150. In this study, concentrations of TBPH and 
TBB in serum were of similar magnitude to components of the Penta-BDE mixture, BDE-153.  
Further, the fraction of TBB of total FM-550 components in serum was significantly less than in 
dust, which might be due to the relatively rapid metabolism of TBB compared to TBPH78.  
TBPH was detected in a single sample of serum of residents of Laizhou Bay, China which was 
within 10 km of a production site of halogenated flame retardants227.  The concentration of 
TBPH was approximately double the maximum concentration detected from residents of 
Quebec, Canada.  TBPH and TBB were not detected in serum from paired mothers and toddlers 
from Uppsala, Sweden, and babies from North Carolina, U.S.228, 229.  Non-detection of these 
compounds might have been due to patterns of NBFR use in Europe or the period in which 
samples were collected (U.S. samples, 2008 to 2010).  We were not aware of any study which 
has attempted to quantify TBCO in samples from humans. TBPH and TBB have been detected in 
serum from humans and though investigations of their toxicokinetics have shown they are 
generally not accumulated at great quantities, due to their known endocrine disrupting effects 
and continual exposure, they might represent risk to human health. Thus further studies to 
monitor potential increases in serum concentrations, and assess differences across geographic 
populations and between age-groups, would be beneficial.   
Numerous studies have suggested that the ingestion of dust is the most important route of 
exposure for children, as higher serum concentrations of BFRs have been reported in children 
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compared to adults216, 217, 221, 228.  Concentrations of BFRs measured on hand-wipes and indoor 
dust were the strongest predictors of concentrations of PBDEs in blood in North America73.  This 
trend regarding greater body burdens of BFRs in children has also been observed with NBFRs, 
including TBB. Recently, a metabolite of TBB (TBBA), was quantified in urine and was 
strongly associated with concentrations of TBB measured in hand-wipes160.  A subsequent study 
of paired children and adults showed that TBBA was detected in 70% of children, though only 
27% of adults169.  Further, applications and environmental concentrations of TBPH and TBB are 
likely increasing which might lead to greater exposures for humans230. These are important 
findings as studies in this thesis (Chapters 5 and 6) have detected some of the greatest 
concentrations of TBPH and TBB in indoor dust globally and have characterized the novel flame 
retardants OH-TBPHs and OH-TBBs.  Studies from Chapter 6 also demonstrated the potential 
for increased concentrations of these NBFRs in microenvironments with greater quantities of 
children’s products.  Due to the importance of dust as a route of exposure, these relatively high 
concentrations of NBFRs might indicate that children in ECEs from Saskatoon, Canada are at 
greater risk of exposure.    
7.4 Assessment of risk of TBPH and TBB 
This thesis attempted to characterize the endocrine disrupting effects of TBPH, TBB, and TBCO 
and investigated concentrations of these compounds in early childhood environments.  Though 
the compounds elicited endocrine disrupting effects in several assay systems and were detected 
at great quantities in indoor dust from ECEs, there has been little analysis of potential risk to 
children.  As such, an abbreviated assessment of risk which focused on children was conducted. 
This assessment integrated data generated in the thesis with important information from the 
literature.   
The assessment of exposure focused exclusively on contaminated indoor dust from ECEs.  
Mean concentrations of TBPH, TBB, OH-TBBs, and OH-TBPHs in dust from ECEs reported in 
Chapters 5 and 6, were used.  Exposure of children to NBFRs was assessed by use of equations 
7.1 and 7.2 
ADDpot = (C x IR x AF x EF)/BM……………………………...……………………………...(7.1) 
156 
 
Where, ADDpot = potential average daily dose (mg/kg-day), C = average contaminant 
concentration in dust (mg/g), IR = intake rate of dust (mg/day), AF = bioaccessibility factor, EF 
= exposure factor, and BM = body mass (kg).  The exposure factor represented the intermittent 
basis on which children were exposed to dust from early childhood environments as it accounted 
for time spent in these environments. The EF was calculated by use of equation 7.2, 
EF = (F x ED)/AT..……………………………………………………………………………(7.2) 
Where, F = frequency of exposure (hrs/day), ED = exposure duration (1-day), and AT = 
averaging time (24 hrs).  Rate of intake from dust was derived from U.S. EPA guidelines of the 
upper percentile of the general population, aged 1-6 yrs69, and mass of children was derived from 
the European Food Safety Authority231.  Bioaccessibility factors were those derived for TBPH, 
TBB, OH-TBBs, and OH-TBPHs in dust from ECEs, presented in Chapter 6.  Frequency of 
exposure represented time spent in childcare during a typical work day in Saskatchewan (9 hrs), 
while exposure duration represented a single day.   
 The exposure assessment used maximum concentrations in dust from ECEs and 
maximum values for variables of exposure (ingestion and bioaccessibility) to constitute a highly 
conservative scenario.  Daily exposures to TBPH, TBB, OH-TBBs, and OH-TBPHs were 
calculated as 5.28x10-4, 1.64x10-3, 6.56x10-7, and 3.75x10-8 mg/kg bm, per day, respectively, 
while exposures assuming 100% bioaccessibility were 2.2910-3, 3.10x10-3, 9.38x10-7, and 
1.30x10-7 mg/kg bm, per day. The assessment of exposure to compounds with limited 
bioaccessibility including TBPH and OH-TBPHs were significantly increased (order of 
magnitude) when 100% bioaccessibility was assumed.  These results demonstrated the 
significance of integration of accurate estimates of bioaccessibility in assessments of risk. A 
similar assessment could not be completed for TBCO as there have been no studies which have 
detected the compound in indoor dust.    
Assessment of risk is the process of estimating the magnitude and probability of adverse 
impacts based on assessments of exposure and effects232.  Risk characterization is generally an 
iterative process which used a weight-of-evidence approach to aggregate multiple lines of 
evidence of toxicity and exposure including concentration of the contaminant, duration of 
exposure, and severity of response, though an abbreviated process was used in this thesis.  To 
complete the assessment of risk, further information regarding hazards of NBFRs was required.  
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Most in vivo assessments of toxicity of TBPH and TBB exposed test organisms to the technical 
mixtures FM-550 or BZ-54.  As these mixtures contained flame retardants in addition to TBPH 
and TBB, information from these studies could not be used in this exercise.  Further, no 
reference doses were readily available for TBPH or TBB.  Though it represented a 
pharmacological study of a mixture of TBPH and TBB, toxicity data from Chapter 3 was used in 
this assessment as it was the only available information derived from an in vivo study of these 
compounds.  The lowest observed adverse effect level (LOAEL) which altered fecundity and 
profiles of transcripts of the HPGL-axis were 1422 mg/kg and 1474 mg/kg for TBPH and TBB, 
respectively.  There have been several recent commentaries regarding the use of NOAELs and 
LOAELs in risk assessment, and this scenario was an excellent example for such critiques. Due 
to the abbreviated form of this assessment, a simple hazard quotient (HQ) was used to estimate 
risk of TBPH and TBB to children.  A hazard quotient is a mathematical function which 
integrates an environmental concentration (EC), in this instance, the calculated concentrations of 
exposure of NBFRs to children and a toxicological benchmark concentration such as a LOAEL.  
If the HQ was ≥ 1, then an effect was expected to occur.  Hazard quotients were calculated by 
use of equation 7.3, 
HQ =EC/LOAEL…………………………..……………………………………………...…...(7.3)                                                                               
The HQs of TBPH and TBB were 3.71x10-7 and 1.12x10-6, respectively, while HQs where 100% 
bioaccessibility was assumed were 1.61x10--6 and 2.10x10-6.  From this simple assessment of risk 
it was calculated that exposure to NBFRs at concentrations detected in dust from ECEs in 
Saskatoon, Canada would not elicit endocrine disrupting effects in children. This assessment 
represented the worst-case-scenario for exposure of children to these NBFRs, but due to limited 
information regarding toxicities, was likely not representative of actual risk.  Thus, the calculated 
HQ could be referenced as guidance, but could not inform decisions regarding use of these 
compounds.   
7.5 Future work 
The research presented in this thesis generated important information regarding the NBFRs, 
TBPH, TBB, and TBCO.  However, this research also provided a foundation for several areas of 
further study:  
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1) Endocrine disrupting effects of TBPH and TBB manifested in the integrative measurement of 
fecundity, and though a global pattern of alterations to transcript abundances was discovered, the 
mechanisms of effect were not apparent130, 172. Targeted research which integrated time point 
information from gene analysis, quantification of hormones, and gonad/brain histology would 
generate information required to ascertain mechanisms of action. Further, these mechanisms 
could be analyzed through the adverse outcome pathway organizational framework to determine 
organismal or population level effects of these compounds.  
2) Novel hydroxylated isomers of TBPH and TBB were characterized in Chapter 5 and their 
concentrations in ECEs and bioaccessibilities were assessed in Chapter 6.  It was noted that the 
ratio of OH-TBPHs or OH-TBBs to TBPH or TBB in indoor dust was significantly less than in 
the technical mixtures163, 164.  This was likely due to differences in physical-chemical 
characteristics which affected environmental fates and emissions of the compounds.  Emissions 
of OH-isomers could be investigated by use of mass migration test chambers which analyze 
concentrations of compounds in the gaseous and particle phases185 and by experiments of 
mechanical abrasion which use X-ray fluorescence imaging coupled to mass spectrometry233.  
These studies would determine if differences in ratios were due to differences in emission 
pathways. 
3) The OH-isomers have the potential for greater potency of toxic effects, as observed with 
hydroxylated PBDEs161.  An initial assessment of OH-TBB indicated that the compound was a 
strong agonist of the PPARγ164 and showed that the OH-isomers elicited toxicities not observed 
from exposures to TBPH or TBB. Differences in potencies of effects might have been due to 
structural similarities to endogenous compounds including E2, T3, or thyroxine and/or greater 
binding affinities with receptors or transport proteins162.  Characterization of toxic effects and 
potencies of these potential endocrine disrupting compounds is required. OH-TBPHs and OH-
TBBs should be initially assessed by a range of in vitro assays which test for receptor moderated 
(ER/AR/TR) and hormone modulating effects. Following positive results, the compounds should 
be further assessed by use of in vivo assay systems.    
4) Further research into the toxicity, toxicokinetics and environmental behaviour of TBCO is 
required. TBCO is structurally similar to HBCD, which has several diastereoisomers that might 
be differentially metabolized in biota and transformed in the environment.  For example, 
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technical formulations of HBCD consist primarily of the γ-isomer, though α-HBCD is the 
predominant isomer detected in biota and might have a greater potency of toxic effect234, 235. 
Diastereoisomers of TBCO might behave similarly in the environment and biota, thus it is 
important to characterize bioaccumulation and metabolism, environmental fate, and potencies of 
toxic effects across isomers.  
5) Following the in vivo study presented in Chapter 4, significant maternal transfer of TBCO to 
eggs of exposed fish was detected.  TBCO is an endocrine disruptor and has previously altered 
expression of genes associated with oocyte meiosis209. Thus, exposure during early life stages 
resulting from maternal transfer might cause deleterious effects on normal development and 
reproductive function.  Due to the short time to sexual maturity of small fish, the assessment of 
developmental toxicities from maternal exposures to TBCO could be investigated.  Analysis of 
endocrine and reproductive function during early life stages and sexual maturity of fish exposed 
via maternal deposition of TBCO could expose potential developmental toxicities and persistent 
effects.  Additionally, continuous breeding of subsequent generations with/out exposure to 
TBCO could function as a method to investigate potential multigenerational or transgenerational 
effects of TBCO. 
7.6 Final thoughts  
Since the initiation of this PhD program, TBPH was listed as a high production volume chemical 
by the U.S. EPA, and both TBPH and TBB have been detected almost ubiquitously in the 
environment. In fact, recent studies from the IADN have shown that atmospheric concentrations 
of TBPH and TBB have continued to increase since previous assessments230. TBCO has been 
detected in the environment.  TBCO was detected in marine animals in the San Francisco Bay 
area, and in sediments and fish in the North Sea, and is the focus of investigation of research 
groups in Illinois, U.S.236.  Additionally, TBPH, TBB and their metabolites have been detected in 
serum and other biological matrices of humans.  It has also been highlighted that brominated 
flame retardants, at the concentrations applied to consumer products and scenarios in which PUF 
would ignite, might not be effective at reducing flammability.  Further, incidences of fires in the 
U.S. have decreased by 22% from 2004 and incidence of death has decreased by 21%237.  These 
insights into the effectiveness of BFRs and incidences of fires demand the reassessment of the 
use of these compounds – is the use of brominated flame retardants beneficial or harmful to 
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humans and the environment?  The recent amendments to TB 117 have highlighted these 
questions as changes to this standard have the potential to significantly alter use of these 
compounds and subsequent exposure to BFRs and NBFRs in North America.   
Work presented in this thesis was some of the first to investigate potential toxicities of 
these novel brominated flame retardants. These investigations have helped to confirm their 
endocrine disrupting effects, identified novel compounds which had not been previously 
characterized, and created information regarding factors which affected concentrations in dust 
from ECEs and bioavailability.  This work will help to inform more accurate assessments of risk 
and regulations regarding these compounds.  
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APPENDIX1 
 
 
 
 
 
 
 
1 Supplementary data are included in this chapter. The figure or table number is presented as 
Cx.Sy, format, where ‘Cx’ indicates chapter number; ‘Sy’ indicates figure or table number. 
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Table C2.S1 Physical-chemical properties of 2-ethylhexyl-2,3,4,5-tetrabromobenzoate (TBB),  
Bis(2-ethylhexyl)-2,3,4,5-tetrabromophtalate (TBPH), and 1,2,5,6-tetrabromocyclooctane 
(TBCO) 
 TBPH TBB TBCO 
Molecular Weight  706.15 549.93 427.80 
Solubility (mg/L) 1.98 x 10-9 b 1.14 x 10-5 c 0.06915b 
Log KOW 11.95
a 8.8c 5.24a 
a Estimated from: KowWIN v1.68 (U.S. EPA) 
b Estimated from: WSKow v1.42  (U.S. EPA) 
c Bearr et al., 2010.29 
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Figure C2.S1.  The control for recovery of signal activity of (A) TBB at 5x10-01 mg/L, (B) 
TBPH at 1000 mg/L, and (C) TBCO at 300 mg/L measured by the yeast androgen screen (YAS).  
A baseline agonist (DHT) concentration of 1.45x 10-3 mg/L was added to each well with 
increasing concentrations added to demonstrate the recovery of signal activity.  Activity is 
presented as mean± SE.  Each assay contained four wells per NBFR exposure concentration.  
Exposures that resulted in effects that were significantly different than inhibition controls 
(agonist + NBFR) are indicated by asterisks (*p<0.05).    
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Figure C2.S2.  The control for recovery of signal activity of (A) TBB at 5x10-01 mg/L, (B) 
TBPH at 0.03 mg/L, and (C) TBCO at 30 mg/L measured by the yeast estrogen screen (YES).  A 
baseline agonist (E2) concentration of 8.17x 10-4 mg/L was added to each well with increasing 
concentrations added to demonstrate the recovery of signal activity.  Activity is presented as 
mean± SE.  Each assay contained four wells per NBFR exposure concentration.  Exposures that 
resulted in effects that were significantly different than inhibition controls (agonist + NBFR) are 
indicated by asterisks (*p<0.05).    
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Table C3.S1. Target gene, primer sequence, and efficiency of 35 genes across the HPGL axis of 
Japanese medaka. 
Target gene Primer sequence (5' - 3') 
Forward                                                    Reverse 
Efficiency 
(%) 
ERα CGGACCAGCACTCAGATCCA CAGGGGAGCAGAGTAGTAGC 110 
ERβ GCTGGAGGTGCTGATGATGG CGAAGCCCTGGACACAACTG 110 
ARα ACCTGGCTCACTTCGGACAC TCTGACGCCGTACTGCTCTG 98 
Neuropep Y CTTCCACAGTCAAGTTACAAC TGATCTGCAAGGACGAATG 95 
cGnRH II TGTCTCGGCTGGTTCTAC GAGTCTAGCTCCCTCTTCC 95 
mfGnRH GTGTCGCAGCTCTGTGTTC GTGTCGCAGCTCTGTGTTC 105 
sGnRH GATGATGGGCACAGGAAGAGT GGGCACTTGCATCTTCAGGA 106 
GnRH RI CTGCGCTGCTCAAAGAACAA GTGGAAGCGAGTGGTGAAGA 104 
GnRH RII GCAGCGGCACAGACATCATC GGACAGCACAATGACCACAGA 100 
GnRH RIII ACTTCCAGAGGAGCCAGTTGAG GCCAGCCAAGAGTCGTTGTC 110 
GTHa GCAGAACGGAGGGATGAAGGA ATTGGAGTAGGTGTCGGCTGTG 104 
LH- β GCCAGCCAGTCAAGCAGAAG GCCAGCCAGTCAAGCAGAAG 90 
CYP19B TCCTGATAACCCTGCTGTCTCG TCCTGATAACCCTGCTGTCTCG 106 
FSHR TTCAGGCCACTGATGATGTTAT CCTTCGTGGGTTCCAGTGAGT 96 
LHR GTCCTGGTCATCCTGCTCGTT AACCGGGAGATGGTCAGTTTGT 98 
HDLR TCTGCCGAACTGTCACTGTC CCACCTGGTCGTCGATGATG 109 
LDLR GTGCTACGAAGGCTACGAGAT AGGTCAATGCGGCGGATTTC 108 
HMGR CCAGCTCGCAGGATGAAGT GTAGTTGGCCAGCACAGACA 108 
StAR TGACAGGTTTGAGAAAGAATG CAATGCGAGAACTTAGAAGG 96 
CYP11A GCTGCATCCAGAACATCTATCG GACAGCTTGTCCAACATCAGGA 108 
CYP17 CGACCACCACCGTACTCAAA CACATGGGGGATGAGCAGAG 102 
CYP19A CTCTTCCTGGGTGTTCCTGTTG GCTGCTGTCTTGTGCCTCTG 89 
20β-HSD TGATCTTGGCTCGTCGTCTG CACGGCTGGACTTCCTTCTC 100 
3β-HSD GGGCGGGACGAAACTCAG GGAGGCGGTGTGGAAGAC 110 
Inhibin A CGTTTCCCTTCCAGCCTTC AAGAGCGTTGCGGATGAG 109 
Activin BA GATGGTGGAAGCAGTGAAG TTCTTGATGGCGTTGAGTAG 110 
Activin BB GGCTAATCGGCTGGAATG CATGCGGTACTGGTTCAC 104 
VTG I ACTCTGCTGCTGTGGCTGTAG AAGGCGTGGGAGAGGAAAGTC 101 
VTG II TCGCCGCAAGAGCAAGAC CTGGAGGAGCTGGAAGAACTG 99 
CHG H TGGCAAGGCACTGGAGTATCAC CTGAGGCTTCGGCTGTGGATAG 95 
CHG HM GGAGCCATTACCAGGGACAG AAGTTCCACACGCAAGATTCC 98 
CHG L TCCTGTCTCTGACTCTGAATGG GCTTGGCTCGTCCTCACC 105 
CYP3A GAGATAGACGCCACCTTCC ACCTCCACAGTTGCCTTG 99 
Annexin 
max2 
CTGATCGTGGCTCTGATGAC CTGCTGAGGTGTTCTGGAAG 96 
RPL-7 GTCGCCTCCCTCCACAAAG AACTTCAAGCCTGCCAACAAC 94 
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Table C3.S2. Toxicant-induced effects on medaka gonadal-somatic index (GSI) and hepatic-
somatic index (HSI). GSI and HSI are presented as mean ± standard error. 
Treatment Female  Male 
 GSI HSI  HSI 
Control 15.7±1.89 2.72±0.20  2.44±0.38 
924 µg/g food 18.1±3.27 4.87±1.00  3.69±0.29 
85 µg/g food 19.7±3.44 3.52±0.36  2.63±0.50 
n = 4, *p-Value < 0.05 
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Figure C3.S1. Profile analysis of daily fecundity of (A) solvent control vs. the greatest dose of 
the TBPH/TBB mixture and (B) solvent control vs. the low dose of the TBPH/TBB mixture. The 
experiment included 4 replicate tanks, and each contained 8 female fish.  The profile 
(parallelism) of TBPH/TBB high was statistically different than solvent control.  Significant 
differences of parallelism were set at p < 0.05.   
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Figure C3.S2. Within-group repeated measures analysis of variance of (A) daily egg production 
and (B) pooled time-points of fish exposed to the greatest dose of the TBPH/TBB mixture. Time-
points were pooled to preserve significant differences after Bonferroni adjustments.  Asterisks 
indicate significant differences (p < 0.05) when compared to 100% fecundity (group 1).   
Significant within-group main effects were also observed in daily egg production. 
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Table C4.S1 Target gene, primer sequence and efficiency of 35 genes across the HPGL axis of 
Japanese medaka. 
Target gene Primer sequence (5' - 3') 
Forward                                              Reverse 
Efficiency 
(%) 
ERα CGGACCAGCACTCAGATCCA CAGGGGAGCAGAGTAGTAGC 110 
ERβ GCTGGAGGTGCTGATGATGG CGAAGCCCTGGACACAACTG 110 
ARα ACCTGGCTCACTTCGGACAC TCTGACGCCGTACTGCTCTG 98 
Neuropep Y CTTCCACAGTCAAGTTACAAC TGATCTGCAAGGACGAATG 95 
cGnRH II TGTCTCGGCTGGTTCTAC GAGTCTAGCTCCCTCTTCC 95 
mfGnRH GTGTCGCAGCTCTGTGTTC GTGTCGCAGCTCTGTGTTC 105 
sGnRH GATGATGGGCACAGGAAGAGT GGGCACTTGCATCTTCAGGA 106 
GnRH RI CTGCGCTGCTCAAAGAACAA GTGGAAGCGAGTGGTGAAGA 104 
GnRH RII GCAGCGGCACAGACATCATC GGACAGCACAATGACCACAGA 100 
GnRH RIII ACTTCCAGAGGAGCCAGTTGAG GCCAGCCAAGAGTCGTTGTC 110 
GTHa GCAGAACGGAGGGATGAAGGA ATTGGAGTAGGTGTCGGCTGTG 104 
LH- β GCCAGCCAGTCAAGCAGAAG GCCAGCCAGTCAAGCAGAAG 90 
CYP19B TCCTGATAACCCTGCTGTCTCG TCCTGATAACCCTGCTGTCTCG 106 
FSHR TTCAGGCCACTGATGATGTTAT CCTTCGTGGGTTCCAGTGAGT 96 
LHR GTCCTGGTCATCCTGCTCGTT AACCGGGAGATGGTCAGTTTGT 98 
HDLR TCTGCCGAACTGTCACTGTC CCACCTGGTCGTCGATGATG 109 
LDLR GTGCTACGAAGGCTACGAGAT AGGTCAATGCGGCGGATTTC 108 
HMGR CCAGCTCGCAGGATGAAGT GTAGTTGGCCAGCACAGACA 108 
StAR TGACAGGTTTGAGAAAGAATG CAATGCGAGAACTTAGAAGG 96 
CYP11A GCTGCATCCAGAACATCTATCG GACAGCTTGTCCAACATCAGGA 108 
CYP17 CGACCACCACCGTACTCAAA CACATGGGGGATGAGCAGAG 102 
CYP19A CTCTTCCTGGGTGTTCCTGTTG GCTGCTGTCTTGTGCCTCTG 89 
20β-HSD TGATCTTGGCTCGTCGTCTG CACGGCTGGACTTCCTTCTC 100 
3β-HSD GGGCGGGACGAAACTCAG GGAGGCGGTGTGGAAGAC 110 
Inhibin A CGTTTCCCTTCCAGCCTTC AAGAGCGTTGCGGATGAG 109 
Activin BA GATGGTGGAAGCAGTGAAG TTCTTGATGGCGTTGAGTAG 110 
Activin BB GGCTAATCGGCTGGAATG CATGCGGTACTGGTTCAC 104 
VTG I ACTCTGCTGCTGTGGCTGTAG AAGGCGTGGGAGAGGAAAGTC 101 
VTG II TCGCCGCAAGAGCAAGAC CTGGAGGAGCTGGAAGAACTG 99 
CHG H TGGCAAGGCACTGGAGTATCAC CTGAGGCTTCGGCTGTGGATAG 95 
CHG HM GGAGCCATTACCAGGGACAG AAGTTCCACACGCAAGATTCC 98 
CHG L TCCTGTCTCTGACTCTGAATGG GCTTGGCTCGTCCTCACC 105 
CYP3A GAGATAGACGCCACCTTCC ACCTCCACAGTTGCCTTG 99 
Annexin 
max2 
CTGATCGTGGCTCTGATGAC CTGCTGAGGTGTTCTGGAAG 96 
RPL-7 GTCGCCTCCCTCCACAAAG AACTTCAAGCCTGCCAACAAC 94 
 
 
192 
 
 
 
 
 
 
 
 
 
Table C4.S2. Toxicant-induced effects on medaka gonadal-somatic index (GSI) and hepatic-
somatic index (HSI). GSI and HIS are presented as mean ± standard error. 
Treatment Female  Male 
 GSI HSI  HSI 
Control 15.69 ± 1.89 2.72 ± 0.20  2.44 ± 0.38 
607 µg/g 15.11 ± 1.84 3.57 ± 0.43  2.56 ± 0.25 
58 µg/g 12.97 ± 1.34 3.77 ± 0.84  1.95 ± 0.13 
n = 4, *p < 0.05 
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Figure C4.S1 Profile analysis of daily fecundity of (A) solvent control vs. the high dose of 
TBCO and (B) solvent control vs. the low dose of TBCO. The experiment included 4 replicate 
tanks, and each contained 8 female fish.  The profile (parallelism) of TBCO low was statistically 
different than solvent control.  Significant differences of parallelism were set at p < 0.05.   
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Figure C4.S2. Within-group repeated measures analysis of variance of (A) daily deposition of 
eggs and (B) pooled time-points of fish exposed to the lesser concentration of TBCO. Time-
points were pooled to preserve significant differences after Bonferroni adjustments.  Asterisks 
indicate significant differences (p < 0.05) when compared to 100% fecundity (group 1).   
Significant within-group main effects were also observed in daily egg production. 
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Figure C5.S1. Chromatogram of extracted ions with m/z 640.9946 (10 ppm window) in negative 
ion mode for commercial standard using pure methanol as mobile phase. 
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Figure C5.S2. Chromatogram of extracted ions with m/z 640.9946 (10 ppm window) in negative 
ion mode for highly purified standard (AccuStandard, Connecticut, U.S.). 
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Figure C5.S3 (A) Chromatogram of extracted ions with m/z 666.9861 (10 ppm window) in 
positive ion mode for BZ-54 standard. (B) Mass spectra of OH-TBPH in positive ion mode with 
mass error of 0.75 ppm to sodium adduct. 
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Figure C5.S4. Ultra-High Resolution LC/mass spectrometry (above) and 1H NMR (bottom) 
analysis of purified OH-TBPH standards. The impurity of TBPH was 100-fold lower than OH-
TBPH2 in purified standard. 
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Figure C5.S5. (A) TBPH was eluted in the first fraction from Florisil cartridges using DCM; (B) 
TBPH isomers were eluted in the third fraction from Florisil cartridges using a mixture of 
methanol:DCM (v/v, 1:1). 
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Figure C5.S6. Comparison of the SIM mode and full scan mode for OH-TBPH analysis in dust 
samples. (A) OH-TBPH isomers could not be detected under full scan mode when ions were 
extracted in a 10 ppm window. (B) Two OH-TBPH isomers were successfully detected using 
SIM mode when ions were extracted in a 10 ppm window. (C) TBPH was observed in full scan 
mode. (D) The total ion intensity in negative ion mode was much greater than those of OH-
TBPH at the similar elution time. (E) Total ion intensity in positive ion mode and comparison to 
TBPH intensity. 
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Table C6.S1. Ionization sources, ions, and instrumental detection limits for the analysis of 
TBPH, TBB, and their OH-isomers. 
 ESI  APCI 
 Ion mode m/z IDLa  Ion Mode m/z IDLa 
TBPH Positive 723.9486 0.01  - - - 
OH-TBPHs Negative 640.9946 0.005  - - - 
TBB - - -  Negative 484.8789 0.83 
OH-TBBs Negative 484.8789 0.008  - - - 
aInstrumental detection limit (ug/L). IDLs have been reported in our previous articles163, 164. 
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Figure C6.S1. Schematic depicting (A) a pre-loaded Tenax incubation envelope, and (B) Tenax 
loaded (sealed) incubation envelopes. 
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Figure C6.S2. Recovery of Tenax and dust (NIST) following incubation in CE-PBET (n=6).  
Error bars represent standard deviation. 
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Figure C6.S3. Distribution of TBPH, TBB or their OH-isomers in gastro-intestinal fluid, Tenax, 
colon fluid, and dust.  
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Table C6.S2. Measurements of bioaccessibility for TBPH, TBB and their OH-isomers in 
dust samples (DS) (n = 14). 
  TBPH ƩOH-TBPHs TBB ƩOH-TBBs 
S
u
m
m
er
 
DS-1 22% 26% 44% 84% 
DS-2 39% 9% 33% 34% 
DS-3 32% 45% 56% 86% 
DS-4 15% 43% 67% 71% 
DS-5 8% 21% 61% 66% 
DS-6 11% 12% 53% 78% 
DS-7 23% 11% 60% 67% 
      
W
in
te
r 
DS-8 25% 35% 70% 81% 
DS-9 9% 40% 74% 71% 
DS-10 43% 55% 19% 35% 
DS-11 22% 21% 25% 47% 
DS-12 13% 11% 72% 69% 
DS-13 34% 18% 32% 66% 
DS-14 19% 32% 61% 85% 
 DS-1 to DS-7 were collected in summer, 2013 and DS-8 to DS-14 were collected 
in winter, 2014. 
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Figure C6.S4. Log transformed concentration of TBPH in higher traffic-higher toy 
environments (HT-HT), lower traffic-lower toy environments (LT-LT), and higher traffic-lower 
toy environments (HT-LT). Dust was collected from each of these environments in ten daycares 
across Saskatoon, SK, Canada in summer (A), and winter (B).  
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Figure C6.S5. Log transformed concentration of TBB in higher traffic-higher toy environments 
(HT-HT), lower traffic-lower toy environments (LT-LT), and higher traffic-lower toy 
environments (HT-LT). Dust was collected from each of these environments in ten daycares 
across Saskatoon, SK, Canada in summer (A), and winter (B). 
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Figure C6.S6. Log transformed concentration of OH-TBPH1 (A,B) and OH-TBPH2 (C,D) in 
higher traffic-higher toy environments (HT-HT), lower traffic-lower toy environments(LT-LT), 
and higher traffic-lower toy environments (HT-LT). Dust was collected from each of these 
environments in ten daycares across Saskatoon, SK, Canada in summer (A,C), and winter (B,D). 
 
 
 
 
 
 
209 
 
 
 
 
 
Figure C6.S7. Log transformed concentration of and ƩOH-TBB1/2/3 in higher traffic-higher toy 
environments (HT-HT), lower traffic-lower toy environments (LT-LT), and higher traffic-lower 
toy environments (HT-LT). Dust was collected from each of these environments in ten daycares 
across Saskatoon, SK, Canada in summer (A), and winter (B). 
 
